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Abstract 
This thesis is an experimental investigation on the binding of self-assembling peptides to 
oligodeoxynucleotides (ODNs) and the characterization of the resulting peptide-ODN 
complexes/aggregates, the first key step in the development of a peptide-based gene delivery system. 
Effects of pH, charge distribution along the peptide backbone, and oligonucleotide sequences on the 
peptide-ODN binding were investigated by a series of physicochemical methods.  
UV-Vis absorption and fluorescence anisotropy experiments demonstrate that aggregates are 
formed after mixing the peptide and ODN in aqueous solution. The aggregates in solution can be 
centrifuged out. Based on this property, the fraction of ODNs incorporated in the peptide-ODN 
aggregates can be obtained by comparing the UV-Vis absorption of the solution before and after 
centrifugation. Binding isotherms are generated by a binding density function analysis of the UV 
absorbance results. The binding parameters are extracted from the analysis of the binding isotherms 
based on the McGhee and von Hippel model.  
Equilibrium binding parameter studies show that the binding of two self-assembling peptides,  
EAK16-II and EAK 16-IV, to model single and double-stranded ODNs at pH 4 is stronger than at pH 
7, and that no binding occurs at pH 11. These results demonstrate that electrostatic interactions play 
an important role in the EAK-ODN binding because EAKs are more positively charged at low pH. 
EAKs bind more strongly to dG16 than to the other ODN sequences dC16 and dGC16. This 
demonstrates that the hydrogen bond might be involved because they promote the binding of the 
lysine residues of the peptide to dG16 to a greater extent than to dC16. The charge distribution along 
the peptides is found to have an effect on the binding. EAK16-IV, whose positively charged residues 
are clustered at one end of the peptide, binds to the ODNs more strongly than EAK16-II, whose 
positively charged residues are distributed throughout the peptide chain, at the same pH. 
The binding process of EAKs to the ODNs was investigated by fluorescence anisotropy and 
static light scattering experiments. The results show that individual EAK and ODN molecules 
complex first, followed by the aggregation of these complexes into large aggregates. The nature of the 
resulting peptide-ODN complexes/aggregates is examined by UV-Vis absorption, fluorescence 
anisotropy, and PAGE experiments. The results demonstrate that free EAK, free ODNs, and small 
EAK-ODN complexes, which can not be centrifuged out, exist in the supernatant, and that large 
aggregates are collected in the pellets after centrifugation of the solution. The size of the resulting 
EAK-ODN complexes/aggregates measured by AFM and DLS is around a few hundreds of 
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nanometers at low EAK concentrations. The accessibility of the ODNs to the quencher in the solution 
is reduced by 40 % and 60 % after binding to EAK16-II and EAK16-IV, respectively, as determined 
by fluorescence quenching experiments on EAK-ODN mixture solutions.  
An ODN protection from Exonuclease 1 degradation is provided by the EAK16-II or EAK16-
IV matrix when they are mixed with the ODNs at pH 4. However, the ODNs are protected to a much 
lower degree when the EAK-ODN aggregates are prepared at pH 7. The EAK-ODN aggregates 
prepared at pH 7 are found to dissociate more easily than those prepared at pH 4 when they are 
incubated with exonuclease I solution at pH 9.5. These results suggest that the ODN protection 
afforded by the EAK-ODN aggregates is correlated with their structural stability after being incubated 
with the nuclease solution. The stability of the EAK-ODN aggregates after dilution is determined by 
UV-Vis absorption. No detectable dissociation of the aggregates is observed over 20 hrs after a 5- and 
10-fold dilution of the solution in the same buffer used for their preparation. The EAK-ODN 
aggregates remain stable after the solutions are centrifuged, and re-dissolved in fresh buffer solutions.  
The ability of an EAK matix to protect ODNs from nuclease degradation together with its 
biocompatibility and low-toxicity suggests that EAK self-assembling peptides could be used as 
carriers for gene delivery. 
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Self-assembling peptides have recently drawn intense attention because they can be designed and 
engineered to provide considerable potential for a number of applications in bionanotechnology. A 
new class of self-assembling peptides, ionic-complementary peptides, was serendipitously discovered 
from a Z-DNA binding protein in yeast a decade ago by Shuguang Zhang (Zhang, et al., 1993). This 
class of short peptides was found to spontaneously form a membrane-like structure when added into 
cell cultures at neutral pH. This observation led to the strategy of using small peptides to construct 
functional supramolecules.  
The molecular structure of these peptides is characterized by alternating hydrophobic and 
hydrophilic amino acid residues, which contain alternating positive and negative charges, enabling 
ionic-complementarity. The ionic complementarity, together with hydrogen bonding and hydrophobic 
interactions, facilitates peptides to self-assemble into very stable nanostructures (Fung, et al., 2003; 
Hong, et al., 2003; Chen, 2005). In addition, these peptides elicit minimal cytotoxicity and immune 
responses and inflammation and are biocompatible (Zhang, 2002). The nano/microstructures 
constructed from the peptide self-assembly have found many biomedical applications including 
scaffolding for tissue engineering (Zhang, et al., 1995; Holmes, et al., 2002), serving as template for 
nanowire fabrication, and understanding of amyloid fibrillogenesis in protein misfolding diseases 
(Rochet and Lansbury, 2000; Lynn and Meredith, 2000; Yang, et al., 2006b). It has been shown 
recently that these peptides can stabilize hydrophobic pyrene microcrystals in aqueous solution and 
unload them into a model cell membrane mimic, egg phosphatidycholine (EPC) vesicle, in a 
controlled manner (Keyes-Bag, et al., 2004). The nanofibers formed from the self-assembly of some 
of these peptides have shown to be potentially excellent materials for controlled molecular release of 
various protein growth factors (Nagai, et al., 2006; Davis, et al., 2006; Lee and Hsieh, 2006). These 
studies show that self-assembling peptides may be promising candidates as carriers for delivering 
both hydrophobic and hydrophilic drugs. Our particular interest is the self-assembling peptide-
mediated delivery of antisense oligonucleotides.  
The major advantage of using self-assembling peptides for gene delivery is the flexibility of 
this method.  The composition of the final peptide-ODN complex can be modified in response to 
experimental results in vitro and in vivo to overcome some challenges in the delivery pathways. These 
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Chapter 1   
challenges include rapid nucleic acid degradation due to backbone instability and inefficient delivery 
of nucleic acids into the specific targeted cells (Smith, et al., 1998). By design, numerous functional 
characteristics including DNA binding and protecting sequences, receptor-based targeting sequences, 
peptides, cell penetrating sequences, fusogenic sequences with properties to release DNA from the 
endosomes, can be incorporated into the peptide sequence (Smith, et al., 1998). This design flexibility 
is important since there is little quantitative information about how efficiently the vector is processed 
through each stage of the complex processes of cellular uptake. 
The binding of the oligonucleotides (ODNs) to the peptides is the first key step in the 
formulation procedures for peptide-based DNA delivery systems (Plank, et al., 1999; Simeoni, et al., 
2003). The reasons are as follows. First, the stoichiometry of complexation may affect cellular uptake 
of the resulting complexes if the cationic peptides interact with the negatively charged phosphate 
backbone of nucleic acids through electronic interactions. Second, other physicochemical properties 
of the resulting peptide/ODN assemblies, such as size, morphology, together with surface 
characteristics, may affect where the ODN is being delivered in vivo and ultimately influence the 
ability of the delivery system to reach its target site. Consequently the choice of any new peptide 
candidate for a peptide-based ODN delivery system requires the characterization of the binding of the 
peptide to the ODNs and of the resulting peptide/ODN aggregates. 
While there has been no study of binding between self-assembling peptides and 
oligonucleotides, numerous techniques have been used to examine the interaction between proteins or 
small ligands and nucleic acids qualitatively and quantitatively (Sauer, 1991; Moss, 2001). 
Footprinting and cross-linking experiments (Nagaich, et al., 1997) have been used to elucidate the 
binding sites or the overall architecture of the complex between protein and DNA. For quantitative 
study, isothermal titration calorimetry (Singh, et al., 2006) and differential scanning calorimetry 
(Plotnikov, et al., 2004; Franco, et al., 2005) are the common methods to determine the equilibrium 
binding constant directly by measuring the heat evolved during the formation of the protein/DNA 
complexes. In most instances, quantitative information is obtained indirectly by monitoring the 
changes in a biological or spectroscopic property of either the ligands or the macromolecule resulting 
from the formation of complexes. These changes can be probed by techniques such as filter binding 
(Agou, 1999), electrophoresis mobility shift assay (Stierle, et al., 2003; Malonga, et al., 2006), 
surface plasmon resonance (Seimiya and Kurosawa, 1996) and fluorescence (Michel, et al., 2003; 
Endoh, et al., 2005). These methods require labeling of the ligand with a chromophore or radioactive 
isotope, or covalent immobilization of the ligand. Such labeling or immobilization of the ligand might 
affect their biochemical activity, resulting in an inaccurate binding isotherm. Nevertheless, these 
techniques are still routinely used to determine the concentrations of the free and bound species, and 
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generate binding isotherms to obtain the affinity and the stoichiometry of ligand-DNA binding. Other 
techniques, such as boundary sedimentation velocity (Jensen and von Hippel, 1977; Scott, et al., 
1999) and UV difference spectroscopy (Boraston, et al., 2000; Sitohy, et al., 2001), do not require 
labeling of the molecule of interest, although sensitivity will be enhanced by labeling (Galletto, et al., 
2003).  
The binding of self-assembling peptides to ODNs may cause changes in physicochemical or 
biological properties in the same way as other basic proteins and peptides do, which may be 
monitored by the above techniques. However, some unique characteristics are expected to be 
encountered when studying the self-assembling peptide-ODN interactions. Since these peptides can 
self-assemble into nanostructures over time, they may bind to the ODN molecules before or after self-
assembly occurs, which might result in some challenges in the binding study. The current work will 
develop a series of experiments to study the binding pathways and equilibrium binding parameters. In 
addition, due to the potential for self-assembly of the peptides into nanostructures, the ODNs may be 
surrounded by peptide nanostructures and thus be protected. As rapid degradation of the ODNs is one 
of the major challenges in the application of oligonucleotides as therapeutic agents (Smith, et al., 
1998), such protection ability is desired. In comparison to chemical modifications of the 
oligonucleotide phosphodiester backbone, which is time-consuming and costly (Ghosh, et al., 1993), 
binding of peptides to the ODNs may provide a simple and fast means to protect the ODNs.  
In this thesis, detailed binding study may suggest some control strategies for the formulation 
of appropriate peptide/ODN complexes, and thus have diverse impacts on the application of self-
assembling peptides in gene delivery. 
 
1.2 Research Objectives 
The research objectives of this study are: 
1) to obtain the equilibrium binding parameters of self-assembling peptides to oligonucleotides, 
understand the binding pathway, and characterize the physicochemical properties of the 
resulting peptide-ODN complexes/aggregates; 
2) to examine the effect of the pH and charge distribution of peptides on their binding to 
oligonucleotides; 
3) to study the nuclease resistance of the ODNs provided by the self-assembling peptide 
matrices, and examine the stability of the peptide-ODN aggregates. 
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1.3 Outline of Thesis 
This thesis consists of six chapters. The scope of each chapter is as follows: 
Chapter 1 briefly introduces the self-assembling peptides and their applications, and the 
importance of this study. The objectives and scope of this thesis are also given in this chapter. 
Chapter 2 reviews self-assembling peptides and their applications. It is followed by an 
introduction to the current techniques used to study the interactions between protein or peptide and 
nucleic acids.  
Chapter 3 describes a series of physicochemical techniques developed to investigate the 
complexation and aggregation of a self-assembling peptide, EAK16-II, with oligonucleotides at 
various pHs. 
Chapter 4 investigates the effect of the charge distribution along a self-assembling peptide on 
its binding to the ODNs. This was done by comparing the binding of EAK16-IV to the ODNs with 
that of EAK16-II studied in Chapter 3.   
Chapter 5 describes how oligonucleotides are protected against nuclease degradation by the 
self-assembling peptide matrices at different pHs. The stability of the peptide-ODN aggregates with 
dilution is also investigated. 
Finally, Chapter 6 summarises the main findings of this study, the contributions of this 
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2.1 Self-assembling Peptide Systems 
Synthetic self-assembling peptides are derived from segments of naturally occurring proteins or 
through molecular design. Their common feature is the capability of self-assembling in aqueous 
solution. Self-assembling peptides have recently emerged as one of the most promising biological 
materials because they can be designed and engineered to provide a broad range of applications, 
including modeling for fibrillogenesis, scaffolding for tissue repair and tissue engineering, drug 
delivery of molecular medicine and fabrication of nanowires (Zhang, 2002; Chen, 2005). Molecular 
self-assembly relies on chemical complementarity and structural compatibility. These fundamentals 
are key to the design of the molecular units required for the fabrication of functional macrostructures, 
which in turn permit the application of molecular self-assembly in bio-nanotechnology. A number of 
self-assembling peptides have been designed and developed (Table 2.1). 
 
2.1.1 Ionic-complementary Peptides 
Among the new self-assembling peptides is a class of ionic-complementary peptides, e.g., EAK made 
of glutamic acid (E), alanine (A), and lysine (K) residues, discovered from a Z-DNA binding protein 
in yeast a decade ago by Shuguang Zhang (Zhang, et al., 1993). Analysis of the Z-DNA binding 
protein revealed an unusual 16-amino-acid sequence with repetitive polar and nonpolar residues, 
EAK16. The observation that this short peptide formed a membrane-like structure when added into 
cell cultures led to the strategy of using small peptides to construct functional supramolecules. 
Detailed investigation into this peptide indicated that its ionic-complementarity might play an 
important role in its unusually stable self-assembly. This class of biological materials has shown 
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Table 2.1. The family of self-assembling peptide 
 
Name Charge distribution sequence (n→c) Type Structure 
DN1 +−: n-QQRFQWQFEQQ-c I α/β 
DN1-QF +−: n-QQRFQFQWQFEQQ-c I α/β 
DN1-2E +−: n-QQRFEWEFEQQ-c N/A α/β 
DN1-3O +−: n-QQOFOWOFQQQ-c N/A α/β 
A6D −: n-AAAAAAD-c N/A N/A 
V6D −: n-VVVVVVD-c N/A N/A 
RAD16-I +−+−+−+−: n-RADARADARADARADA-c I β 
RAD16-II ++−−++−−: n-RARADADARARADADA-c II β 
RAD16-IV ++++−−−−: n-RARARARADADADADA-c IV β 
DAR16-IV −−−−++++: n-ADADADADARARARAR-c IV α/β 
DAR16-IVT −−−−++++: n-DADADADARARARARA-c IV α/β 
DAR32-IV −−−−++++: n-(ADADADADARARARAR)2-c IV α/β 
RADA8-I +−+−: n-RADARADA-c I r.c 
RAD8-II ++−−: n-RARADADA-c II r.c 
RGDA16-I +−+−+−+−: n-RADARGDARADARGDA-c I r.c 
RAEA16-I +−+−+−+−: n-RAEARAEARAEARAEA-c I β 
RAEA8-I +−+−: n-RAEARAEA-c I r.c 
KADA16-I +−+−+−+−: n-KADAKADAKADAKADA-c I β 
KADA8-I +−+−: n-KADAKADA-c I r.c 
EAH8-II −−++: n-AEAEAHAH-c II r.c 
EFK16-II −−++−−++: n-FEFEFKFKFEFEFKFK-c II β 
EFK12-I −+−+−+: n-FEFKFEFKFEFK-c I β 
EFK8-I −+−+: n-FEFKFEFK-c I β 
ELK16-II −−++−−++: n-LELELKLKLELELKLK-c II β 
ELK8-II −−++: n-LELELKLK-c II β 
EAKA16-I +−+−+−+−: n-AEAKAEAKAEAKAEAK-c I β 
EAKA8-I −+−+: n-AEAKAEAK-c I r.c 
EAK16-II −−++−−++: n-AEAEAKAKAEAEAKAK-c II β 
EAK12-a ++−−++: n-AKAKAEAEAKAK-c II r.c 
EAK12-b +−−++: n-AKASAEAEAKAK-c N/A r.c 
EAK12-c +−−−++: n-AKAEAEAEAKAK-c N/A r.c 
EAK12-d −−−−++: n-AEAEAEAEAKAK-c IV/II α/β 
EAK8-II −−++: n-AEAEAKAK-c II r.c 
KAE16-IV ++++−−−−: n-KAKAKAKAEAEAEAEA-c IV β 
EAK16-IV −−−−++++: n-AEAEAEAEAKAKAKAK-c IV β 
KLD12-I +−+−+−: n-KLDLKLDLKLDL-c I β 
RADSC-14 +−+−: n-RADSRADSAAAAAC-c I Ν/Α 
RADSC-16 +−+−+−: n-RADSRADSRADSAAAC-c I N/A 
β: β-sheet; α: α-helix; r.c.: random coil; N/A: not applicable. Modified from Refs (Zhang, 2002; 
Chen, 2005). 
 
Ionic-complementary peptides are characterized by an alternating hydrophobic and 
hydrophilic amino acid residue. These peptides have been classified into several types. The 
classification is based on the hydrophilic surfaces of the molecules, which have alternating positively 
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and negatively charged amino acids alternating by one residue, two residues, and three residues and 
so on. The most simple and widely studied charge distribution of peptides are − + − + − + − +, − − + 
+ − − + +, and − − − − + + + + referred to as type I, type II, and type IV, respectively. These charge 
distributions can be repeated, or the orientation of these charges can be reversed to yield entirely 
different molecules. These well-defined sequences allow the peptides to undergo self-assembly 
because of their amphiphilicity and ordered charged residues. Self-assembly is driven by electrostatic 
interactions, hydrogen bonds, and/or van der Waals’ forces. Studies of a broad range of peptides have 
shown the importance of ionic complementarity in their self-assembly and applications in 
bionanotechnology.  
Hecht and his group performed a well controlled experiment using ionic-complementary 
peptides to understand the relationship between secondary structure and molecular structure (Xiong, 
et al., 1995). They designed four peptides: two of them made of L, E, and K residues possessed α-
helical intrinsic propensities, and the other two made of I, D, and R had non-α-helical intrinsic 
propensities. The two peptides with the same intrinsic propensities have different charge distributions: 
α-helical periodicity (− − + + − − + +) and β-strand periodicity (− + − +). With this design, they were 
able to determine that the secondary structure is dominated by periodicity, if the periodicity is 
different from the intrinsic propensity. This demonstrates the importance of charge distribution in 
determining the secondary structure of peptides. However, this is not always the case. An ionic-
complementary peptide EAK16 discovered in 1993 showed that the secondary structure detected was 
entirely different from that predicted by computer simulation (Pennisi, 1993). This surprising 
observation may be due to the unique molecular structure of this particular peptide. EAK16 is an 
amphiphilic peptide containing alternative hydrophobic and hydrophilic amino acid residues (Figure 
2.1). Different from the surfactant-like molecules, EAK16 self-assembles into β-sheets conformation 
(Figure 2.2) and further forms stable membrane-like structures upon addition of salts to the solution. 
The amphiphilic character together with the ionic complementarity contributes to the stable 
macrostructure formation. The resulting membranes can withstand high temperatures of up to 90 °C 
for more than 4 h in 1 % sodium dodecyl sulfate (SDS) solution. They are also resistant to digestion 
with several proteases, including trypsin, α-chymotrypsin, papain, and protease K. 
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Figure 2.1. (A) Chemical structure of an ionic-complementary self-assembling peptide-EAK16-II. It 
contains alternating hydrophobic (A) and hydrophilic (E and K) residues, which generates a unique 
amphiphilic structure with a hydrophobic region on one side and a hydrophilic one on the other. The 
charged residues are arranged in a fashion as type II, where pairs of negatively (E) and positively (K) 
charged side chains alternate in sequence. (B) The 3-D molecular model of EAK16s. The top, middle, 
and bottom scheme represent the molecular structures of EAK16-I, EAK16-II, and EAK16-IV, 
respectively. The length of the backbone of EAK16s is around 7 nm while the width ranges from 0.3 
to 0.7 nm (image generated from ACD/3D freeware, Toronto, Ont., Canada) (Chen, 2005). 
 
There are several important features of ionic-complementary peptides. First, their charge 
distribution can be altered through simple molecular design, resulting in several types of peptides, 
such as the I, II and IV-types. Figure 2.1 shows the results of a sequence design based on the same 
components (E, A, and K), which generate EAK16-I, EAK16-II, and EAK16-IV. The design of the 
charge distribution has an impact on the secondary structure and self-assembly. 
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Figure 2.2. (A) A scheme of EAK16-II self-assembly through hydrophobic interaction and ionic-
complementarity. Electrostatic interactions together with hydrogen bonds and hydrophobic 
interactions drive peptides to form stable β-sheets. (B) A proposed model of EAK16-II self-assembly 
into β-sheet-based aggregates. The peptides are proposed to self-assemble in an antiparallel fashion to 
favor the minimum energy state. In fact, some evidence has shown that EAK16-I and -II have a high 
frequency peak from Fourier-transform infrared (FTIR) measurements, which implies the antiparallel 
β-sheet formation (Chen, 2005). 
 
A second important feature is the ease with which the ionic-complementary peptide family 
can be expanded with the same charge distribution using different amino acids. For instance, the 
positively and negatively charged residues of EAK16 can be substituted with positively and 
negatively charged R and D while maintaining the ability to self-assemble into macroscopic 
materials.  DAR is such a self-assembling peptide. However, if the positively charged residues, K and 
R, were replaced by negatively charged residues, E and D, the peptide would not be able to self-
assemble and form macroscopic materials, although β-sheet structures have been observed in the 
presence of salt. If the A is changed to a more hydrophobic residue, such as L, I, F or W, the molecule 
will have a greater tendency to self-assemble. 
A third feature particularly important for the class of ionic-complementary peptides 
discovered by Zhang et al. is that a minimum number of amino acids are required in order to have the 
ionic self-complementarity. For example, the minimum number of amino acids required to build 
aggregates with type IV peptides is sixteen, while the creation of type I and type II peptidic 
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aggregates requires four and eight amino acids, respectively. The sequence of these short peptides can 
also be applied in the construction of polypeptides such as poly-EAK (Goeden-Wood, et al., 2003).  
Since ionic-complementarity plays an important role in determining the stable conformation 
of a peptide through electrostatic interactions, the change of charge status of amino acids in the 
peptides obtained by changing pH is anticipated to affect their self-assembly. Such pH effect was 
observed by Aggeli et al. in the study of the DN1 peptide (QQRFQWQFEQQ) (Aggeli, et al., 2003). 
This peptide formed a stable gel at a pH less than 5. At pH above 5, the fibrils were observed to 
flocculate, rendering the gel unstable. At this pH, both E and R were charged, making the peptides 
stack together in various ways, which led to amorphous aggregates. This study suggests an effective 
method of controlling the macroscopic properties of the aggregates of self-assembling peptides by 
changing the pH of the solution. This method would prove useful for the encapsulation and controlled 
release of biologically important molecules from the peptide gels. 
The pH-dependence of nanostructure formation reported by Hong et al. using the EAK16-II 
and EAK16-IV peptides did not match the above expectation (Hong, et al., 2003). EAK16-II formed 
fibrillar assemblies regardless of pH values. EAK16-IV formed globular assemblies only at near 
neutral pH conditions (pH 6.5-7.5). When prepared above pH 7.5 or below pH 6.5, EAK16-IV 
formed fibrillar assemblies, whose structures were indistinguishable from the fibrils formed by 
EAK16-II. 
Concentration is another parameter affecting peptide self-assembly. The concentration 
dependence of peptide self-assembly is expected to resemble that of surfactants. Atomic force 
microscopy (AFM) studies revealed that EAK16-II or Aβ peptide formed isolated filaments and 
globules even at concentrations below the critical aggregation concentration (CAC) (Walsh, et al., 
1999; Fung, et al., 2003; Hong, et al., 2004 & 2005). The isolated structures are referred to as 
protofibrils, which are formed prior to the self-assembly of larger fibrils. The observation of 
protofibrils at concentrations below the CAC seems to contradict the micellization theory. Surfactants 
are only present as monomers when the concentration is below the critical micelle concentration 
(CMC). The difference may be explained with a nucleation mechanism: the nuclei are formed either 
through the peptide itself at the concentrations above the CAC, or by the impurities present as “seeds” 
at the concentrations below the CAC.  
 
2.1.2 Lipid-like Self-assembling Peptides 
A class of short lipid-like amphiphilic peptides (peptide detergents) can self-assemble into nanotubes 
or nanovesicles, which can stabilize membrane proteins outside their natural cell membrane milieu, 
incorporate segments of homopolymeric, natural amino acids, or serve as template for fabrication of 
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nanowires. Each peptide in this class has a tail consisting of consecutive hydrophobic amino acids 
and a polar head consisting of one or two charged residues.  
. Although a variety of detergents and lipids as surfactants have been used to stabilize and 
crystallize membrane proteins for several decades, they are still unable to significantly maintain 
structural stability of membrane proteins during experimental handling. New types of surfactants are 
needed, such as A6D (AAAAAAD) and V6D (VVVVVVD). These peptides were able to stabilize the 
photosystem complexes and glycerol-3-phosphate dehydrogenase in solid-state devices (Yang and 
Zhang, 2006). This new type of peptide detergents was very effective in stabilizing membrane 
proteins and maintaining their functions, providing a powerful tool for membrane proteins research 
and application (Yang and Zhang, 2006).  
 
2.2 Applications of Self-assembling Peptides 
2.2.1 Drug Delivery 
Rapid progress in genomics and proteomics has generated a large number of novel drugs, which have 
been designed to act against specific targets in the body. However, these drugs have experienced only 
limited success in clinical studies, due to low solubility, poor stability, low cellular uptake across 
plasma membrane, or lack of specific targeting (Anderson, 1998; Gorecki and MacDermot, 1997). 
Thus, effective drug delivery vehicles are being researched to make new therapies available for 
clinical use. Viral vectors and cationic polymers, lipids, polypeptides, and proteins have been the 
predominant drug delivery carriers (Selvam, et al., 2006; Pietersz, et al., 2006; Torchilin, 2005; 
Jones, et al., 2006). To date, there has been little lasting impact in the clinical practice of medicine 
conferred by these delivery systems.  
Peptide-mediated drug delivery agents are emerging as alternatives since they possess the 
safety of nonviral systems and preserve some ideal cell penetration characteristics of viral systems. 
Peptides are a fundamental component of all living cells and of many substances that are necessary 
for the proper functioning of an organism, such as enzymes, hormones, and antibodies. Self-
assembling peptides spontaneously form nanostructures, which have shown potential in encapsulation 
of a broad range of therapeutic agents from hydrophilic gene therapeutics to hydrophobic 
chemotherapeutics. The main attraction for these peptides is their versatility. They can be easily 
synthesized and tailored to exhibit the desired encapsulation and cell penetration properties. 
A self-assembling peptide RAD16-II (Davis, et al., 2006) has been used to prolong delivery 
of insulin-like growth factor 1 (IGF-1), a cardiomyocyte growth and differentiation factor, to the 
myocardium, using a "biotin sandwich" approach. Biotinylated IGF-1 was complexed with tetravalent 
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streptavidin and then bound to biotinylated self-assembling peptides. This biotin sandwich strategy 
allowed binding of IGF-1 but did not prevent self-assembly of the peptides into nanofibers within the 
myocardium. After injection into rat myocardium, biotinylated nanofibers provided sustained IGF-1 
delivery for 28 days, and targeted delivery of IGF-1 in vivo increased activation of protein kinase B 
in the myocardium.  
Recently, this peptide has also been used to deliver platelet-derived growth factor (PDGF)-
BB into myocardium by the same group. Intramyocardial delivery of PDGF by RAD16-II nanofibers 
leads to long-term improvement of the cardiac performance after experimental infarction without 
apparent pulmonary toxicity. Local myocardial protection may allow prevention of heart failure 
without systemic toxicity (Hsieh, et al., 2006; Lee and Hsieh, 2006). 
EAK16-II has been successfully used to stabilize pyrene microcrystals in aqueous solution, 
up to ten-thousand times beyond its solubility limit in water of 7 ×10¯7 M, and unload molecular 
pyrene into a cell membrane mimic, egg phosphatidycholine (EPC) vesicle, in a controlled manner. 
The complete transfer of pyrene crystals occurred within a few hours (Keyes-Bag, et al., 2004).  
The biological hydrogels formed from the self-assembly of RAD16-I are promising materials 
for various controlled molecular release applications (Nagai, et al., 2006). The diffusion properties of 
dyes, such as bromophenol blue, 8-hydroxypyrene-1,3,6-trisulfonic acid trisodium salt and 1,3,6,8-
pyrenetetrasulfonic acid tetrasodium salt, and Coomassie Brilliant Blue G-250, through RADA16 
hydrogels have been reported. The apparent diffusivities of the dyes decreased with increasing 
peptide concentration, providing an alternate route of controlling release kinetics. In addition, strong 
electrostatic interactions between nanofiber and promophenol blue result in no release from the 
hydrogels, suggesting the release profiles can be tailored through controlling the nanofiber-diffusant 
interactions at the molecular level. 
Controlled delivery of drugs in response to environments has the potential of targeting 
therapies and personalized treatments. Two self-assembling peptide motifs KLD12-I, which adopt 
stable β-sheet structures spontaneously in aqueous solution induced by the repetition of alternating 
ionic hydrophilic and hydrophobic amino acids, were linked with a peptide sequence SGRSANA  
which is specifically cleaved by a disease-associated protease (Law, et al., 2006). In aqueous solution, 
this peptide self-assembles as a gel scaffold, where drugs are encapsulated. Upon treatment of this 
peptide solution with the appropriate protease, the matrix can be degraded in a controlled fashion, 
where the degradation rate is fine-tuned by varying the peptide composition and the release 
therapeutic payloads.  
Self-assembling peptide DN1 and its derivatives have been found to form β-barrel channels 
that are incorporated in the lipid bilayers of vesicles loaded with an active ingredient (Agelli, et al., 
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2003). This active compound can be a small biological molecule, a protein, or DNA. If these 
molecules can not penetrate the lipid bilayer, then the β-barrels are the only means of release of the 
active compound outside the vesicle. Thus the β-barrel in this case acts as a component of a 
formulation of slow or sustained release of an active compound. On a particular note, the self-
assembly of the monomeric peptide into β-barrel aggregates can be triggered in response to changes 
in the pH of the aqueous solution. 
A series of surfactant peptides made of a hydrophobic tail attached to a polar head group 
consisting of one or two positively charged residues at the C- or N-terminus have been shown to self-
assemble in aqueous solution to produce nanovesicles or nanotubes (Zhang and Zhao, 2004; Guler, et 
al., 2005). One example is the hydrophilic, bioactive peptide RGDS covalently linked to a cholesterol 
hydrophobic moiety (Chol-AAAAGGGKRGDS), which is able to encapsulate a hydrophobic 
molecule during self-assembly into cylindrical nanostructures (Guler, et al., 2005). This encapsulation 
can stabilize hydrophobic cargoes such as pyrene in the core of these nanostructures. These 
supramolecular systems could be used to combine encapsulation of hydrophobic drugs with 
presentation of bioactive epitopes for targeted drug delivery since the RGD peptide is also known to 
bind to integrins that are more highly expressed in blood vessels of human tumors (Arap, et al., 
1998). Another group of surfactant self-assembling peptides was created by Shugang Zhang and his 
coworker (Zhang and Zhao, 2004). By choosing and linking specific sequences of amino acids, they 
generated short peptides with a positively charged end made of the amino acids lysine or histidine, 
such as LLLLLLKK. When placed in a solution of DNA, the positively charged peptides self-
assembled into nano-capsules and tubes, encapsulating the negatively charged DNA. This “minivan” 
was then able to deliver the DNA to at least some cells growing on laboratory plates as the minivan 
surface can be tagged with a receptor that is specific to a particular cell (Gorman, 2003). 
In summary, self-assembling peptides combine a large loading capacity with cell 
targeting/penetrating abilities designed atn the molecular level to form a versatile drug construct. The 
ability to optimize the balance between hydrophilic and hydrophobic peptide residues to enhance the 
loading and release capacity should make these peptides effective biocompatible carriers in gene 
therapy and chemotherapy.  
 
2.2.2 Model for Studying Amyloid Fibrillogenesis 
The structural transition of amyloid disease-related proteins such as prion proteins from α-helix to 
insoluble and cytotoxic β-sheet amyloid fibrils plays a key role in a variety of fatal diseases known as 
Alzheimer's and prion diseases (Watson, et al., 2005). The amyloid fibril is a misfolded and 
undesirable state for proteins and its formation may block cell-to-cell communications and damage 
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neuronal pathways. It is necessary to study the nature of the proteins in such critical diseases in order 
to clarify the folding pathway of proteins. Many fibrous peptides and proteins including both natural 
and designed amyloid and fibrous peptides have been investigated to provide useful information for 
constructing and manipulating peptide conformations. Notable examples include islet amyloid 
polypeptide (IAPP) from endocrine hormones, tansthyretin (TTR) from transport molecules, and Aβ 
and prion protein from the nervous system (Kowalewski and Hotzman, 1999; Walsh, et al., 1999; 
Sipe and Cohen, 2000; Kundu, et al., 2003). 
There are similarities between the self-assembly process of self-assembling peptides and 
amyloid fibrils. First, self-assembling peptides produce fibrillar nanostructures similar to those 
formed from a typical amyloid peptide Aβ. Second, some self-assembling peptides can undergo 
conformational transitions identical to amyloid peptides. Third, both self-assembly processes follow 
the nucleation and growth mechanism. Fibril formation is triggered above a critical concentration. 
(Fung, et al., 2003; Hong, et al., 2004 & 2005). Finally, the protofibrils play an important role in both 
self-assembly processes. Therefore, self-assembling peptides can be a good model for understanding 
amyloid fibril formation. 
The ionic self-complementary peptide KTEAETKTEAKVDAKADVE, derived from the C-
domain of Arabidopsis thaliana copper metallochaperone (CCH), adopts an extended conformation in 
solution with a high content of β-sheet structure that induces a pH-dependent fibril formation. Freeze 
drying electron microscopy reveals the existence of well ordered amyloid-like fibrils in the solutions 
of this peptide (Mira, et al., 2004). 
Mihara and his group have designed a class of self-assembling peptides that undergo a self-
initiated and spontaneous α−helix-to-β−sheet (α-to-β) transition and self-assemble into amyloid 
fibrils in a neutral aqueous solution (Takahashi, et al., 1999a & 2000). A series of these peptides are 
composed of two amphiphilic α-helices with double-heptad repeats (ALEQKLA)2. The two peptide 
chains are linked by a disulfide bond between Cys residues at the C-terminus. A 1-
adamantanecarbonyl (Ad) group as a hydrophobic domain is attached to the N-terminus of the 
peptide. The peptide initially shows an α-helix structure that gradually changes to β-structure in a 
neutral aqueous solution, whereupon the Ad group causes intermolecular peptide association through 
hydrophobic interactions. This structural transition results in amyloid fibril formation, which seems to 
follow a nucleation process and a subsequent autocatalytic transition reaction. The α-to-β transition 
was studied under different conditions including peptide concentration, temperature, pH, solvent, salt, 
and detergent by Mihara et al. Increases of peptide concentration or temperature enhance the α-to-
β conformation transition. The highest transition rate is observed at neutral pH. The addition of 
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organic solvents and salts can retard and even inhibit the transition. Both cationic and anionic 
detergents similarly retard or inhibit the structural transition in a concentration-dependent manner. 
Furthermore, hydrophobic domains generated by these peptides seem to create the same 
conformational defects that may form unstable α-helices in the aggregates. When a critical amount of 
α-helices accumulate in the aggregates, they give rise to long-range (intermolecular) interactions and 
the peptide undergoes an α-to-β transition in an autocatalytic manner. It has been shown that the 
hydrophobicity of the peptide affects the stability of the intermediate α-helical aggregates, which 
controls the α-to-β transition. The same group has also found that the ionic complementarity is 
important for amyloid fibril assembly (Takahashi, et al., 1999b & 2002; Mihara, et al., 2005).  
 The study of the self-assembly mechanism of amyloid may lead to a treatment for 
conformational diseases. Since amyloid fibril formation has been characterized as pathogenic, the 
major strategy for treatment of conformational diseases is to inhibit the amyloid fibril formation. This 
can be achieved by inhibiting various pathways to amyloid fibril assembly. For example, adding 
small inhibitors or adjusting physiological condition has been found to affect amyloid fibril 
formations (Yang, et al., 1999). Some researchers focus on intermediate α-helix aggregates, which 
may be the major cause of cellular toxicity. It is found that when the amino acids controlling the 
kinetics of intermediate formation are replaced, fibrillogenesis kinetics is significantly altered 
(Kirkitadze, et al., 2001).  
 
2.2.3 Tissue Engineering 
Advanced tissue engineering requires biocompatible materials that serve as substrates for cell growth, 
differentiation and biological function. Self-assembling peptides are being developed as biomaterials 
for creating cartilage, blood vessels, and other tissues, or as substrates for nerve cell growth and 
synapse formation, immobilized peptides, and proteins (Holmes, 2002). A major benefit of synthetic 
materials is that they minimize the risk of biological contamination. Self-assembling peptides also 
frequently show favourable properties concerning biocompatibility, immunogenicity and 
biodegradability, producing non-toxic waste products.  
One of these peptides, EAK16-II, has been found to be nontoxic; it has no effect on the 
growth-rate of nerve growth factor-differentiated rat PC-12 cells when added into the cell culture 
medium (Zhang, et al., 1993). Meanwhile, two ionic-complementary peptides, EAK16-II and 
RAD16-II, have been reported to form matrices that support mammalian cell attachment (Zhang, et 
al., 1995). The cells that attached to a peptide-coated substrate exhibited a flat, spread morphology, 
similar to the morphology that was observed when the cells attached to a fibronectin-coated substrate. 
In contrast, the same cells retain a round shape and do not spread on the malleable RAD16-II 
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membranes. The cells remained well attached, even after transferring the membrane to a fresh culture 
well.  
 The RAD16-I nanofiber scaffold creates a permissive environment for axons not only to 
regenerate through the site of an acute injury but also to knit the brain tissue together. The 
regenerated axons reconnect to target tissues with sufficient density to promote functional return of 
vision, as evidenced by the fact that the presence of sunflower seeds in the binding site can induce 
response from treated rates (Ellis-Behnke, 2006). RAD16-II scaffolds are able to establish a three-
dimensional environment for in vitro promotion of angiogenesis (Narmoneva, et al., 2005).  
In summary, self-assembling peptides may be promising scaffolding materials in tissue 
engineering applications such as neurite outgrowth, cartilage repair, and responsive gel formation. 
Not only are these peptide matrices highly biocompatible and biodegradable, they also possess 
diverse biological functionalities. Ease of molecular design and engineering will make these small 
peptides smart biological materials for future tissue engineering. 
 
2.2.4 Fabrication of Nanowires 
The design and fabrication of complex nanostructures with specific geometry and composition is one 
of the main challenges of nanotechnology. In the computing industry, the fabrication of nanowires 
using the “top-down” approach faces tremendous challenges. Thus, the possibility of fabricating 
conducting nanowires by molecular means using self-assembled nanotubes is of particular interest to 
the electronics industry. One can readily envision that nanotubes might serve as templates for 
metallization. Once the template has been removed, a pure conducting wire is left behind and 
immobilized on a surface. 
Self-assembling peptide, such as A6D and V6D, mimic the structure of phospholipids with the 
D polar head group and the A6 or V6 apolar tail. They have been shown to form nanotubes readily 
(Yang and Zhang, 2006). These nanotubes have the potential to act as templates for the formation of 
nanowires. Furthermore, the nanotubes may be useful as an encapsulating vesicle for drug delivery. 
Chemical modification of the peptide monomer may expand the function of these structures. For 
example, a specific cell-surface ligand can be directly incorporated into a vesicle for targeted delivery 
of insoluble drugs to particular cells (Zhao and Zhang, 2006). 
A Phe-Phe dipeptide, the Alzheimer’s β-amyloid diphenylalanine structural motif, has been 
applied to construct nanowires (Reches and Gazit, 2003). This dipeptide can self-assemble into 
discrete and stable nanotubes. The resulting nanotubes were added to boiling ionic silver solution, and 
the silver within the nanotubes was reduced with citric acid. The peptide in the nanotube was 
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degraded by a proteinase K enzyme to reveal discrete nanowires with a long persistence length. The 
procedure is shown in Figure 2.3. 
Based on the understanding of the peptide nanotube assembly process, the same group 
recently designed a method for surface decoration of the peptide nanotube to form a tri-layered 
(silver-peptide-gold) coaxial nanowire (Carny, et al., 2006). After peptide nanotubes were self-
assembled from the FF dipeptide, a linker peptide, whose sequence was CFF, FFC or CGSGFF, was 
added. These linker peptides contained a FF motif, which can interact with the peptide nanotube 
surface, and a cysteine residue, which provided the reactive thiol group for binding to gold. Gold 
particles were found to bind evenly on the surface of the nanotubes. 
These early studies suggest that the construction of nanostructures using self-assembling 
peptides as templates may become an alternative to the more conventional methods used currently in 
nanotechnology. 
 
Figure 2.3. The process of nanowire fabrication. 
 
2.3 Protein-DNA Interactions and Characterization Techniques 
Although binding of self-assembling peptides to oligonucleotides has not been reported, protein-DNA 
interactions have been widely studied to understand basic cellular processes including DNA 
metabolism and gene expression. Most protein-DNA interactions in these processes are specific, 
which have been examined to identify the binding sites on the DNA or on the protein surface facing 
the DNA by techniques like filter binding, gel retardation, footprinting, and southwestern blotting 
(Moss, 2001). In contrast, most single-stranded DNA-binding proteins (SSBs) bind non-specifically 
to single-stranded DNA (ssDNA), such as EcoSSB, gp32 of T4 bacteriophage, TaqSSB, TthSSB, and 
replication protein A (RPA) in eukaryotes (Kur, et al., 2005). These non-specific interactions have 
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been studied quantitatively using techniques that monitor changes in the biological or 
physicochemical properties resulting from the formation of complexes (Bujalowski and Lohman, 
1987). In most instances, these techniques are gel mobility shift assay (Morii, et al., 1996; Stierle, et 
al., 2003), filter binding assay (Agou, et al., 1999), boundary sedimentation velocity (Galletto, et al., 
2003), surface plasmon resonance (Seimiya and Kurosawa, 1996), UV difference spectra (Boraston, 
et al., 2000), and fluorescence assay (Michel, et al., 2003; Endoh, et al., 2005). Except boundary 
sedimentation velocity and UV difference spectra, all these methods require labeling of the ligand 
with a chromophore or radioactive isotope, or covalent immobilization of the ligand. Other 
characterization approaches, such as differential scanning calorimetry (Singh, et al., 2006) and 
isothermal titration calorimetry (Plotnikov, et al., 2004), directly measure the heat evolved in the 
binding to estimate the forces stabilizing a given complex. Structures or morphologies of protein-
DNA complexes can be obtained by X-ray crystallography and nuclear magnetic resonance (NMR) at 
atomic resolution for small complexes. Large multiprotein complexes, beyond the scope of these two 
techniques, are generally examined by electron microscopy and atomic force microscopy (Dodson 
and Echols, 1991). 
 The focus of this review is the applications of these techniques which were used in this thesis 
to study the nonspecific interactions of proteins or cationic peptides with nucleic acids or 
oligonucleotide.  
 
2.3.1 Electrophoresis Mobility Shift Assay (EMSA) 
A gel mobility retardation assay is based on the electrophoretic mobility of a DNA fragment bound to 
a protein being lower than that of either the DNA fragment or protein alone. This technique typically 
requires radioactive labeling of the DNA which is used as the probe. The mixture of bound and free 
species is separated on a polyacrylamide gel, which is subsequently exposed to a radiographic film. 
The eventual protein/DNA interaction is visualized by the presence of a radiographic band on the 
film.  
This method has been used to identify DNA sequences that were bound specifically by the 
sunflower homeodomain leucine-zipper protein Hahb-4 (Palena, et al., 1999). Binding analysis 
suggests that Hahb-4 preferentially binds the dyad-symmetrical sequence CAAT(A/T)ATTG. A 
prerequisite to such a DNA binding ability is that Hahb-4 forms a dimer as implied by the non-
hyperbolic plot of the percentage of DNA bound as a function of protein concentration. This specific 
interaction had a dissociation constant (Kd) of 1.31 × 10¯14 M2, which was increased 2-4 folds when 
the nucleotides at positions 1, 5, or 9 of the dyad-symmetrical sequence were replaced. The removal 
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of the leucine zipper also promoted a decrease in specificity and an increase in dissociation constant 
(Kd = 5.03 × 10¯5 M) due to the absence of dimer formation.  
This method has also been used to study the binding of peptides to nucleic acids. The gel 
retardation analysis revealed that a synthetic 73-residue peptide from human Tristetraprolin (TTP) 
bound to the tumor necrosis factor (TNF) AU-rich elements (AREs) with a TTP-RNA dissociation 
constant of 10 nM (Blackshear, et al., 2003). The value was comparable with the results obtained 
from fluorescence anisotropy experiments, another technique used in the same study. The 
electrostatic interaction between 9-residue (GRKKRRQRRR) or 12-residue (RKKRRQRRRGGC) 
fragments of the Tat peptide and an 18-mer antisense oligonucleotide against RIα mRNA was also 
studied by gel retardation analysis (Zhang, et al., 2003). The ODNs were completely bound at a 
Tat/ODN ratio as low as 2:1.  
Although traditional gel mobility shift assay is one of the most common methods to study 
certain macromolecular systems, it may be not suitable for some systems where the species 
distribution obtained at equilibrium is changed during the experimental procedure. First, there may be 
dissociation or association of the various species when the sample is loaded in the gel well due to the 
change in ionic strength from the equilibration buffer to the electrophoresis buffer. Second, there may 
be dissociation of some complexes during electrophoresis due to the effect of mass action. These 
concerns have motivated the development of a cryogenic method that would obviate the potential 
problems associated with labile dissociation or association (Cann, 1989). In this low-temperature gel 
mobility shift technique, solutions of protein and DNA mixtures at equilibrium are rapidly quenched 
to -40°C via an ethylene glycol-based carrier medium. The quenched samples are then 
electrophoresed at -35°C in a polyacrylamide gel matrix. The rapid and sustained drop in temperature 
results in almost complete stabilization of the equilibrium species distribution. Autoradiogram 
analysis of the relative abundances for the bound and free DNA sites is carried out over a range of 
initial binding ratios to yield the binding curve and equilibrium constant as in the usual gel-shift 
assay. This cryogenic version of the gel-shift method has been successfully used in the λcI repressor-
OR binding study (Bain and Ackers, 1998), for which conventional gel-shift assay has not been 
feasible due to the instability of the protein/DNA complex at room temperature (Dixon, et al., 1991). 
 Another approach developed on the basis of electrophoresis mobility shift assay (EMSA) is 
capillary electrophoresis with high sensitivity laser-induced-fluorescence (LIF) detection. Capillary 
electrophoresis (CE) separates analytes on the basis of their mass-to-charge ratio. The key features of 
the method are the rapid separation and quantification of bound and free DNA in uncoated capillaries 
with no gel matrices. The effect of the gel matrix on dissociation constant measurements is absent in 
this method (Glenn and Etzkorn, 1998). CEMSA has the advantages of automation, no radioactivity, 
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high resolution, on-line detection, and the use of small amounts of samples (Glenn and Etzkorn, 
1998). The dissociation constant for GCNK58, a DNA-binding-region of the yeast transcription factor 
GCN4, binding to the AP1 DNA site, was investigated by CEMSA with LIF detection of fluorescein-
labeled DNA (Glenn and Etzkorn, 1998), which was 35 ± 4 nM. The interaction of calf-thymus DNA 
with human serum albumin (HSA) in aqueous solution under physiological conditions was 
investigated using CE at constant DNA concentrations of 12.5 mM (phosphate) and various HSA 
contents 0.04 to 0.3 mM (Malonga, 2006). The results revealed two types of HSA-DNA complexes 
with a strong and weak binding characteristed by K1 = 4.5 × 105 M−1 and K2 = 6.1 × 104 M−1, 
respectively. The two major binding sites were located at the G-C base pairs and the backbone 
phosphate groups. The protein-DNA interaction stabilized the HSA secondary structure and a minor 
alteration of the B-DNA structure was observed, while no major protein conformational changes 
occurred. 
 
2.3.2 UV Difference Spectroscopy 
The protein interaction with the sugar-phosphate backbone of DNA may perturb the base stacking in 
DNA molecules, allowing the bases to absorb more UV-Vis light energy and resulting in difference in 
the absorption spectra, which can be used to quantify such binding. In Figure 2.4, The UV absorbance 
difference between complexed and naked DNA is measured while titrating a fixed amount of DNA 
with a protein. The UV absorbance difference initially increases when increasing protein 
concentration and eventually reaches a plateau. The stoichiometry ratio for the binding of the protein 
to DNA can be easily determined from Figure 2.4B,.  
 
Figure 2.4. (A) UV-Vis differential spectra of DNA interacting with methylated β-lactoglobulin 
protein. Each successive curve represents the absorption of one accumulative addition of the protein 
solution to a fixed amount of DNA solution. (B) Plots of absorbance as a function of molar ratio of 
concentrations of protein to DNA. Solid and dash line refer to absorbance obtained at 260 nm and 280 
nm, respectively (Sitohy, et al., 2001). 
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Sitohy et al. (2001) applied UV differential spectra to study the binding of esterified or native 
whey proteins and nucleic acids. Adding native forms of whey proteins to DNA did not produce any 
difference in the spectra. In contrast, positive differential spectra between 210 and 340 nm were 
observed after addition of methylated α-lactalbumin proteins corresponding to a molar ratio (MR) of 
protein/DNA as low as 138 at neutral pH. UV absorption differences increased with increasing MR 
and leveled off at DNA saturation. The saturation point with methylated α-lactalbumin proteins was 
reached at a MR of 1100. In contrast, a relatively higher MR of 2750 was required to reach saturation 
with the ethylated form of the proteins. Lysozyme, a native basic protein, showed a behavior similar 
to what was observed in the case of the methylated α-lactalbumin but with a relatively lower MR of 
700. The amounts of proteins needed to saturate the nucleic acids were found to be much higher than 
those needed to neutralize it. This phenomenon demonstrated some specific protein-binding sites 
along the DNA other than the negative charges on the sugar-phosphate DNA backbones. The 
observation that addition of 0.1 % SDS suppressed completely all spectral differences and the 
presence of 5 M urea only partially reduced the spectral differences suggested that hydrophobic 
interactions played an important role. Peptidic hydrolysates of esterified and native proteins or their 
cationic fractions produced negative differential spectra when mixed with DNA at pH > 7. The 
negative differences in the UV absorption spectra were most promising in the case of peptidic 
hydrolysates of methylated derivatives of whey proteins. 
 
2.3.3 Fluorescence Spectroscopy 
Changes in the fluorescence emission spectrum of a protein upon binding to DNA are often used to 
determine the stoichiometry of binding and equilibrium binding constants. In some cases the data can 
also give an indication of the location of particular residues within the protein with which DNA binds. 
Similar to CD, titration curves of changes in fluorescence parameters, such as intensity, anisotropy, 
fluorescence energy transfer, or lifetime, as a function of protein or DNA concentration are normally 
fitted with binding models to extract the binding parameters. As one of the most sensitive 
spectroscopic techniques, fluorescence spectroscopy can yield the binding constants of many protein-
DNA interactions at low concentrations, typically in the nanomolar to micromolar range. This 
technique is generally quick and easy to perform. Among different fluorescence techniques, 
fluorescence anisotropy and steady-state fluorescence are the most commonly used methods 
(Lakowicz, 1999). 
Fluorescence anisotropy was employed to study the binding of ICP8, the major single-
stranded DNA (ssDNA) binding protein of the Herpes simplex virus type I, to a 5'-fluorescein-labeled 
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32-mer oligonucleotide (Gourves, et al., 2000). The model-free binding isotherms were generated 
from plots of the fluorescence anisotropy as a function of ICP8 concentration using the binding 
density function method developed by Lohman and Bujalowski (Bujalowski and Lohman, 1987; 
Lohman and Bujalowski, 1991). Fitting the binding isotherm with the method of Epstein (Epstein, 
1978) revealed that ICP8 formed a nucleoprotein filament on ssDNA with a binding site size of 10 
nucleotides/ICP8 monomer, an association constant K = 0.55 ± 0.05 × 106 M¯1, and a cooperativity ω 
= 15 ± 3. The equilibrium constant was largely independent of salt concentration. In comparison with 
other ssDNA-binding proteins, such as phage T4 and gp32, ICP8 bound weakly to ssDNA with low 
cooperativity. In addition, the reaction product was more stable at high salt concentrations, and 
fluorescence enhancement of etheno-ssDNA by ICP8 was higher than for other ssDNA binding 
proteins. 
Arosio and his coworkers also used fluorescence anisotropy to study the binding of the Ku 
heterodimer to DNA with fluorescein attached at the 5’-end (Arosio, et al., 2004). The dissociation 
constant (Kd) for the binding of Ku to a DNA binding site of the proper length (>20 bp) was found to 
be 22-29 nM at 300 mM NaCl. The binding isotherms for the DNA complexes with heterodimers 
were analyzed with two independent models, Adair’s equation using multiple identical binding sites, 
that did not overlap, and the McGhee and von Hippel model that considered the presence of 
overlapping binding sites. The analysis demonstrated that there was no or very weak nearest-neighbor 
cooperativity among the Ku molecules. These models can most likely be applied to study the 
interaction of Ku with duplexes of any length. Furthermore, salt dependence studies indicated that 
electrostatic interactions played a major role in the binding of Ku to DNA. The Kd decreases 
approximately 60-fold as the salt concentration is lowered from 300 to 200 mM.  
The complexation of a synthetic peptide (PGEk) with phosphodiester d(TTAGGG)4 (TMO) 
and phosphorothioate Sd(TTAGGG)4 (TMS) oligonucleotides was studied by steady-state 
fluorescence (Besschetnova, et al., 2006). The PGEk peptide consisted of 64 amino acids and 
comprised a hydrophobic domain derived from the human epidermal growth factor (hEGF) as cell 
targeting moiety and a hydrophilic domain derived from the nuclear localization signal sequence 
(NLS). The intrinsic fluorescence intensity of PGEk and fluorescence polarization were respectively 
found to decrease and increase upon PGEk binding to the ODNs. Binding isotherms were examined 
by Scatchard plot and the stoichiometry of the complexes was found to be three PGEk peptides per 
one ODN. The binding of the first two PGEk molecules to TMO and TMS occurred noncooperatively 
with the high association constants K1(TMO) of 7 ± 1 × 107 M¯1 and K1(TMS) of 3 ± 0.5 × 107 M¯1, 
respectively. The third PGEk molecule bound to TMO cooperatively with a still high association 
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constant K2(TMO) of 4.0 ± 1.5 × 106 M¯1. The third PGEk molecule bound rather weakly to the TMS 
oligonucleotide with K2 (TMS) of 8 ± 2 × 105 M¯1. 
The binding of the drug, quinolones, Nal, or Oxo to the polynucleotides under low-salt buffer 
conditions were determined for poly(dA)·(dT), poly[d(A-T)], poly(dG)·(dC), poly[d(G-C)] and E. coli 
DNA by steady-state fluorescence spectroscopic techniques (Jain and Rajeswari, 2002). The 
fluorescence data were analyzed using a two step mechanism which involved two different drug-
nucleic acid complexes. Complex [DN]1 was formed through nonspecific interaction and the 
formation of complex [DN]2 involved intercalation of the drug into DNA bases. The order of binding 
for Nal and Oxo was: poly[d(G-C)] > poly[d(A-T)] > E. coli > poly(dG)·(dC) > poly(dA)·(dT). 
Quinolones bound more avidly to alternating than to block copolymers of dG/dC and dA/dT stretches. 
Such a two-step process was also identified in the binding of KWGK to a 21-mer duplex of the GC-
rich region of the c-myc gene under low-salt conditions using UV-Vis absorption, fluorescence and 
circular dichroism. The first step was driven by electrostatic interaction only, and the second step by 
intercalation only. The resulting stacking structure increased progressively the melting temperature of 
the duplex and two lysine residues beside tryptophan formed hydrogen bonds with DNA bases and 
stabilized the DNA (Jain and Rajeswari, 2003).  
DNA binding to a 29-residue GCN4 basic region peptide, GCN4br, as well as to br-C 
peptide, a monomeric basic-region analogue with a stabilized α-helix at its C-terminal end, was 
studied by fluorescence spectroscopy (Zhang, et al., 2002b). The fluorophore NBD was attached at 
the N-terminus of the br-C peptide as a fluorescent probe. Quantitative analysis of the fluorescence 
quenching of the NBD-br-C peptide caused by the major groove of the duplex DNA facing toward 
the bound peptide indicated the formation of a 1:1 complex with a dissociation constant of 1.41 ± 
0.22 μM. Competitive displacement fluorescence assays for the binding of the br-C and GCN4br 
peptides to DNA gave dissociation constants of 0.65 ± 0.09 μM and 3.9 ± 0.5 μM, respectively. The 
difference in the dissociation constants for these two peptides corresponded to a free energy 
difference of 1.1 kcal/mol that was attributed to the helix stabilization achieved in the br-C peptide.  
Intrinsic fluorescence experiments were used to characterize the interaction between variants 
of the HIV-1 Tat (32-72) BP1 peptide and TAR RNA (Metzger, et al., 1997). The dissociation 
constants for both the wild-type BP1 and cysteine-defective BP1 peptides were found to be in the 
range of 60 to 70 nM, which indicated that the free sulfhydryl groups of the cysteines within the 
peptide BP1 were not required to bind to the TAR RNA with a high affinity. This finding triggered 
the authors to use an extrinsic fluorescence assay to study the binding of the Tat peptide to TAR RNA 
by using a mutant BP1 peptide (C34S, C37W) (BP1SW) as probe. The dissociation constant for the 
binding of BP1SW to TAR RNA was 9 nM. The change of the BP1SW fluorescence intensity upon 
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TAR RNA binding was used to investigate the binding kinetics by stopped-flow experiments. The 
results suggested a two-step binding model, with a rapid diffusion-limited formation of a tight, but 
unspecific complex, followed by a relatively slow structural rearrangement step (k ≈ 60 s¯1) to form 
specific BP1SW-TAR complexes.  
Porschke and Ronnenberg have studied the kinetics of interaction between a DNA duplex and 
the KWK lysine oligopeptides by the field-jump method using fluorescence detection (Porschke and 
Ronnenberg, 1981). The binding process was identified to be a two-step association mechanism, 
where a bimolecular step driven by electrostatic interaction was followed by a slow intramolecular 
transition where the aromatic residues (W) stacked via intercalation with the DNA base pairs. The 
equilibrium binding studies of KWK to DNA yielded the stacking constant of 0.3 and 6 for native and 
denatured DNA in the second step, respectively (Montenay-Garestier, et al., 1981). It suggested that 
stacking was strongly favored in ssDNA. The dissociation rate constant was 4000 s¯1 for the first step, 
and 440 s¯1 for the second step, which corresponded to halftimes of 0.17 and 1.6 ms, respectively. The 
dissociation of the KWK-DNA complex first involved a slow extraction of the aromatic amino acids 
from the DNA helix, followed by rapid release of the cationic peptide from the DNA template. 
Apparently, such fast dissociation of KWK from complexes with a halftime of about 1.6 ms could not 
provide the KWK-DNA complexes with sufficient circulation time for their application in gene 
delivery. One way to slow down dissociation was to increase the number of lysine residues. The 
rationale is that the rate constant for the disruption of electrostatic bonds between DNA and lysine 
oligopeptides decreases with increasing number of lysines. Such expectation was proved by Smith et 
al. (Smith, et al., 1998). They designed a series of peptides based on the KnWK family, where n = 4, 
5, 6, 7, 8, 10 and 12. To facilitate the characterization of the DNA complexes, a 125I- or 131I-labeled 
tyrosine (Y) was added at the N-terminus of the peptide. A lysine (K) was added on the left side of 
tyrosine to provide a branching residue for attachment of receptor ligands and reporter groups at its ε-
amino group. Since molecular simulation indicated that the series of such designed peptides would 
have an α-helical configuration, the peptide would orientate at the surface of the DNA after insertion 
of the tryptophan (W) into the DNA helix. Thus, an alanine (A) residue was included in the sequence 
to the side chains of tryptophan and the second Lys to the N-terminus on opposite sides of the 
putative helix. The obtained YKAKnWK peptide was noncovalently bound to DNA through 
electrostatic interaction. By dynamic light scattering, small complexes (<100 nm) were formed with 
all the peptides at phosphate-to-lysine ratios that ranged from 1:0.1 to 1:10, except at charge ratios of 
1:1 where large aggregates (>1000 nm) formed. These complexes were stable at room temperature for 
at least 5 days, overcoming the problem of rapid dissociation experienced by the KWK-DNA 
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complexes. Application of the YKAKnWK peptides to the transfer of DNA into HepG2 cells showed 
that only the peptides with n ≥ 8 were able to enhance gene transfection (Smith, et al., 1998).  
Lohman et al. (Lohman, et al., 1980) have found that the binding constant for pentalysine-
DNA interactions decreased dramatically with both increasing NaCl concentration and pH. The data 
were consistent with an electrostatic interaction between the cationic peptide and DNA, driven by the 
entropic contribution of counterion release to the free energy of binding. This work was extended 
with oligolysines containing tryptophan by examining the thermodynamics of binding of KWKn with 
n = 1, 2, 4, or 6 to polynucleotides (Mascotti and Lohman, 1993). The quenching of the tryptophan 
fluorescence upon interaction with the polynucleotides was monitored to generate binding isotherms. 
Then, the equilibrium binding constants were determined by analysis of the binding isotherms using 
the non-cooperative McGhee and von Hippel (1974) model. As observed with pentalysine, the free 
energy of binding of these peptides was entirely entropy driven. Fluorescence studies also found that 
other oligolysine and lysine-rich peptides such as KGWGK, KWK6, and Kn (n=3-8) bound to oligo- 
and polynucleotides with binding constants in the range of 1×103~1×105 M−1 (Matsuno, et al., 2001; 
Roy, et al., 1992; Ballin, et al., 2004). 
An amphiphilic peptide MPG (GALFLGFLGAAGSTMGAWSQPKKKRKV), containing a 
hydrophobic domain derived from the fusion sequence of HIV gp41 and a hydrophilic domain 
derived from the NLS of SV40 T-antigen, was designed by Divita’s group to deliver antisense ODN, 
plasmid DNA, and siRNA (Morris, et al., 1997; Morris, et al., 1999; Simeoni, et al., 2003). The 
quenching of intrinsic fluorescence of MPG was used to monitor the binding of MPG to the 
oligonucleotides (Morris, et al., 1997). The MPG-ODN induced a remarkable quenching of the 
intrinsic fluorescence emitted by the Trp residue of MPG. The maximum emission peak did not shift 
suggesting that the environment of the Trp residue was not modified. The quenching of the intrinsic 
fluorescence was most likely due to direct interaction of MPG with the phosphate or with the 
nucleoside moiety of the oligonucleotides. A quadratic equation was used to fit the fluorescence 
quenching data to determine the binding parameters. Best fits were obtained for a ratio of four and 
eight peptide molecules per the 18-mer single- and 18/36-mer double-stranded oligonucleotides, 
respectively. MPG exhibited relatively high affinity for all oligonucleotides tested with apparent 
dissociation constants in the 1−2 ×10¯8 M range. The resulting compact structure (with a 20-fold 
excess of peptide) not only stabilizes the nucleic acids and protects them from nuclease degradation in 
cell culture media but also drives them efficiently to mammalian cells in culture. Similar experiments 
were done to study the binding of MPG to plasmid DNA (Morris, et al., 1999). The results revealed 
high affinity for binding of MPG to pRL-SV40 (3.2 kb) and pJ30-antisense-Hucdc25C plasmid (4.9 
kb) with respective dissociation constants of 0.5 ×10¯8 M and 1.8 ×10¯8 M.  
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Pep-2 (KETWFETWFTEWSQPKKKRKV), an analogue of the Pep-1 peptide, has been used 
to deliver a short 15-mer antisense HypNA-pPNA chimera directed specifically against cyclin B1 
(Morris, et al., 2004). Binding of cargoes to Pep-2 was monitored by fluorescence spectroscopy. Pep-
2 exhibited a high affinity for PNAs with a dissociation constant of 22 ± 4 nM, and formed stable 
peptide-based nanoparticles around the cargo with an estimated diameter between 100 and 200 nm.  
In general, fluorescence methods enable the determination of the binding parameters of 
peptides to DNA at equilibrium with no need to separate the interacting species. Thus this technique 
is generally quick and easy to perform.  
 
2.3.4 Summary 
In the above sections, various techniques were presented to study the binding of proteins or peptides 
to nucleic acids. These techniques are based on the biological or spectroscopic changes observed 
upon the formation of the complexes. Traditional or other advanced EMSA techniques typically 
require the radioisotope labeling of the interesting species. In addition, separation of the unbound and 
bound species on a polyacrylamide gel or an electrical field may cause the dissociation or association 
of complexes and affect the measured binding parameters. Other techniques, such as fluorescence 
spectroscopy, difference CD spectroscopy, or difference UV absorption spectroscopy, detect 
spectroscopic changes resulting from the formation of protein-DNA complexes. These spectroscopic 
techniques permit the study of interactions at equilibrium in solution, without separation of the 
unbound and bound species. They are generally fast and easy to perform. However, the determination 
of the binding parameters from the experimental data needs careful interpretation and analysis. 
Nevertheless, these spectroscopic methods are still the primary techniques used for any binding study.  
 
2.4 Construction of Binding Isotherms 
In order to generate binding isotherms from the experimental data obtained by spectroscopic 
techniques, such as UV-Vis absorbance or fluorescence, it is commonly assumed that a linear 
relationship exists between the signal change and the degree of binding. However, if a linear 
relationship does not hold, then the calculated apparent isotherms will be incorrect. In the general 
case, where multiple ligands bind to a macromolecule or a large supramolecular aggregate (micelle, 
lipid mono- or bilayer), the fractional signal change and the extent of binding often do not have a 
simple linear relationship. It is thus essential that true binding isotherms be built even when a direct 
proportionality does not exist between the fractional signal change and the degree of binding. The 
binding density function (BDF) analysis provides a means to achieve this aim.  
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The thermodynamic basis for the BDF analysis is that the distribution of ligands bound in 
different states (average number of ligands bound per macromolecule) is strictly determined at 
equilibrium by the free ligand concentration (Bujalowski and Lohman, 1987; Schwarz, et al., 1987). 
From the thermodynamic point of view, the free and the bound ligand can be considered as existing in 
different states at equilibrium in the system where there is no aggregate formation. This statement 
requires that the respective chemical potentials be equal at equilibrium. This requirement results in 




f νϕμμ +=+   (2-1) 
 
where the subscripts f and b refer to the free and bound ligand state, respectively. The chemical 
potentials and  are obtained under standard conditions. fofμ
o
bμ f and Lf are the activity coefficient and 
the concentration of the free ligand, respectively. ϕ(ν) is the activity of the bound ligand, which is a 
function of the average binding density ν. ν is defined as the amount of bound ligand per 
macromolecule given by ν = Lb/Mt, where Mt is the concentration of the macromolecule. Equation 2-1 
can be rewritten into Equation 2-2  
 
)(νϕ=fKL      (2-2) 
 
where  represents the basic binding constant. At equilibrium, any 
given binding system can be quantitatively characterized by a thermodynamic association isotherm 
which reveals the relationship between binding density and the concentration of free ligand. This 
relationship holds irrespective of the possibility that bound and/or free ligand molecules assume any 
number of different structural states. According to Equation 2-2, the ligand binding density ν at 




f under a given solution condition. 
The relationship between ν and Lf reflects the underlying molecular binding mechanism (Schwarz, 
2000; Schwarz and Reiter, 2001).  
It results from Equation 2-2 that if the average ligand binding density ν is the same for x 
solutions containing different ligand and macromolecule total concentrations (Lt, Mt)x, then the free 
ligand concentration Lf will also be the same in each solution. The mass conservation equation shown 
in Equation 2-3 can be applied for a set of x concentration pairs (Lt, Mt)x which have the same ν and 
Lf values. 
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ftt LML +⋅=ν     (2-3) 
 
In practice, ν and Lf can be determined from the slope and intercept of the plot of Lt vs Mt for x 
solutions which have the same ν and Lf.  
In order to obtain the Lf and ν values, a set of concentration pairs (Lt, Mt)x that correspond to 
pairs of Lf and ν values have to be found, which is achieved through the BDF analysis described in 
the following section. A commonly adopted experimental routine to monitor binding takes advantage 
of the changes in a signal Φ (e.g., UV absorbance, fluorescence intensity, or CD ellipticity) upon the 
formation of complexes. If the signal is from the macromolecule, then it is related to the individual 




MisfMfs    (2-4) 
 
where, Mf and Mi are the concentrations of free and bound macromolecule, respectively. sf is the 
molar signal of the free macromolecule. si is the molar signal of each macromolecular species at 
concentration Mi with i ligands bound.  
The mass conservation equation, which relates Mf and Mi to the total concentration of 




iMfMtM     (2-5) 
 
Equation 2-4 can be converted to Equation 2-6 by applying the mass conservation given in Equation 




iivfsistMtMfs )/)((    (2-6) 
 
Equation 2-6 can be used to define a relative change in Φ (Lohman and Bujalowski, 1991). 
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In Equation 2-7, (si −sf )/sf  is the molecular signal change in the complex containing i ligands, which 
is an intrinsic molecular property of the system. Equation 2-7 indicates that ∆Φ is a unique function 
of νi, where ∆Φ is referred to as the macromolecular binding density function (MBDF). At 
equilibrium, each separate value of νi is a function of the free ligand concentration Lf only, which is 
strictly determined by the average binding density ν as indicated in Equation 2-2 (Lohman and 
Bujalowski, 1991; Schwarz, 1977 & 2000). Therefore, ∆Φ is a function of Lf and hence ν only. The 
solutions with a set of x pairs of total concentrations (Lt, Mt)x for which ∆Φ is the same, will have the 
same ν  and Lf values. Consequently, ∆Φ is an appropriate function to use in finding the set of 
concentration pairs (Lt, Mt)x which have the same ν  and Lf values. The outcome can determine the 
true values of Lf and ν from the slope and intercept of the plot of Lt vs Mt for a given ∆Φ value. Such 
a procedure is illustrated in Figure 2.5 and Figure 2.6. 
 
 
Figure 2.5. Theoretical titration curves of the signal ∆Φ as a function of ligand concentration for two 
different macromolecule concentrations. The figure is reprinted from Jezewska and Bujalowski 
(1996). 
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Figure 2.6. Plot of ligand concentration Lt as a function of macromolecule concentration Mt for a 




In Figure 2.5, the horizontal line intersecting four titration curves is characterized by the same 
∆Φ value. The points where this horizontal line intersects each titration curve defines the four sets of 
(Lt, Mt)x (x = 1 to 4) concentrations which have the same ν  and Lf values. One set of (ν, Lf) values can 
be obtained from the slope and intercept of the plot of Lt vs. Mt in Figure 2.6 for a given ∆Φ value. A 
binding isotherm can be generated by drawing several such horizontal lines and determining the ν and 
Lf values. Such a derivation is independent of specific binding models and as such, can be generalized 
to any binding system. Execution of this procedure requires to generate ∆Φ vs. ligand concentration 
plots for different macromolecule concentrations. 
The above derivation works when the signal arises from the macromolecule. If the observed 
signal arises from the ligand, then the binding density function requires a slightly different analysis. 
Although the expression of the BDF depends on whether the observed signal arises from the 
macromolecules or the ligands, it remains a unique function of the binding density. Accordingly the 
above procedure for generating the binding isotherm is suitable for both cases as long as the systems 
exhibit a change in the physicochemical or biological signals (Lohman and Bujalowski, 1991). Tables 
2.2 and 2.3 (Lohman and Bujalowski, 1991) summarize the expressions of the BDF when the 
experimentally observed signal is due to changes in the fluorescence or absorbance of the 
macromolecule and ligand, respectively.  
The expressions for the binding density function listed above are for spectroscopic changes, 
but they can be universally extended to any kind of change which is only function of the average 
binding density. The basic idea about the binding density function (BDF) analysis was independently 
proposed in 1987 by two groups who applied it to protein-nucleic acid binding (Bujalowski and 
Lohman, 1987) and peptide-liposome interaction (Schwarz, et al., 1987). However, the underlying 
concept can be applied to any macro- or supramolecular binding system (Schwarz, 2000).  
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Table 2.2.  Macromolecular binding density functions (MBDF) for different spectroscopic signals 
Method ∆Φ (MBDF) Comments 
Absorbance ∑ Δ=Δ
i i
iiA νε )/(  
where
 oAoAAA /)( −=Δ
ffii εεεε /)( −=Δ
 
εf and εi are the extinction coefficients for the free and 
bound macromolecule. Ao and A are the absorbance 
of the macromolecule solution in the absence and 
presence of ligand, respectively.  
Fluorescence ∑ Δ=
i i
iiFQ ν)/(  
where  
oIoIIQ /)( −=
fFfFiFiF /)( −=Δ  
Ff and Fi are the molar fluorescence for the free and 
bound macromolecule. Io and I are the fluorescence 
of the macromolecule solution in the absence and 
presence of ligand, respectively. 
 
Table 2.3.  Ligand binding density functions (LBDF) for different spectroscopic signals 
Method ∆Φ (LBDF) Comments 
Absorbance ∑ Δ=Δ
i i
iitMtLA νε )/()/(  
where  
oAoAAA /)( −=Δ  
ffii εεεε /)( −=Δ  
εf and εi are the extinction coefficients for the free 
ligand and each state of the bound ligand. Ao and A 
are the absorbance of the ligand solution in the 




iiFtMtLQ ν)/()/(  
where  
oIoIIQ /)( −=  
fFfFiFiF /)( −=Δ  
Ff and Fi are molar fluorescence for the free ligand 
and each state of the bound ligand. Io and I are the 
fluorescence of the ligand solution in the absence and 
presence of macromolecule, respectively. 
 
In the self-assembling peptide-oligonucleotide binding system, the binding may result in the 
formation of aggregates due to the potential for self-assembly of peptides into nanostructures. In that 
case, an oligonucleotide molecule is either in the aggregated or soluble state. This situation is likely to 
occur since it is not uncommon that the ligand-nucleic acid binding causes aggregate formation or 
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condensation of the DNA (Morris, et al., 1997 & 1999; Teif, et al., 2005). How to extend the BDF 
analysis to such a binding system and to generate binding isotherms is of interest. Although the 
research for extending the BDF analysis to such a binding system has not been conducted yet, some 
studies may provide insights/hints to identify the experimental signal that yields the binding density 
function ∆Φ, which is the key element in the BDF analysis. Such an example is found in the 
investigation of the ligand-induced DNA aggregation or condensation (Teif, et al., 2001 & 2005) 
where the fraction of condensed/aggregated DNA has been shown to be a unique function of the 
binding density. The following section reviews the arguments made by Teif et al.  
The principles of the calculation of the equilibrium binding of large ligands to DNA were 
formulated in the late 1960s to the 1970s (Crothers, 1968; McGhee and von Hippel, 1974). DNA 
condensation is one of the processes that may be treated using this formalism. There are several 
possible descriptions of DNA condensation caused by ligand binding. The two-state model is one of 
them (Figure 2.7). This model implies that a DNA molecule is either in the starting (soluble) or 
condensed (aggregated) state, intermediate state being forbidden. The ligands may reversibly bind 
each DNA state with different binding constants and different stoichiometric parameters.  
The parameters corresponding to the soluble or condensed DNA are denoted by the subscript 
j (= 1 or 2, respectively). Each DNA molecule consists of L base pairs (units). nj DNA molecules are 
in state j with gj bound ligands. Co is the molar concentration of free ligands in solution, while cj = 
gj/(njL) is the relative concentration of ligands bound to DNA in the form i; in other words, the 
binding density for the DNA in state j. The binding is supposed to be reversible, i.e., each ligand can 
change its location at the DNA chain, dissociate, and bind again to other DNA molecules. 
 
 soluble         condensed        soluble
K1 K2 K1
Ligand concentration  
 
Figure 2.7. The two-state model. DNA may be in one of the two states: soluble or condensed. The 
two DNA states bind ligands with different binding constants, K1 and K2, and different 
stoichiometries.  
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The change in the free energy [ΔF (g1,g2,co)] resulting from the binding of gj ligands to nj 









jjjjjo WRTggFnCggF μψ  (2-8) 
 
where Fj is the free energy of a DNA molecule in the j state in the absence of adsorbed ligands; ψj is 
the free energy corresponding to a DNA molecules in the state j with gj bound ligands; μ is the 
chemical potential of the free ligand, which has the same expression as the left-hand side of Equation 
2-1; W is the number of ways in which the bound ligands can be arranged on the DNA molecule of L 
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   (2-10) 
 
Kj is the binding constant for the ligands that are bound to DNA in the state j; mj is the number of 
DNA base pairs covered by one ligand molecule upon binding to DNA in state j; and rj equals 0.5 or 1 
depending on whether a bound ligand interacts with one or two DNA strands of double-stranded 
DNA, respectively. Equation 2-10 suggests that the binding density cj is strictly determined by the 
free ligand concentration Co since rj and mj are constant values. Thus, the Equation 2-10 can be 
rewritten under the form KjCo = ϕ(cj);  in other words, the thermodynamic basis for the BDF analysis 
is fulfilled.  
The expression of the fraction of condensed DNA molecules ϑ is also obtained by 
minimizing ΔF and its expression is given in Equation 2-11 
 
)1/( 1212 USUS +=ϑ      (2-11) 
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where S12 is the equilibrium constant for the transition between the soluble and condensed states of 




















U   (2-12) 
 
Given that rj and mj are constant values, Equation 2-12 suggests that U is only function of the binding 
density cj, which is determined by the free ligand concentration Co, as indicated in Equation 2-10. 
Thus, U is a unique function of the free ligand concentration and hence the average binding density, 
and so is ϑ  thanks to Equation 2-11. In other words, ϑ can be considered as an appropriate binding 
density function (i.e. ϑ = ∆Φ = f(Lf)= ϕ(ν)), whose expression can be expected to be more 
complicated than those listed in Tables 2.2 and 2.3.  
In the case where a peptide binds to DNA, ϑ  can be calculated from the UV-Vis absorbance 
of the DNA solution in the absence of ligand and that of the supernatant of the peptide-DNA solutions 
after they have been centrifuged. Once plots of the fraction of condensed DNA molecules ϑ vs. ligand 
concentration for different DNA concentrations are obtained, the binding isotherms can be generated 
based on the BDF analysis. This thesis draws heavily from these considerations to characterize the 
binding of two self-assembling peptides to DNA molecules. 
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Chapter 3 
 Interaction of a Self-Assembling Peptide with Oligonucleotides: 
Complexation and Aggregation 
3.1 Introduction 
Self-assembling peptides have recently emerged as one of the most promising biomolecular materials 
in bio-nanotechnology research (Zhang, et al., 1993 & 1994 & 2002; Aggeli, et al., 1999; Chen, 
2005). The self-assembly of peptides not only relates to many naturally occurring states of proteins, 
such as amyloid fibrillogenesis (Aggeli, et al., 1999), but also provides useful biomolecular building 
blocks for a wide variety of supramolecular fabrications (Zhang, et al., 1993 & 2002; Chen, 2005). 
Among the new self-assembling peptides is a class of ionic-complementary, amphiphilic peptides, 
e.g., EAK made of glutamic acid (E), alanine (A), and lysine (K) residues (Zhang, et al., 1993). This 
new class of peptides originates from zuotin, a yeast protein that preferentially binds to left-handed Z-
DNA (Zhang, et al., 1993). The molecular structure of these peptides contains alternating positive and 
negative charges, enabling ionic-complementarity. This ionic complementarity, together with 
hydrogen bonding, hydrophobic, and van der Waals interactions promotes self-assembly of the 
peptide molecules into highly stable aggregates (Hong, et al., 2003; Fung, et al., 2003; Chen, 2005). 
The nano/microstructures constructed from the peptide self-assembly have found many biomedical 
applications, including scaffolding for tissue engineering (Zhang, et al., 1995; Holmes, et al., 2000) 
and biological surface patterning (Zhang, 2002). It has been shown recently that these peptides can 
encapsulate a hydrophobic organic compound and unload it into a model cell membrane in a 
controlled manner (Keyes-Bag, et al., 2004). It is interesting to see if these self-assembling peptides 
can also be used for carrying DNA or RNA in gene delivery, which is the current bottleneck to gene 
therapy (Plank, et al., 1999; Simeoni, et al., 2003). Our particular interest is the self-assembling 
peptide-mediated delivery of antisense oligonucleotides and short-interfering RNAs (siRNAs) 
(Bergen and Pun, 2005). 
The first key step to develop an oligonucleotide delivery system is to form peptide-
oligonucleotide complexes (Plank, et al., 1999; Simeoni, et al., 2003). This entails the study of the 
binding of the peptide to oligonucleotides and the conformations of the resulting peptide-
oligonucleotide complexes. The peptide and oligonucleotides used in this work are EAK16-II, a well-
studied self-assembling peptide (Zhang, et al., 1993) referred to as EAK later on, and both single- and 
double-stranded oligodeoxynucleotides (ODNs), namely a guanine hexadecamer (dG16), a cytosine 
 46        
Chapter 3     
hexadecamer (dC16), and their duplex (dGC16).  It has been argued that many peptide-nucleic acid 
interactions are not sequence-specific, resulting from non-covalent molecular interactions (Schwarz 
and Watanabe, 1983; McGhee and von Hippel, 1974; Muller, et al., 1991; Scatchard, 1949; Latt and 
Sober, 1967; Crothers, 1968; Schwarz, 1970; Epstein, 1978; Tsodikov, et al., 2001; Bujalowski and 
Lohman, 1987; Morii, et al., 1996). Thus, the dG16 and dC16 hexadecamers were chosen to assess how 
a purine or a pyrimidine affects the binding of a self-assembling peptide to an oligonucleotide. Since 
most therapeutic antisense oligonucleotides and siRNAs are short nucleic acids of less than 22 
nucleotides in length, the choice of 16 mers is somewhat arbitrary but within the usual therapeutic 
oligonucleotide length range.   
While there has been no study of binding between self-assembling peptides and 
oligonucleotides, numerous investigations have been done on the binding between proteins and 
nucleic acids (Plank, et al., 1999; Simeoni, et al., 2003). Characterization of the binding between a 
ligand protein and a nucleic acid requires the determination of the concentrations of the free and 
bound species involved. These quantities can be obtained by relating them to changes in the 
physicochemical or biological properties resulting from the formation of complexes (Bujalowski and 
Lohman, 1987). In most instances, these changes can be probed by techniques such as gel mobility 
shift assay (Morii, et al., 1996; Stierle, et al., 2003), filter binding assay (Agou, et al., 1999), surface 
plasmon resonance (Seimiya, et al., 1996), and fluorescence (Michel, et al., 2003; Endoh, et al., 
2005). These last methods require labeling of the ligand with a chromophore or radioactive isotope, or 
covalent immobilization of the ligand. Besides being time consuming, labeling or immobilization of 
ligands can affect their biochemical activity, resulting in an inaccurate binding isotherm. Other 
characterization methods, such as boundary sedimentation velocity (Jensen and von Hippel, 1977) 
and UV difference spectra (Boraston, et al., 2000), do not require labeling of the molecule of interest, 
although labeling can be used if the behavior of a specific species needs to be isolated (Galletto, et al., 
2003). 
In this work, UV absorption measurements were adopted in conjunction with centrifugation 
of solutions of oligonucleotide and peptide, where the concentration of the oligonucleotide left in the 
supernatant could be determined. This method, also referred to as the depletion method (Creagh, et 
al., 1996), has the advantage of not requiring large quantities of samples or any chemical labelling. 
As will be shown later, this combination of UV absorption and centrifugation may be used for a wide 
range of solution systems where both molecular binding and subsequent aggregation occur. 
Oligodeoxynucleotides naturally exhibit a characteristic absorbance in the UV-Vis range. Upon 
peptide binding, aggregates made of peptide-ODN complexes formed. These aggregates could be 
centrifuged out, leaving behind a mixture of unbound ODNs and some EAK-ODN complexes in the 
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supernatant. The concentration of ODN in the supernatant was determined by UV absorption. The 
experimental results were treated with a binding density function analysis (Bujalowski, and Lohman, 
1987; Bujalowski, and Klonowaka, 1994) to generate isotherms of the binding between peptide and 
ODNs. The outcome was analyzed further with the modified non-cooperative McGhee and von 
Hippel (MvH) model for the purpose of comparing the effects of solution conditions and ODN types 
(McGhee and von Hippel, 1974; Tsodikov, et al., 2001).   
Some unique challenges are encountered when studying the interaction of a self-assembling 
peptide with an ODN.  Since the peptide can self-assemble into nanostructures, EAK nanofibers in 
the present case (Zhang, et al., 1993; Fung, et al., 2003), there is a question as to whether EAK would 
bind to the ODN molecules directly, or EAK would first self-assemble into its aggregates to which 
the ODN binds subsequently. This paper presents a series of experiments designed to demonstrate 
that EAK binds to ODNs in molecular form, before the peptide self-assembly takes place. The 
peptide-ODN aggregates are believed to form after an initial step of molecular binding between 
peptide and ODN molecules, and a subsequent association of the peptide-ODN (intermediate) 
complexes into aggregates, possibly assisted by the inherent self-assembly capability of the peptide.   
After binding and nanostructure formation with the peptide, the ODN was further evaluated 
for its accessibility to solvent species by fluorescence quenching experiments, as this property is 
critically important to assess the stability and potency of ODNs during their delivery both in vitro and 
in vivo (Plank, et al., 1999; Simeoni, et al., 2003). This study represents the first example in the 
literature where the binding of a self-assembling peptide to oligonucleotides is characterized.  
 
3.2 Experimental Section 
Materials and Methods   
All reagents were of analytical grade and obtained from BDH (Poole, UK). The pH dependence of the 
binding of EAK to the ODNs was investigated by performing experiments at three different pHs. The 
pH 4 buffer was made with 0.171 M acetic acid and 0.029 M sodium acetate adjusted with acetic acid 
(Akinrimisi, et al., 1963); the pH 7 buffer was made with 0.01 M tris(hydroxymethyl)methylamine 
and 0.005 M sodium sulfate adjusted with sulfuric acid (Akinrimisi, et al., 1963); the pH 11 buffer 
was made with 0.1 M glycine and 0.1 M sodium chloride adjusted with sodium hydroxide (Bolumar, 
et al., 2003). 
 The EAK16-II peptide whose sequence is shown in Table 3.1 and the C-terminus 
carboxyfluorescein labeled EAK (FAM-EAK) were purchased from Research Genetics (Alabama, 
USA) and used without further purification. 
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Four single-stranded oligodeoxynucleotides (ssODNs), namely dG16, dC16, FAM-dC16 (dC16 
labeled with carboxyfluorescein at the 5’-end), and dC16-Rh (dC16 labeled with 
carboxytetramethylrhodamine at the 3’-end) were obtained with 95 % purity from Eurogentec North 
America (San Diego, USA) with HPLC purification. The ODN sequences are listed in Table 3.1. 
Solutions of the double-stranded ODNs (dsODNs) at different pHs were prepared one day before use 
by mixing two equimolar amounts of complementary ssODNs in the corresponding buffer in 
Eppendorf tubes, placing the tubes in a 95 ºC water bath for 5 minutes, turning off the water bath, and 
letting the solution slowly cool to room temperature.   
Table 3.1. Type, name, and sequence of oligonucleotides (ODNs) and self-assembling peptide. 
Type Name Sequence 
dG16 5’-GGG GGG GGG GGG GGG G-3’ 
dC16 5’-CCC CCC CCC CCC CCC C-3’ 




dC16-Rh 5’-CCC CCC CCC CCC CCC C-Rhodamine-3’ 
dGC16
5’-GGG GGG GGG GGG GGG G-3’ 
 
UV-Vis Absorbance. UV-Vis absorption spectra were obtained on a Hewlett-Packard 8452A 
diode array spectrophotometer (California, USA) using a 50 μL quartz cuvette from Hellma 
(Müllheim, Germany).  
Samples for the construction of binding isotherms were prepared at pH 4, 7, and 11. For each 
pH, three or four ODN concentrations of about 3 μM and 7 μM were used. At each ODN 
concentration, six to seven samples were prepared with EAK concentrations ranging from 0 to 0.2 
3’-CCC CCC CCC CCC CCC C-5’ 
Double-stranded 
ODN 
                      5’-GGG GGG GGG GGG GGG G-3’ 
(dsODN) FAM-dGC16
                    3’-CCC CCC CCC CCC CCC C-Fluorescein-5’
EAK                       n-AEAEAKAKAEAEAKAK-c
 
EAK16-II 
FAM-EAK         n-AEAEAKAKAEAEAKAK-c-Fluorescein
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mg/mL (equivalent to 0-120 μM) by mixing the ODN solution with different amounts of EAK 
powder. The resulting solutions were stirred vigorously for a few seconds with a vortex mixer and 
incubated at 25 ºC for 30 mins. The EAK-ODN aggregates formed in the solution were removed by 
centrifugation at 10,000 rpm for 2 minutes with a Centrifuge 5410 from Eppendorf (Hamburg, 
Germany). The supernatant was collected and its absorbance was measured on the spectrophotometer 
at wavelengths between 190 and 800 nm. Beer’s Law was used to determine the total ODN 
concentration and the concentration of the ODN left in the supernatants from the absorbance of the 
ODN at 260 nm of the initial solution (ODo) and the supernatant (ODs), respectively. The term (ODo-
ODs)/ODo was defined as the relative UV-Vis absorbance change ∆ODr. The obtained ∆ODr were 
then analyzed using the ligand binding density function (23) to generate binding isotherms. 
Polyacrylamide Gel Electrophoresis (PAGE). PAGE was applied to detect whether EAK-
dsODN complexes/aggregates were present in the supernatant after centrifugation. Samples 
containing 3.6 μM of dGC16 with 0, 0.01, 0.1, or 0.2 mg/mL (0, 6, 60, or 120 μM) of EAK were 
prepared at pH 4 and 7. The supernatants obtained by centrifuging the samples were analyzed with 
non-denaturing 20 % PAGE. The polyacrylamide gels were 14 cm long × 15 cm wide × 0.5 mm 
thick. PAGE was performed in pH 4 or pH 7 buffer at 10 V/cm for 2 hrs. The gels were stained with a 
solution of 0.5 mg/mL ethidium bromide for 30 mins before being visualized with a Bio-Rad UV 
Transilluminator gel document system (California, USA).  
Steady-State Fluorescence. Fluorescence spectra of dC16 labeled with carboxyfluorescein at 
the 5’-end (FAM-dC16), dC16 labelled with carboxytetramethylrhodamine at the 3’-end (dC16-Rh), and 
EAK labeled with carboxyfluorescein at the C-terminus (FAM-EAK) were acquired on a Photon 
Technology International steady-state fluorometer (New Jersey, USA) equipped with a Ushio UXL-
75Xe Xenon arc lamp and PTI 814 photomultiplier detection system. The peak absorption 
wavelength of the solution was chosen as the excitation wavelength (λex). For the FAM-dC16 and 
FAM-EAK solutions, λex was 452 nm at pH 4 and 494 nm at pH 7, respectively; for the dC16-Rh 
solutions, λex was 560 nm at both pH 4 and pH 7. 
Steady-State Fluorescence Anisotropy. Anisotropy of the supernatants obtained after 
centrifuging the solutions was measured using the steady-state fluorometer with polarizers fitted on 
the excitation and emission monochromators. Each sample was excited with vertically polarized light, 
and the fluorescence intensity was separately detected with the emission polarizer set in the vertical 
(IVV) and horizontal (IVH) orientations. In a fluorescence anisotropy experiment, the polarization 
dependence of the emission monochromator was corrected by the G factor (Lakowicz, 1999). To 
obtain the G factor, the excitation polarizer was set to the horizontal direction, and the fluorescence 
intensities were measured individually with vertical (IHV) and horizontal (IHH) emission polarization. 
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The G factor is given by the IHV /IHH ratio. The fluorescence anisotropy (r) was calculated using 









=      (3-1) 
 
The wavelength corresponding to the maximum absorption of FAM was chosen as the excitation 
wavelength (λex). The fluorescence intensity was monitored at 514 nm, the peak wavelength of the 
emission spectra.  
Time-Resolved Fluorescence Decays. Fluorescence decays were acquired by the time-
correlated single photon counting technique on a time-resolved fluorometer (IBH system 2000, 
Glasgow, UK). Samples containing 3.6 μM of the chromophore-labeled dC16 were prepared in the 
presence and the absence of 0.2 mg/mL (120 μM) EAK at pH 4. The excitation wavelength (λex) and 
emission wavelength (λem) were set to the wavelength corresponding to the absorption and emission 
maxima of the chromophores. For FAM-dC16, λex and λem were 452 nm and 514 nm, respectively; for 
dC16-Rh, λex and λem were 560 nm and 580 nm, respectively. A right angle configuration was used 
between the excitation and emission monochromators. All decay curves were collected over 512 
channels with the rate of 59.3 ps/ch and with a total of 20,000 counts in the channel of maximum 
intensity. The analysis of the decay curves started by acquiring the instrument response function 
obtained with a scattering solution, which was then convoluted with a sum of exponentials shown in 
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where i=1, 2,… N; N is the minimum number of exponentials required to achieve a good fit (N<4). 
The fitting parameters were optimized using the Marquardt-Levenberg algorithm (Press, et al., 1992). 
The fits of the fluorescence decays were deemed satisfactory when the χ2 value was smaller than 1.2 
and the residuals and autocorrelation function of the residuals were randomly distributed around zero. 
Static Light Scattering (SLS). SLS intensity of solutions of EAK, ODNs, and their mixtures 
was monitored at right angle with the steady-state fluorometer by irradiating the solution at 350 nm 
where the ODNs and EAK do not absorb or emit.   
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Dynamic Light Scattering (DLS). The hydrodynamic diameter of the EAK-ODN 
complexes/aggregates in the pH 4 buffer was obtained with a Zetasizer Nano ZS instrument equipped 
with a 4 mW He-Ne laser operating at 633 nm (Malvern, UK). All measurements were performed at 
25 ºC at a measurement angle of 173º. Dust particles were found to be absent in the buffer solutions 
used to prepare the samples, as confirmed by dynamic light scattering. DLS experiments were 
performed 30 mins after sample preparation.  
Atomic Force Microscopy (AFM). A Picoscan atomic force microscope (Molecular 
Imaging, Arizona, USA) was used to study the morphology of the EAK-ODN complexes/aggregates 
in solution. It was operated in magnetic AC (MAC) tapping mode in solution using magnetically 
coated cantilevers, Type II MAClevers (Molecular Imaging, Arizona, USA), with a spring constant of 
0.5 N/m and a resonance frequency of ~27 kHz at room temperature. A volume of 400 μL of each 
solution was deposited on a freshly cleaved mica surface, inside a Teflon liquid chamber, where the 
AFM images were acquired. 
3.3 Theoretical Background 
As will be shown in the Results and Discussion section, interaction of EAK with ODN results in 
aggregates composed of EAK and ODN. The fraction of ODNs in the aggregates can be obtained 
from the relative change in absorbance, ∆ODr, described in the Experimental Section. It has been 
shown (Teif, and Lando. 2001; Teif, 2005) that the fraction of ODN in aggregates is a unique 
function of binding density (ν), which is in turn a sole function of the free ligand concentration (Pf). 
The binding density, ν, is defined as (McGhee and von Hippel, 1974; Ballin, et al., 2004) 
 
tb DP /=ν      (3-3) 
 
with Pb being the concentration of the total bound peptide and Dt the total ODN concentration 
expressed in terms of phosphate groups. Thus, ∆ODr is a unique function of Pf. The ligand binding 
density function proposed by Bujalowski and Lohman (Bujalowski and Lohman, 1987; Bujalowski 
and Klonowaka, 1994) can be adopted to construct a binding isotherm by creating a data set (ν, Pf). 
This procedure is described in more detail in the Section 2.4 of Chapter 2. Briefly, for any given 
∆ODr, Equation 3-4 relates Pf to the total peptide concentration and the total ODN concentration: 
  
txftx DPP ν+=
     (3-4) 
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where Ptx and Dtx represent the total concentrations of peptide and ODN at the xth ODN concentration 
(there are four ODN concentrations for each system, see Figure 3.1), respectively. Since Pf and ν are 
constant values for a given ∆ODr, the binding density ν can be obtained from the slope of the plot of 
Pt vs. Dt.  
The procedure for building binding isotherms consists of using three or four ODN 
concentrations and plotting the fraction of ODN in the aggregates, i.e., ∆ODr, as a function of the 
total peptide concentration (Figure 3.1). Each plot could be fitted reasonably well with the empirical 
equation ∆ODr = A×Pt /(1+B×Pt), where A and B are regression parameters which are listed in Table 
3.2. In this paper, sets of ν and Pf were obtained from the plot of Pt vs. Dt for a given ∆ODr. Seven-to-
ten ∆ODr values were chosen. For each ∆ODr value, the value of Pt was read from the fits of the 
curves shown in Figure 3.1 and plotted as a function of Dt. Then Pf and ν were obtained from the 
intercept and slope of the plot of Pt vs. Dt. Plotting ν/Pf versus ν generated the binding isotherms 
(Figure 3.2).  
The interaction/binding between EAK and ODN molecules most likely starts with the 
formation of the EAK-ODN complexes as will be argued in the Results and Discussion section, 
which is followed by further association of the complexes into aggregates. This process is described 
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where Kc and Ka are the equilibrium constants for the formation of EAK-ODN complexes from 
unimolecular ODN and EAK and for the formation of EAK-ODN aggregates from the association of 
EAK-ODN complexes, respectively. One important aspect of the procedure described above is that, 
although ∆ODr represents the fraction of ODNs present in the aggregates and does not account for the 
ODNs present in the supernatant as EAK-ODN complexes, ∆ODr is still a unique function of Pf and ν 
as demonstrated by the work of Teif et al. (Teif, and Lando. 2001; Teif, 2005). 
No suitable theoretical model could be found in the literature to describe the molecular 
binding (Kc) and aggregation (Ka) simultaneously unless the binding isotherm for each of the two 
steps has been constructed, which is not experimentally favored. To facilitate the analysis of the 
binding isotherms, i.e., the ν/Pf versus ν trends shown in Figure 3.2, the modified non-cooperative 
McGhee and von Hippel (MvH) model (McGhee and von Hippel, 1974; Tsodikov, et al., 2001) was 
used 
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where K is the overall binding constant, accounting for both molecular binding and aggregation steps.  
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B) C pH 4 C) GC pH 4 


































F) GC pH 7 D) G pH 7 E) C pH 7 
Figure 3.1. Plots of ∆ ODr as a function of the total EAK concentration. (A) pH 4, phosphate 
concentration of dG16 equals 32 μM (■), 64 μM (○), 94.4 μM (▲), and 152 μM (◇). (B) pH 4, 
phosphate concentration of dC16 equals 24 μM (■), 48 μM (○), 90 μM (▲), and 116.8 μM (◇). (C) 
pH 4, phosphate concentration of dGC16 equals 64 μM (■), 128 μM (○), 240 μM (▲), and 288 μM (
◇). (D) pH 7, phosphate concentration of dG16 equals 16 μM (■), 32 μM (○), 64 μM (▲), and 96 
μM (◇). (E) pH 7, phosphate concentration of dC16 equals 16 μM (■), 32 μM (○), 64 μM (▲), and 
96 μM (◇). (F) pH 7, phosphate concentration of dGC16 equals 32 μM (■), 64 μM (○), and 128 μM 
(▲). The solid and dashed lines represent the best fits to the equation ∆ODr = 
A×[EAK]/(1+B×[EAK]), but do not have any physical meaning. The A and B parameters have been 
listed in Table 3.2. Data in the range of 20-70 % of maximal ∆ODr are used to obtain the ν and ν/Pf 
values reported in Figure 3.2. 
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Table 3.2. Parameters A and B retrieved from the fits of the ∆ODr versus [EAK] plots shown in 
Figure 3.1 with the empirical equation: ∆ODr = A×[EAK] / (1+B×[EAK]). 
pH 4 dG16
Concentration 2.0 μM 4.0 μM 5.9 μM 9.5 μM 
A (10−4) 18.454 ± 3.465 4.513 ± 0.507 3.574 ± 0.613 2.846 ± 0.248 
B (10−4) 18.088 ± 3.853 3.645 ± 0.599 2.750 ± 0.751 2.053 ± 0.306 
 
pH 4 dC16
Concentration 1.5 μM 3.0 μM 5.0 μM 7.3 μM 
A (10−4) 19.262 ± 2.549 9.747 ± 0.981 6.954 ± 1.074 5.871 ± 0.583 
B (10−4) 22.309 ± 3.481 10.073 ± 1.249 6.547 ± 1.328 5.996 ± 0.823 
 
pH 4 dGC16
Concentration 2.0 μM 4.0 μM 7.5 μM 9.0 μM 
A (10−4) 4.871 ± 0.671 2.436 ± 0.414 1.599 ± 0.153 1.247 ± 0.140 
B (10−4) 5.539 ± 1.048 2.440 ± 0.670 1.367 ± 0.254 0.878 ± 0.236 
 
pH 7 dG16
Concentration 1.0 μM 2.0 μM 4.0 μM 6.0 μM 
A (10−4) 3.309 ± 0.387 2.612 ± 0.176 1.834 ± 0.163 1.237 ± 0.095 
B (10−4) 3.318 ± 0.587 2.425 ± 0.269 1.636 ± 0.267 0.844 ± 0.160 
 
pH 7 dC16
Concentration 1.0 μM 2.0 μM 4.0 μM 6.0 μM 
A (10−4) 1.341 ± 0.082 1.001 ± 0.027 0.752 ± 0.036 0.621 ± 0.034 
B (10−4) 1.686 ± 0.175 1.035 ±0.063 0.585 ± 0.085 0.339 ± 0.081 
 
pH 7 dGC16
Concentration  1.0 μM 2.0 μM 4.0 μM 
A (10−4) 0.748 ± 0.019  0.631 ± 0.035 0.503 ± 0.011  
B (10−4) 0.442 ± 0.038  0.306 ± 0.077 0.082 ± 0.023 
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Figure 3.2. Plot of ν/Pf versus ν for the binding of EAK to dG16 (■), dC16 (∆), and dGC16 (×) at (A) 
pH 4 and (B) pH 7. The solid lines represent the best fits to Equation 3-5. The parameters used in the 
fits are listed in Table 3.3. 
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It was noted that the MvH model describes the initial complexation process only, and does 
not take into account the second aggregation step. Nevertheless, we opted to use the MvH model for 
the following reasons: First, the main goal of the current study was to find differences or similarities 
in the process leading to the formation of EAK-ODN aggregates under different experimental 
conditions, e.g., pHs and nucleotide types; in other words, the MvH model is used for comparison 
purpose, as has been practiced before (Casas-Finet, et al., 1993). Second, the binding constant K 
calculated from the MvH model actually shows trends for the binding strength of EAK to different 
ODNs and under various solution conditions, which are also comparable with those reported for the 
binding of other DNA/peptide pairs. With these considerations, the binding isotherms shown in 
Figure 3.2 were fitted with Equation 3-5. Third, our experimental data are for equilibrium analyses. 
Although one can derive equilibrium equations for aggregation systems from the kinetic expressions 
of some aggregation models, such as the colloidal coagulation model, there are certain unique 
features in our systems that have not been dealt with in any of these coagulation models. The reasons 
are as follows: 1) our system starts with an initial complexation between peptide and oligo 
molecules, which we showed with the detection of dimers. It is then followed with aggregation of 
complexes, which we showed with the detection of aggregates.  None of the current coagulation 
models actually describes this two-step event.  It is reasonable to assume the kinetics is different 
between complexation and aggregation.  It has been shown (von Hippel et al.) for the peptide-oligo 
complexation, the conventional kinetics, such as those based on the law of mass action, does not 
work. Thus, the conventional coagulation approaches will not be appropriate, even for dimer or 
oligomer formation. 2) if we were to use the McGhee and von Hippel (MvH) model for the first 
complexation and a coagulation model for our aggregation kinetics, the current coagulation model 
tends not to work as it has many limitations, e.g., the coagulates are from the association of spherical 
particles, the collisions are binary and that fluctuations in density are sufficiently small, and the 
clusters are considered to move due to free Brownian motion. One of these limitations is the 
assumption of spherical particles.  From our experiments, we have fibrillar aggregates, which indicate 
the aggregation mechanisms in our case may be very different from other colloidal aggregation that 
the current coagulation models apply to.  It is conceivable that the similar arguments used in the MvH 
model, related to the structure of the particles and arrangement probabilities, have to be implemented 
in the coagulation model. This however has not been considered yet in any of the current analyses. 3) 
we may try to develop a coagulation model by taking into account the detailed structural information 
and using a similar approach to that of von Hippel et al.; however, this will take tremendous effort 
and be beyond the scope of the current work. 
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3.4 Results and Discussion 
This study aims at describing the interaction of EAK with ODNs. To reach this goal, several issues 
were addressed by carrying out a number of separate experiments. Each issue is treated in a separate 
part in this section. The structure of this section is briefly laid out here. First, proof of the binding of 
EAK to the ODNs was obtained by conducting absorption measurements on the supernatant of 
centrifuged solutions of the EAK-ODN mixtures. Second, PAGE, fluorescence anisotropy, and UV-
Vis absorption measurements were conducted to confirm that the quantity ∆ODr is an appropriate 
representation of the fraction of ODNs incorporated in the EAK-ODN aggregates. Third, fluorescence 
anisotropy and steady-state light scattering experiments established that the time scale over which the 
EAK-ODN aggregates form is much shorter than that over which the self-assembly of EAK occurs. 
Fourth, the size of the EAK-ODN aggregates was determined using AFM and dynamic light 
scattering. Fifth, the modified MvH model was used to compare the binding of EAK to the ODNs 
under different pHs and nucleotide types. Sixth, the accessibility of the ODNs to the solvent once 
encapsulated inside the EAK-ODN aggregates was investigated by performing fluorescence 
quenching experiments. 
 
3.4.1 Effect of pH on Binding 
EAK contains four glutamic acids (Glu, E) and four lysines (Lys, K) with pKa values of 4.25 and 
10.53, respectively (Lehninger, 1993). The carboxylic acid of Glu and the amine of Lys are 
negatively and positively charged at pH 7, respectively. Therefore, EAK exhibits alternating negative 
and positive charges along its backbone at pH 7. Since glutamic acid residues are mostly protonated 
under acidic conditions at pHs below 4.25, EAK molecules are expected to be positively charged at 
pH 4. Similarly Lys becomes neutral at pHs above 10.53, so that EAK molecules are expected to be 
negatively charged at pH 11. Since the binding of negatively charged ODNs to cationic molecules, 
such as lysine-rich peptides, is believed to be due to electrostatic attraction (Gottschalk, et al., 1996), 
the different charges born by EAK at different pHs should affect the binding of EAK to the ODNs, 
with a higher binding constant being expected at lower pHs. To check whether this prediction is 
correct, the binding of EAK to dC16, dG16, and dGC16 was monitored at pH 4, 7, and 11. Solutions 
were prepared with different EAK concentrations at two ODN concentrations. The absorbance of the 
solution supernatant was measured after the EAK-ODN aggregates had been centrifuged out. The 
relative change in absorbance, ∆ODr, was calculated by following the procedure described in the 
Experimental Section. Plots of ∆ODr as a function of the total EAK concentration were generated for 
each ODN concentration at pH 4 and 7 (Figure 3.1)).  
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In Figure 3.1, ∆ODr is found to increase with increasing total EAK concentration, eventually 
leveling off for the single-stranded dG16 and dC16 at pH 4. This trend indicates that more EAK binds 
to the ODNs upon increasing the EAK concentration, until the ssODNs are saturated. ∆ODr increases 
with increasing EAK concentration at pH 7 for both the ssODNs and the dsODN; however, it requires 
higher EAK concentration to reach the plateau. Furthermore at a given ODN concentration, the ∆ODr 
values at pH 7 are significantly lower than those at pH 4. These results suggest that increasing the pH 
from 4 to 7 results in a much weaker binding between EAK and the ODNs. At pH 11, no binding of 
EAK to the ODNs could be detected as the EAK concentration was varied from 0 to 120 μM and 
∆ODr equaled zero. Considering that the charge of EAK is changed from positive to neutral, and then 
to negative when the pH is increased from 4 to 7, and then to 11, the trends shown in Figure 3.1 
confirm the important role played by the electrostatic forces in the binding of EAK to the ODNs.  
 Figure 3.1 also shows the effect of the nucleotide type on binding. The ∆ODr values for dG16 
are higher than those for dC16 at a given EAK concentration, implying that more EAK binds to dG16 
than to dC16.  
 
3.4.2 Nature of the ODNs Remaining in the Supernatant after Centrifugation 
The fraction of the ODN in the EAK-ODN aggregates was determined from the relative UV 
absorbance change of the solution, ∆ODr, by assuming that no EAK-ODN aggregates remained in the 
supernatant after centrifugation. The validity of this assumption was verified first by fluorescence 
anisotropy experiments.  
Fluorescence anisotropy reflects changes in the rotational correlation time of a chromophore, 
which is related to the hydrodynamic volume of the species to which the chromophore is attached. 
Larger particles have a longer rotational correlation time, hence a larger anisotropy (Lakowicz, 1999). 
Solutions containing 3.6 μM of FAM-dGC16 or of FAM-dC16 were mixed at pH 4 and pH 7 with EAK 
concentrations ranging from 0 to 0.2 mg/mL (0-120 μM). The solutions were centrifuged and the 
fluorescence anisotropy of the supernatants was measured. The anisotropy of the supernatants was 
plotted in Figure 3.3 as a function of EAK concentration. The fluorescence anisotropy of FAM-
labeled ODNs equals 0.11 ± 0.01 and 0.04 ± 0.01 at pH 4 and pH 7, respectively. It does not equal 
0.02 or so as expected for a free chromorphore, because FAM cannot rotate freely and rapidly when it 
is covalently bound to ODNs. The lower anisotropy for FAM-ODN at pH 7 might be due to the decay 
time of FAM-ODN which increases from 3.3 ns to 4.1 ns when the pH of the solution is raised from 4 
to 7. When the FAM-labeled ODN solution was mixed with increasing EAK concentrations, the 
anisotropy of the FAM-labeled ODN species left in the supernatants ranged from 0.08 to 0.12 and 
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0.03 to 0.04 at pH 4 and pH 7, respectively, which was very close to that of the FAM-labeled ODN. 
These experiments indicate that, within the limit of accuracy of fluorescence anisotropy, the 
hydrodynamic volume of the fluorescently labeled species present in the supernatant of the EAK-
ODN solutions remains the same as that of FAM-ODN. The results demonstrate that unimers of ODN 
existed in the centrifuged solutions; no EAK-ODN aggregates were detected. 
To estimate the resolution limit of the fluorescence anisotropy experiments, the anisotropy of 
a 1 μM solution of FAM-dC16 was measured as a function of EAK concentration at pH 4 and was 
plotted in Figure A in the Appendices. With the K and n values (Table 3.3) retrieved from the analysis 
of the binding isotherms (Figure 3.2) using Equation 3-5, the fraction of ODNs incorporated in the 
EAK-ODN aggregates could be calculated and is also plotted in Figure A. It was found that ~10 
mol% of ODNs needs to be present in the EAK-ODN aggregates to induce a detectable change in 
fluorescence anisotropy. Consequently the small anisotropy found in Figure 3.3 suggests that if EAK-
ODN aggregates are left in the supernatant, they account for less than 10 mol% of the total ODN 
population. In other words, ΔODr shown in Figure 3.1 is an accurate representation of the fraction of 
ODNs in the EAK-ODN aggregates within ± 10 mol%.   
UV-Vis absorption experiments were performed to demonstrate the existence of EAK-ODN 
complexes in the supernatant that were not detected in the anisotropy experiments. The absorption 
spectra of the samples containing 3.9 μM of dC16–Rh in the presence and absence of 60 μM EAK 
were acquired before and after centrifugation. As shown in Figure 3.4, the absorption spectrum of a 
mixture of dC16-Rh and EAK is different from that of free dC16-Rh. Mixing dC16-Rh with EAK 
induced a decrease in the absorbance at the 563 nm band characteristic of dC16-Rh, and the 
appearance of a new prominent absorption band at 524 nm. The ratio of absorbance at 524 and 563 
nm (OD524/OD563) for dC16-Rh is 0.50 ± 0.01 and is concentration-independent as shown in Figure 
3.4B. This ratio changes to 0.89 and 0.78 after mixing with EAK, before and after centrifugation, 
respectively. Since EAK does not absorb where dC16-Rh does, the spectra and ratio of OD524/OD563 
for the mixtures would not be different from that of dC16-Rh alone if there were no complexation 
between EAK and dC16-Rh. The increase in the ratio of OD524/OD563 might be due to the dimer 
formation of rhodamine (Förster and König, 1957; Hamman, et al., 1996) after EAK complexed with 
dC16-Rh. Since most aggregates are centrifuged out and the ratio of OD524/OD563 after centrifugation 
is similar to that before centrifugation, what remains in the supernatant causing the higher 
OD524/OD563 ratio must be complexes, which are too small to be centrifuged out.  
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Figure 3.3. Fluorescence anisotropy of the supernatant of EAK solution mixed with 3.6 μM of (A) 
FAM-dGC16 at pH 4 (λex =452 nm, λem =514 nm), (B) FAM-dGC16 at pH 7 (λex =494 nm, λem =514 
nm), (C) FAM-dC16 at pH 4 (λex =452 nm, λem =514 nm), and (D) FAM-dC16 at pH 7 (λex =494 nm, 
λem =514 nm). 
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Figure 3.4. UV absorption spectra of dC16-Rh in the presence and absence of EAK at pH 7. (A) 3.9 
μM dC16-Rh (●), 60 μM EAK(+), 3.9 μM dC16-Rh and 60 μM EAK before centrifugation (−) and 
after centrifugation (×); (B) dC16-Rh at concentration of 3.9 μM (●), 2.0 μM (−), and 1.3 μM (×). 
 
Using the extinction coefficients of the rhodamine dimer reported in the literature (Hamman, 
et al., 1996), the data given in Figure 3.4A can be analyzed to estimate the concentrations of ODNs 
present in the solution as unimers (1.39 μM), complexes (1.63 μM), and aggregates (0.88 μΜ). In this 
situation, ΔODr would equal (0.88 μM)/(3.9 μM) = 0.23, close to the value of 0.28 obtained from the 
K and n values listed in Table 3.3. The agreement observed between the ΔODr values obtained 
through two different means supports the protocol discussed in the Theoretical Background for 
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analyzing the UV-Vis binding results (Figure 3.2). Despite the substantial amount of complexes 
remaining in the supernatant after centrifugation, no increase in anisotropy was observed in the 
supernatant (Figure 3.3C), whereas the presence of aggregates in the solution results in an observable 
increase in the anisotropy of the solution (Figure A). These observations suggest that the aggregates 
are much larger and more compact than the complexes, resulting in reduced mobility of the 
fluorescein label. More importantly, they highlight the structural difference between the flexible 
complexes and the large, compact and rigid aggregates. 
Non-denaturing PAGE experiments were further conducted to investigate the nature of 
dsODN in the supernatant after centrifugation. Samples containing 3.6 μM of dGC16 mixed with 0, 6, 
60, or 120 μM of EAK were centrifuged and their supernatants were run on a 20 % native gel at pH 4 
and pH 7. As shown in Figure 3.5A, for the gel obtained at pH 4 and stained with ethidium bromide, 
the bands corresponding to the supernatants of EAK-dGC16 mixtures (Lanes 2-4) appear at the same 
position as the band corresponding to dGC16 (Lane 1). A similar observation was obtained for the gel 
run at pH 7 with the EAK-dGC16 mixtures (Figure 3.5B). These results suggest that no EAK-dGC16 
aggregates of a size equivalent to 6-100 bp duplexes (Sambrook, et al., 1989) (i.e., the separation 
range of a 20 % polyacrylamide gel) remain in the supernatants after centrifugation.   
The above three experiments have shown that the centrifugation has separated the EAK-ODN 
aggregates from the original EAK-ODN solution. In the supernatant, there exist free EAK and ODN 
molecules, as well as EAK-ODN complexes. The fact that the complexes were not detected in either 
PAGE or anisotropy experiments is due to the inherent resolution limits of the anisotropy and PAGE 
experiments.   
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Figure 3.5. 20 % PAGE of 3.6 μM of dGC16 mixed with EAK at (A) pH 4 and (B) pH 7. The EAK 
concentrations are 0, 6, 60, 120 μM in lanes 1, 2, 3, and 4, respectively. 
3.4.3 Pathway of the EAK-ODN Binding 
Considering that EAK in solution has the potential to self-assemble and form aggregates, two most 
likely pathways can be proposed for the formation of EAK-ODN aggregates. In Pathway 1, EAK self-
assembles into the aggregates onto which the ODNs bind to form the EAK-ODN aggregates. In 
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Pathway 2, the self-assembly of EAK occurs on a time scale which is much longer than the binding of 
molecular EAK onto ODNs. In this case, the complexation of molecular EAK with ODN molecules 
occurs first, and is followed by the association of these complexes into aggregates. To identify which 
pathway is leading to the formation of EAK-ODN aggregates, the time scale over which EAK self-
assembles in solution was estimated. To this end, the fluorescence anisotropy of EAK and EAK-dG16 
mixtures was measured at pH 4 and 7 over a one hour period immediately after sample preparation 
using carboxyfluorescein-labeled EAK (FAM-EAK). These experiments were performed with 0.1 
mg/mL (60 μM) EAK solutions where 1 in 100 EAK molecules was fluorescently labeled. To these 
solutions, 5 μM of dG16 was added. The steady-state fluorescence anisotropy of EAK and the EAK-
dG16 mixtures was measured at pH 4 and 7 as a function of time. The results are shown in Figure 
3.6A and Figure 3.6B. Whether at pH 4 or 7, the fluorescence anisotropy of FAM-EAK alone remains 
constant as a function of time and equals 0.10 and 0.05, respectively. This trend indicates that EAK 
does not self-assemble in solution within a 1 hr period, at least to the resolution limit of the anisotropy 
measurements. On the other hand, addition of dG16 to the EAK solution results in a large increase in 
anisotropy, which reflects a large increase in the hydrodynamic volume of the species present in 
solution. These species are the EAK-ODN aggregates which may be centrifuged out. 
The interaction between individual EAK and ODN molecules was further confirmed by SLS 
experiments on EAK and EAK-dG16 mixtures. The light scattered by the EAK solution remained 
constant within the first 20 mins at pH 4 and pH 7 as shown in Figure 3.7A and Figure 3.7B, 
respectively. As a control, the light scattered by dG16 in the buffer solution and by the buffer solution 
alone was also monitored for 20 mins. The SLS intensity of both solutions remained constant and 
close to the SLS intensity of the solution containing EAK only. These results indicate that the size of 
EAK remains constant during the first 20 mins after sample preparation. In comparison, the SLS 
intensity of the EAK-ODN mixtures increased initially and then leveled off within 30 mins at both 
pHs. Since an increase in SLS intensity reflects an increase in particle size, these results confirm that 
the size of the complexes/aggregates increases up to a plateau ~ 30 minutes after mixing, a conclusion 
similar to that drawn from the anisotropy experiments (Figure 3.6). It is noted that the time scales for 
the formation of EAK-ODN aggregates shown in Figures 3.6 and 3.7 are slightly different. This is 
due to experimental delays between the time the EAK-ODN mixture was prepared and the 
measurement was conducted, which resulted in inaccuracy for the first 5 minutes. However, one can 
still conclude that the time scale for the formation of EAK-ODN aggregates is much shorter than that 
needed for EAK to self-assemble.  
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Figure 3.6. Fluorescence anisotropy of a 0.1 mg/mL EAK solution containing 1 mol % of FAM-EAK 
in the presence (●) and in the absence (○) of (A) 3.6 μM of dG16 at pH 4 (λex =452 nm and λem =514 
nm) and (B) 4.3 μM of dG16 at pH 7 (λex =494 nm and λem =514 nm).  
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Figure 3.7. SLS experiments performed on (○) the buffer and on solutions containing (▲) 3.6 μM 
dG16 and 0.1 mg/mL EAK, (□) 0.1 mg/mL EAK, (×) 3.6 μM dG16 at (A) pH 4 and (B) pH 7. λex =λem 
=350 nm. 
 
3.4.4 Size Characterization of EAK-ODN Aggregates by AFM and DLS 
The size of the EAK-ODN aggregates was characterized using AFM and DLS. Images of the 
dG16-EAK solution taken 8 and 60 mins after sample preparation are shown in Figure 3.8. Both small 
fibers and large aggregates were found after 8 and 60 mins and the sizes of these objects did not 
change during the 1 hr time period. The sizes of the smaller fibers are 36 nm wide, 5.2 nm tall and 
over 100 nm long. The large aggregates appear to be giant clusters of small fibers with lateral 
 67        
Chapter 3     
dimensions of 650 nm and a height of 35 nm. Two control experiments were performed: No 
nanostructure could be detected when a 2 μM dG16 solution was imaged by AFM. Sparsely 
distributed globular structures with a diameter of 34 nm and a height of 1 nm were observed for the 
0.1 mg/mL (60 μM) EAK solution 45 mins after solution preparation, which indicated that the 
majority of EAK molecules do not self-assemble into fibers (images shown in Section B of the 
Appendices). The small fibers and giant aggregates observed in the AFM images of the EAK-dG16 
solution are likely due to the association of the EAK-ODN complexes into aggregates. Since the 
morphologies of the aggregates observed after 8 and 60 mins are very similar, it suggests that the 
entire complexation process between dG16 and EAK is completed within a short time period, less than 
10 mins, which agrees with the conclusions drawn from the anisotropy (Figure 3.6) and SLS (Figure 








Figure 3.8. AFM images of the EAK-ODN complexes formed in a solution containing 3.6 μM dG16 
and 0.1 mg/mL EAK. The complexes were imaged in solution at pH 4. (A) 8 mins, (B) 60 mins, (C) 
70 mins, and (D) 75 mins. Images in C and D are zoomed in views of the marked areas in B and C, 
respectively.  
400 nm 100 nm 
C) B) 
 30 nm 
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In addition, the hydrodynamic diameter of the EAK-ODN aggregates in solution was 
obtained by DLS. The hydrodynamic diameter of the EAK-dG16 aggregates at pH 4 with varying 
concentrations of EAK was measured 30 min after sample preparation (Figure 3.9). The dG16 
solutions at 7.2 μM exhibited a species with a hydrodynamic diameter of ~ 7.5 nm which was 
attributed to isolated ODNs in solution. The diameter of the species present in the dG16 solution 
increased to around 150 nm upon adding EAK and remained constant as the EAK concentration was 
increased from 0.01 to 0.04 mg/mL (6-24 μM). This result suggested that EAK binds first to ODN 
molecules, followed by aggregate formation. The hydrodynamic diameter increased to 1000 and 2000 
nm when the EAK concentration was increased to 60 and 90 μM, respectively. This might be due to 
the excess EAK binding to preformed EAK-ODN complexes, resulting in a further increase in 
diameter. Under the condition used in Figure 3.9, dG16 is fully incorporated in the EAK-ODN 
aggregates for an EAK concentration of 60 μM, as shown in Figure 3.1 (empty square, Figure 3.1). 
Since 0.1 mg/mL (60 μM) of EAK exhibited a size of ~ 4 nm 40 minutes after preparation (Figure 
3.9), it indicates that EAK does not self-assemble during that time and is present as single molecules. 
The observed large diameters in the EAK-ODN mixture solution are due to the aggregates of ODN 
and EAK in solution. 
The results obtained by fluorescence anisotropy, SLS, and DLS all demonstrate that neither 
EAKs nor the ODNs self-assemble on their own within the first hour after sample preparation.  
Consequently the formation of EAK-ODN aggregates at pH 4 and pH 7 must result from the 
association of ODN and EAK unimers into complexes, which then self-assemble into aggregates (cf. 
Scheme I).   
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Figure 3.9. Population histogram of the EAK-ODN complexes as a function of particle diameter 
determined by dynamic light scattering. The EAK-ODN solutions contained 7.2 μM of dG16 with 
increasing EAK concentration at pH 4. The sample of EAK alone was 0.1 mg/mL (60 μM) and was 
measured 40 minutes after preparation. The concentration of dG16 alone was 7.2 μM.  
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3.4.5 Binding Parameters  
The curves shown in Figure 3.1 were used to generate plots of ν/Pf as a function of ν (Figure 3.2).  
Equation 3-5 was used to obtain the binding constant, K, and the binding site size, n. The K and n 
values obtained for the binding of EAK to the ODNs at various pH values are listed in Table 3.3. As 
discussed in the Theoretical Background section, the association of the EAK-ODN complexes into 
aggregates is not accounted for by the MvH model. However the fits of ν/Pf versus ν with the MvH 
model shown in Figure 3.2 are rather good. 
 
Table 3.3. Binding constant K and binding site size n retrieved from the fits of the data shown in 
Figure 3.2 with Equation 3-5. 
pH 4 pH 7 pH 11 
ODNs 
n K (104 M-1) n K (104 M-1) N K (M-1) 
dG16 1.66 ±0.05 7.6 ±1.2 1.16 ± 0.1 3.4 ± 0.5 No Interaction 
dC16 1.96 ± 0.02 4.7 ± 0.6 1.63 ± 0.03 2.0 ± 0.2 No Interaction 
dGC16 3.16 ± 0.2 4.2 ± 0.8 2.6 ± 0.3 0.7 ± 0.02 No Interaction 
* Each fit has R2 > 0.94 with at least 5 data points. The error on the K and n values is estimated by 
generating three binding isotherms based on the trends shown in Figure 3.2. These binding isotherms 
were generated by taking arbitrarily the larger, intermediate, and smaller ν/Pf values obtained 
according to the error bars shown in Figure 3.2. The three binding isotherms were fitted with the 
McGhee and von Hippel model (Equation 3-5). And the spread in the K and n values retrieved from 
the fits provided an estimate of the errors on K and n, as reported in Table 3.3.   
 
It is observed in Figure 3.1 that more EAK is required to form the same quantity of EAK-
ODN aggregates when the pH is increased from 4 to 7, as a result of weaker electrostatic forces at pH 
7. This observation is reflected quantitatively in Table 3.3, where the binding constant at pH 4 is 2.2-, 
2.3-, and 6.0-fold larger than that at pH 7 for dG16, dC16, and dGC16, respectively. The equilibrium 
constants obtained for the binding of EAK onto the ODNs range from 7.0 × 103 to 7.6 × 104 M−1. In 
comparison, oligolysine and lysine-rich peptides such as KWKGK, KWK6, K4N4, K4N6, and Kn (n=3-
8) have been reported to bind to oligo- and polynucleotides with binding constants in the range of 
1×103~1×105 M−1 (Latt and Sober, 1967; Roy, et al., 1992; Matsuno, et al., 2001; Ballin, et al., 2004). 
These values are comparable to those listed in Table 3.3.  
The base composition of the ODN sequences, guanine in dG16 and cytosine in dC16, appears 
to affect the binding of EAK to the ODNs since EAK binds more strongly to dG16 than to dC16 at both 
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pH 4 and 7 (Table 3.3). Statistical analysis of protein-DNA complexes has established that Lys binds 
more readily to guanine (G) than to cytosine (C) (Lejeune, et al., 2005). Binding of Lys to G occurs 
more effectively via hydrogen bonds to the two acceptors of the G base, whereas Lys binds 
preferentially to the phosphate oxygens of the C nucleotide. Furthermore, the study found that Lys 
has the highest propensity to interact with nucleotides, whereas Glu and Ala have the lowest 
(Lejeune, et al., 2005). Since the interactions between nucleotides and glutamic acid are poor and 
since the favorable electrostatic forces between the negatively charged backbone of the ODNs and 
EAK are expected to be similar for dG16 and dC16, the observation that dG16 binds more strongly to 
EAK than dC16 is rationalized by the enhanced formation of hydrogen-bonds between the lysines of 
EAK and the guanines of dG16. 
The data listed in Table 3.3 indicate that EAK binds preferentially to ssODNs rather than to 
their duplex. This phenomenon has been observed for other peptides (Simeoni, et al., 2003). This 
might be caused by the formation of hydrogen bonds between the amino acids of EAK and the 
nucleotide bases of ssODNs. This favorable interaction disappears in the case of dsODNs, since each 
nucleotide base hydrogen-bonds with the opposite base in the complementary strand of the duplex.    
 
3.4.6 Solvent Accessibility of ODNs in the EAK-ODN Aggregates 
One important aspect of the structure of the EAK-ODN aggregates is whether the ODNs are located 
inside or outside the aggregates. ODNs located inside the aggregates will be less accessible to the 
solvent than those located on the surface, and hence be protected from the outside environment. The 
accessibility of the ODN to the solvent was measured by performing fluorescence dynamic quenching 
experiments. dC16 was labeled either at the 5’-end with fluorescein (FAM-dC16, λex = 452 nm, λem = 
514 nm) or at the 3’-end with rhodamine (dC16-Rh, λex = 560 nm, λem = 580 nm) to investigate 
whether both ends of dC16 are protected from the solvent. The fluorescence emission of a solution 
containing 3.6 μM of the labeled dC16 was monitored as the quencher KI was added to the solution in 
the presence or absence of 0.2 mg/mL EAK. Throughout these experiments, the potassium ion 
concentration was maintained constant and equal to 0.3 M by addition of K2SO4 to the KI solution, 
ensuring constant ionic strength. 
As the KI concentration increased, the fluorescence intensity of fluorescein or rhodamine 
decreased. The Io/I ratio was plotted as a function of iodide concentration in Figure 3.10A and 3.10 B 
for fluorescein and rhodamine, respectively. The quantities Io and I represent the fluorescence 
intensity of the chromophore without and with quencher, respectively. The Io/I ratio was found to 
increase linearly with iodide concentration for both chromophores in the absence or presence of EAK. 
However the increase was stronger in the absence of EAK. 
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The fluorescence decays of FAM-dC16 and dC16-Rh were acquired in the presence and 
absence of EAK. They were fitted with two exponentials according to Equation 3-2. The pre-
exponential factors and decay times obtained from the fits are listed in Table 3.4. Although 
fluorescein itself displays a single lifetime of 4.1 ns (Sjoback, et al., 1995), the decay becomes more 
complex when fluorescein is covalently attached to an ODN where it shows two decay times. This 
phenomenon has been reported (Sjoback, et al., 1998) to be due to a change in the conformation of 
fluorescein when it is covalently linked to an ODN. The binding of EAK onto the labeled ODN does 
not change the lifetime of the chromophore significantly as shown in Table 3.4.  
To ensure that the quenching is dynamic, the fluorescence decays of the FAM-dC16-EAK 
mixture were acquired in the absence and presence of 0.2 M KI. The average lifetime of the decays 
was determined and the ratio of the average lifetime of the solution without KI (το) over that of the 
solution with 0.2 M KI (τ) was found to be 1.8, i.e. το/τ =1.8. The Io/I ratio obtained from the steady-
state fluorescence measurements equaled 1.9 for a concentration of 0.2 M KI, a value comparable to 
the το/τ ratio. The agreement obtained between the Io/I and το/τ ratios strongly suggests that the 
quenching is dynamic (Lakowicz, 1999). Fitting the Io/I vs. [I−] trends shown in Figure 3.10 with the 
Stern-Volmer equation given in Equation 3-6 yields the bimolecular quenching rate constant, kq, 
which reflects the accessibility of the chromophore to the solvent (Lakowicz, 1999). 
 
][1][1/ QkQKII oqSVo τ+=+=    (3-6) 
 
The slopes of the straight lines referred to as the Stern-Volmer constants, KSV, are listed in Table 3.5. 
As indicated in Equation 3-6, kq is determined from the ratio KSV/το where το is the lifetime of the 
chromophore in the absence of quencher (Lakowicz, 1999). 
Since the fluorescence decay of the choromophores without quencher is biexponential, the 
average lifetime oτ  was used to calculate the bimolecular quenching rate constant kq from the slope 
KSV of the plots in Figure 3.10. The values of KSV, oτ , and kq are listed in Table 3.5. In the absence of 
EAK, kq for FAM-dC16 and dC16-Rh equals 2.5×109 M−1s−1 and 3.5×109 M−1s−1, respectively. The 
bimolecular quenching rate constant is related to the quenching efficiency, size, and diffusion 
coefficient of the chromophore and quencher. Since the iodide ions have quenching efficiencies near 
unity (Lakowicz, 1999) and the overall sizes of the two labeled ODNs are comparable, the differences 
in kq found for FAM-dC16 and dC16-Rh (Table 3.5) must reflect differences in the efficiency of iodide 
at quenching the excited chromophores. Indeed, FAM and Rh are neutral and positively charged at 
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pH 4, respectively. Considering electrostatic forces alone, the negatively charged iodide ions are 
expected to quench Rh more efficiently than FAM. In addition, FAM is expected to be less mobile 
than Rh as an 8- and 12-atom linker connects the 5’-end and the 3’-end phosphate groups of dC16 to 
FAM and Rh, respectively. In the presence of EAK, kq decreases for both FAM-dC16 and dC16-Rh. 
For FAM-dC16, kq decreases from 2.5×109 M−1s−1 to 1.5×109 M−1s−1. Similarly, for dC16-Rh, kq 
decreases from 3.5×109 M−1s−1 to 2.0×109 M−1s−1. Considering that the diffusion coefficient of the 
fluorophore-labeled ODN of 16 bases would be around 1.3 ×10¯6 cm2/s (Gordan, 2005), which is 10-
fold lower than that of iodide ion with 1.9 ×10¯5 cm2/s (Weast, 1971), kq will be affected by at most 
10 % by the diminution of the diffusion coefficient of the ODNs after incorporation in the EAK-ODN 
aggregates. Thus, the decrease in kq observed in Table 5 (~ 40%) suggests that the accessibility of 




 Figure 3.10. Stern-Volmer plots for a solution of 3.6 μM of fluorescently labeled dC16 free and 
bound to 0.2 mg/mL of EAK at pH 4 quenched by KI. Solid lines represent the fits to the Stern-
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Volmer equation with parameters listed in Table 3.5. (A) FAM-dC16 (▲), FAM-dC16-EAK (□), and 
(B) dC16-Rh (▲), dC16-Rh-EAK (□). 
 
Table 3.4. Pre-exponential factors and decay times obtained from the analysis of the fluorescence 
decays of the fluorescent ODNs in the absence and presence of EAK in pH 4 buffer, respectively. 
 τ1 (ns) α1 τ2 (ns) α2 τ  (ns)* χ2
FAM-dC16 
(without KI) 
3.9 0.67 2.0 0.33 3.3 1.12 
EAK-FAM-dC16
(without KI) 
3.7 0.63 1.7 0.37 3.0 1.00 
EAK-FAM-dC16
(with KI) 
2.8 0.43 1.0 0.57 1.7 1.15 
dC16-Rh 
(without KI) 
3.9 0.60 1.5 0.40 2.9 1.13 
EAK-dC16-Rh 
(without KI) 
3.8 0.58 1.3 0.42 2.8 1.37 









The change in accessibility of the ODNs upon EAK binding was quantified with the relative 





q kk /=γ      (3-7) 
 
where kqb and kqf are the bimolecular quenching constants for the chromophore-labeled ODNs in the 
presence and absence of EAK, respectively. The values of γ  for the two different labels are listed in 
Table 3.5. The relative accessibility changes of dC16 for both types of labels are similar and smaller 
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than unity, being 0.60 and 0.57 for the 5’-labeled FAM-dC16 and the 3’-labeled dC16-Rh, respectively. 
Since γ is smaller than 1.0, the accessibility of the 5’− and 3’−ends of dC16 to the solvent is reduced 
after the binding of EAK to dC16. Since the γ values corresponding to the two labels are similar, the 
accessibility of both ends of dC16 to the solvent is reduced by the same extent, about 40 %. The fact 
that different sections of the ODN exhibit a similar reduction in accessibility suggests that the entire 
ODN molecule is protected by the EAK molecules inside the EAK-ODN aggregates.  
 
Table 3.5. Stern-Volmer quenching constants KSV, bimolecular quenching rate constant, kq, 
fluorescence lifetime το, and relative accessibility change γ when dC16 is in the absence or presence of 
0.2 mg/mL of EAK in pH 4 buffer. 
5’ end fluorescein labeling 3’ end rhodamine labeling  














labeled dC16  
(free) 





4.6 ± 0.1 3.0 1.5 ± 0.1 0.60 5.5 ± 0.2 2.7 2.0 ± 0.1 0.57 
 
 
It is worth noting that while the negatively charged ODNs should repel the quencher (I−), the 
negative charges on the ODNs are, at least partially, neutralized by the positively charged EAK in the 
EAK-ODN aggregates. Consequently the iodide ions would be expected to be more efficient at 
colliding with the ODNs in the presence of EAK. Interestingly the opposite is observed, which 
strengthens the claim that EAK protects the ODN from its environment.   
Unprotected ODNs are rapidly degraded in vitro and in vivo due to the presence of nucleases. 
The reduction of accessibility to the solvent experienced by the ODNs upon assembly with EAK 
suggests that the degradation of the complexed ODN will be reduced when used in biological 
systems. Further investigations are underway to verify the stability of the EAK-ODN aggregates and 
the potential of ODN encapsulation by EAK for oligonucleotide delivery.  
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3.5 Summary 
In this work the molecular interaction of EAK with ODNs in solution was studied by a number of 
physicochemical methods. UV-Vis absorption experiments show that the binding between EAK and 
ODNs results in the formation of EAK-ODN aggregates which could be centrifuged out. 
Fluorescence anisotropy, PAGE, and UV-Vis experiments demonstrate that EAK-ODN complexes, as 
well as EAK and ODN unimers, exist in the supernatant of the centrifuged EAK-ODN mixtures. The 
binding isotherms between EAK and ODNs are established from the UV-Vis absorption results 
through a binding density function analysis. Fluorescence anisotropy and static light scattering 
experiments show that the process of EAK binding to ODNs starts with EAK-ODN molecular 
complexation, followed by association of the complexes into aggregates. For comparison purpose, the 
binding isotherm was fitted with the modified non-cooperative MvH model to extract the equilibrium 
“binding constants”. The binding is found to be strongest at pH 4. No binding is observed at pH 11. 
The equilibrium binding constant decreases 2-6 folds when the pH changes from 4 to 7. Since the 
equilibrium binding constant decreases as EAK becomes less positively charged, the interaction 
between EAK and ODNs must occur mainly via electrostatic interactions, but hydrogen bonding 
between EAK and the nucleotides of the ODNs may also be involved. Hydrogen bonds are believed 
to promote the binding of EAK to dG16 to a greater extent than to dC16. Furthermore, EAK has a 
slight preference to bind with the ssODNs than to the dsODN.   
The size of EAK-ODN aggregates was determined by AFM and DLS, and found to equal ~ 
150 nm at low EAK concentrations. Fluorescence quenching experiments showed that the 
accessibility of ODNs to the solvent was reduced upon EAK binding. EAK-ODN aggregates can 
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Chapter 4 
Binding of the Self-Assembling Peptide EAK16IV to 
Oligodeoxynucleotides: Effect of Charge Distribution  
 
4.1 Introduction 
Self-assembling peptides have recently drawn intense interests following their use in various 
biomedical engineering applications, including scaffolding for tissue engineering (Zhang, et al., 1995; 
Holmes, et al., 2000), biological surface patterning (Zhang, 2002), and drug delivery (Keyes-Bag, et 
al., 2004). In the application of oligonucleotide (ODN) delivery, self-assembling peptides offer 
several advantages over many other natural and synthetic peptides. The self-assembling peptides can 
not only be made cationic to enhance associations with ODNs via electrostatic interactions, but also 
possess unique distributions of charges and hydrophobic residues along their backbone that enable 
them to self-assemble into stable nanostructures.  
Among the self-assembling peptides is a class of ionic-complementary peptides, e.g., EAK 
peptides, which are made of glutamic acid (E), alanine (A), and lysine (K) residues (Zhang, et al., 
1993). EAK originates from zuotin, a yeast protein that preferentially binds to left-handed Z-DNA 
(Zhang, et al., 1993). It has alternating hydrophobic (A) and hydrophilic (E and K) amino acids. The 
pKa values of E and K are 4.25 and 10.53, respectively. Therefore, E and K are negatively and 
positively charged at pH 7, which enables ionic-complementarity. The electrostatic and hydrophobic 
interactions, together with hydrogen bonding lead to the self-assembly of the peptides into highly 
stable structures in solution (Fung, et al., 2003; Hong, et al., 2003; Jun, et al., 2004). In a previous 
study with EAK16II, an EAK peptide, this feature was taken advantage of to embed ODNs in an 
EAK matrix and protect the ODNs from the surrounding medium (Wang, et al., 2006). The binding 
of EAK16II to ODNs was controlled by adjusting the pH of the solution (Wang, et al., 2006). The 
dependence of the binding upon the solution pH demonstrated that electrostatic interactions play an 
important role in the binding. This observation could be rationalized by considering how the charge 
status of E and K in EAK16II is being affected by pH (Wang, et al., 2006).  
Since electrostatic interaction has been found to be the main driving force for the binding of 
EAK16II to the ODNs, it is important to investigate the effect that the distribution of charges along 
the EAK peptides has on the binding of EAK onto ODNs. Thus, the binding of EAK16IV, another 
EAK peptide, to ODNs was studied. EAK16IV and EAK16II have the same amino acid composition 
but a different charge distribution, given by the sequence − − − − + + + + and − − + + − − + + for 
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EAK16IV and EAK16II at neutral pH, respectively. As reported by Hong et al (2003), EAK16IV and 
EAK16II self-assemble into distinct nano/microstructures as a result of their different charge 
distribution. EAK16IV forms globular assemblies at neutral pH, but fibrillar assemblies at other pH 
values. EAK16II forms fibrillar assemblies regardless of pH. The substantial changes observed with 
the structures of the assemblies generated by EAK16II and EAK16IV suggested that the different 
charge distribution of the peptide would also affect its binding to ODNs. To determine whether this 
would be the case, the binding of EAK16IV to ODNs was investigated at different pHs. 
The effect of charge distribution on EAK16IV-ODN binding was investigated by 
characterizing the binding of EAK16IV to ODNs in terms of the binding strength, the size of the 
EAK16IV-ODN aggregates, and the accessibility of the ODNs in the aggregates to the solvent. These 
results were then compared to those obtained with EAK16II. The fraction of ODNs in the EAK16IV-
ODN aggregates formed upon the addition of EAK16IV to ODN solutions was determined from the 
UV-Vis absorption of the supernatant obtained after centrifuging the EAK16IV-ODN solutions. The 
binding isotherms were generated by analyzing the data obtained from the absorption measurements 
with a binding density function (Bujalowski and Lohman, 1987; Lohaman and Bujalowski, 1991; 
Bujalowski and Klonowaka, 1994). The binding constant was obtained by applying the modified non-
cooperative McGhee and von Hippel (MvH) model to the binding isotherms (McGhee and von 
Hippel, 1974; Tsodikov, et al., 2001). In addition, the existence of the main species present in the 
peptide-ODN solutions was established by the combination of fluorescence anisotropy, 
Polyacrylamide Gel Electrophoresis (PAGE), Dynamic Light Scattering (DLS), Atomic Force 
Microscopy (AFM), and UV-Vis absorption. The time scale over which aggregation occurs was 
determined by Static Light Scattering (SLS). The size of the resulting EAK16IV-ODN aggregates 
was investigated with AFM and DLS. The accessibility of the ODNs to the solvent was evaluated by 
fluorescence quenching experiments, as this property is critically important to assess the stability and 
potency of ODNs during their delivery both in vitro and in vivo (Plank, et al., 1999; Simeoni, et al., 
2003). 
 
4.2 Experimental Section 
4.2.1 Materials 
All materials, including reagents, buffers (Akinrimisi, et al., 1963; Bolumar, et al., 2003), and 
oligonucleotides were the same as those reported in an earlier study (Wang, et al., 2006). The peptide 
EAK16IV, whose sequence is n-AEAEAEAEAKAKAKAK-c, was purchased from Research 
Genetics (Alabama, USA) and used without further purification. 
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4.2.2 Methods 
The physicochemical methods applied in this work have been described in details in an earlier 
publication (Wang, et al., 2006). The following is the brief description for each of the methods.  
UV-Vis Absorption Spectroscopy. UV-Vis absorbance measurements were conducted on a 
Biochrom ultrospec 4300 pro UV-Vis spectrophotometer (Cambridge, England).  
Samples used to construct the binding isotherms were prepared at pH 4, 7, and 11. For each 
pH, two ODN concentrations were used. At each ODN concentration, six to eight samples were 
prepared with EAK concentrations ranging from 0 to 0.1 mg/mL (equivalent to 0-60 μM). The EAK-
ODN aggregates formed spontaneously upon mixing and 30 minutes after sample preparation these 
aggregates were removed by centrifuging the solutions at 10,000 rpm for 2 min. UV-Vis absorption 
spectra of the supernatants were recorded. The fraction of ODNs in the aggregates was then 
calculated from the relative UV-Vis absorbance change ∆ODr equal to (ODo-ODs)/ODo, where ODo is 
the absorbance at 260 nm of the initial solution and ODs is the absorbance at 260 nm of the 
supernatant. The obtained ∆ODr was then analyzed using the ligand binding density function 
(Bujalowski and Lohman, 1987; Lohaman and Bujalowski, 1991) to generate the binding isotherms. 
Polyacrylamide Gel Electrophoresis (PAGE). Non-denaturing 20 % PAGE was used to 
determine the composition of the supernatant of the EAK16-IV-ODN solutions.  
Steady-State Fluorescence Anisotropy. Fluorescence anisotropy was measured to 
demonstrate that a negligible amount of EAK16IV-ODN aggregates remained in the supernatant after 
centrifugation. Experiments were conducted on a Photon Technology International steady-state 
fluorometer (New Jersey, USA) equipped with a LPS 220-B xenon arc lamp and PTI 814 
photomultiplier.  
Static Light Scattering (SLS).  SLS was monitored with the steady-state fluorometer to 
investigate the binding pathway of EAK16-IV to ODNs. 
Dynamic Light Scattering (DLS). The ODN and EAK16IV solutions were separately 
filtered through a polycarbonate membrane with a pore size of 200 nm before mixing. The size of the 
EAK-ODN aggregates was measured by DLS on a Zetasizer Nano ZS instrument. 
Atomic Force Microscopy (AFM). A Picoscan AFM from Molecular Imaging was used to 
characterize the nanostructure of the EAK-ODN complexes/aggregates.  
Steady-State Fluorescence. Steady-state fluorescence was utilized to study the solvent 
accessibility of the ODNs in the EAK-ODN aggregates. Fluorescence spectra were acquired on the 
steady-state fluorometer. 
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Time-Resolved Fluorescence Decays. The decay time of the fluorophore-labeled ODN with 
or without EAK peptide was obtained from fluorescence decay measurements on an IBH model 2000 
time-resolved fluorometer. The principle and analysis (Press, et al., 1992; Lakowicz, 1999) was 
described in an earlier work (Wang, et al., 2006).  
 
4.2.3 Binding Assay 
The procedure which was applied to construct the isotherms for the binding of EAK16IV to ODNs is 
the same as the one described in in the Section 2.4 of Chapter 2. Briefly, the relative change in 
absorbance (∆ODr), which equals the fraction of ODNs in the aggregates, was plotted as a function of 
the EAK concentration for three or four ODN concentrations in Figure 4.1. It has shown that the 
fraction of ODN in aggregates is a unique function of binding density (Teif, and Lando. 2001; Teif, 
2005) (ν =Pb/Dt), which is in turn a sole function of free ligand concentration (Pf). Based on the 
ligand binding density function proposed by Bujalowski and Lohman (Bujalowski and Lohman, 
1987; Lohaman and Bujalowski, 1991; Bujalowski and Klonowaka, 1994), Equation 4-1 relates ν and 
Pf to the total peptide concentration and the total ODN concentration for a given ∆ODr. 
 
txftx DPP ν+=      (4-1) 
 
In Equation 4-1, Ptx and Dtx represent, respectively, the total concentrations of peptide and ODN at the 
xth ODN concentration. For a given ∆ODr, the binding density (ν) and free peptide concentration (Pf) 
can be obtained from the slope and y-intercept of the plot of Pt vs. Dt, respectively. One important 
aspect of the procedure described above is that, although ∆ODr represents the fraction of ODN 
present in the aggregates and does not account for the ODN present in the supernatant as EAK16IV-
ODN complexes, ∆ODr can still be used to find out Pf and ν. 
Each curve shown in Figure 4.1 could be fitted reasonably well with empirical equations of 
the form ∆ODr = A× PtC/(BC+ PtC) or ∆ODr = A×Pt /(1+B×Pt), where A, B and C are regression 
parameters listed in Table 4.1. Seven-to-ten ∆ODr values were chosen. For each ∆ODr value, the 
value of Pt was read from the fits of the curves shown in Figure 4.1 and plotted as a function of Dt. 
Then Pf and ν were obtained from the intercept and slope of the plot of Pt versus Dt. The Pf and ν 
values enable the construction of the binding isotherms as the ν/Pf versus ν plots given in Figure 4.2. 
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Figure 4.1. Plots of ∆ODr as a function of the total EAK concentration. (A) pH 4, phosphate 
concentration of dG16 equals 23.2 μM (■), 64 μM (○), 89.6 μM (▲), and 152 μM (◇). (B) pH 4, 
phosphate concentration of dC16 equals 29.6 μM (■), 48 μM (○), 80 μM (▲), and 110 μM (◇). (C) 
pH 4, phosphate concentration of dGC16 equals 44.8 μM (■), 128 μM (○), and 185.6 μM (▲). (D) pH 
7, phosphate concentration of dG16 equals 16 μM (■), 50.2 μM (○), 64 μM (▲), and 107 μM (◇). 
(E) pH 7, phosphate concentration of dC16 equals 16 μM (■), 36.8 μM (○), 64 μM (▲), and 118.4 μM 
(◇). (F) pH 7, phosphate concentration of dGC16 equals 32 μM (■), 57.6 μM (○), 128 μM (▲), and 
182.4 μM (◇). The solid and dashed lines represent the best fits to the equation ∆ODr = 
A×[EAK]C/(BC+[EAK]C) or ∆ODr = A×[EAK]/(1+B×[EAK]), but they do not have physical 
meaning. The A, B and C parameters have been listed in Table 4.1. Data in the range of 20-70% of 
maximal ∆ODr are used to obtain the ν andν/Pf values reported in Figure 4.2. 
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Table 4.1. Parameters A, B or C retrieved from the fits of the ∆ODr versus [EAK] plots shown in  




Concentration 1.45 μM 4 μM 5.6 μM 9.5 μM 
A 0.95 1.19 1.00 3.88 
B 2.81 ×10−6 6.90 ×10−6 8.98 ×10−6 6.78 ×10−5
C  2.59 1.25 2.70 1.17 
 
pH 4 dC16
Concentration 1.85 μM 3.0 μM 5.0 μM 6.88 μM 
A 0.93 1.09 2.91 0.99 
B 2.75 ×10−6 3.59 ×10−6 3 ×10−5 7.94 ×10−6
C  2.59 1.79 1.14 2.59 
 
pH 4 dGC16
Concentration  1.4 μM 4.0 μM 5.8 μM 
A  1 2.04 1 
 7.35 ×10−6 3 ×10−5 1.75 ×10−5
B  1.05 1.14 1.41 
 
pH 7 dG16
Concentration 1.0 μM 3.14 μM 4.0 μM 6.69 μM 
A  1.16 ×104 4.75 ×104 3.65 ×104 2.89 
B 9.42 ×104 2.23 ×104 1.85 ×104 1.35 ×10−4
C  N/A N/A N/A 0.94 
 
pH 7 dC16
Concentration 1.0 μM 2.3 μM 4.0 μM 7.4 μM 
A 3.03 ×104 1.77 ×104 1.18 ×104 0.79 ×104
B  4.29 ×104 1.78 ×104 1.31 ×104 0.92 ×104
 
pH 7 dGC16
Concentration 1.0 μM 1.8 μM 4.0 μM 5.7 μM 
A 6.18 ×104 3.49 ×104 1.77 ×104 1.48 ×104
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Figure 4.2.  Plot of ν/Pf versus ν for the binding of EAK16-IV to dG16 (■), dC16 (○), and dGC16 (▲) 
at (A) pH 4, and (B) pH 7. The solid lines represent the best fits to Equation 4-2. The parameters used 
in the fits are listed in Table 4.2. 
  
The binding isotherms in Figure 4.2 were fitted with Equation 4-2 derived by McGhee and 
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In Equation 4-2, K and n are the binding constant and binding site size, respectively. N is the total 
number of phosphate groups of ODN molecules equal to 16 and 32 for ssODN and dsODN 
molecules, respectively.  
The applicability of the MvH model to the binding of a peptide onto ODNs has been 
discussed earlier. In the present study, the parameters K and n retrieved from the fit of the binding 
isotherms obtained for EAK16IV with Equation 4-2 are compared to the K and n values reported for 
the binding of EAK16-II to the same ODNs (Wang, et al., 2006). In so doing, the effect of charge 
distribution on the binding strength of the peptide to ODNs can be characterized. 
 
4.3 Results and Discussion 
The description of the effect that the charge distribution of peptides has on their binding to 
ODNs began with the characterization of the binding of EAK16IV to ODNS in terms of binding 
strength, size of EAK16IV-ODN aggregates, and accessibility of the ODNs to the solvent. These 
results were then compared to those obtained with EAK16II. The clear differences observed between 
the trends obtained with EAK16II and EAK16IV enable one to assess the effect that the peptide 
charge distribution of EAK16II and EAK16IV has on its binding onto ODNs. 
 
4.3.1 Binding of EAK16IV to ODNs 
The earlier study on the binding of EAK16II onto ODNs showed that the binding was strongest at pH 
4, weaker at pH 7, and inexistent at pH 11 (Wang, et al., 2006). The pKa values of the four glutamic 
acids and four lysines in all EAK16-type peptides equal 4.25 and 10.53 (Lehninger, 1993), 
respectively. Therefore, earlier results suggested that, at pH 4, the positively charged EAK16II 
associates strongly with the negatively charged ODNs, whereas at pH 11, negatively charged 
EAK16II does not bind to the ODNs. An intermediate binding strength is observed at pH 7. Such a 
pH effect on binding would be expected to be similar for EAK16IV. The binding of EAK16IV to 
dC16, dG16, and dGC16 at pH 4, 7, and 11 was thus investigated and was compared with the results 
obtained with EAK16II to study the charge distribution effect on the binding.   
Plots of ∆ODr, which represents the fraction of ODNs in the EAK16IV-ODN aggregates, as a 
function of the total EAK16IV concentration are shown in Figure 4.1 for three or four ODN 
concentrations. ∆ODr increases with increasing total EAK16IV concentration at both pH 4 and 7. 
∆ODr eventually levels off for the single-stranded dG16 and dC16 (ssODNs) at pH 4, as the ssODNs 
become saturated with the peptides. EAK concentrations larger than 60 μM are required to reach 
saturation at pH 7. The increase of ∆ODr with EAK concentration in the low EAK16IV concentration 
range is much less pronounced at pH 7 than at pH 4. Furthermore at a given ODN and EAK 
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concentration, the ∆ODr values at pH 7 are significantly lower than those at pH 4. These results 
suggest that the binding between EAK16IV and the ODNs at pH 4 is stronger than at pH 7. At pH 11, 
no binding of EAK16IV to the ODNs could be detected. Considering that EAK16IV is positively 
charged at pH 4, neutral at pH 7, and negatively charged at pH 11, the trends shown in Figure 1 
indicate that electrostatic interactions are the main driving force for the binding of EAK16IV to the 
ODNs. Figure 4.1 also shows that the strength of the binding of EAK16IV to different ODN 
sequences follows the trend dG16 ≥ dC16 > dGC16 at pH 4 and dG16 is higher than both dC16 and dGC16 
at pH 7, which is similar to what was observed with EAK16II (Wang, et al., 2006).  
The formation of large aggregates between EAK16IV and the ODNs can be demonstrated not 
only by centrifuging out the aggregates from the solution and confirming the reduction in ODN 
concentration by conducting UV-Vis absorption measurements (Figure 4.1), but also by monitoring 
the fluorescence anisotropy of a fluorescently labeled ODN as EAK is added to the solution (Figure 
4.3).  The fluorescence anisotropy of the labeled ODNs increases with increasing EAK concentration 
as they are incorporated into the aggregates of ODN and EAK16IV. The increase in fluorescence 
anisotropy is less pronounced at pH 7 than at pH 4, reflecting the weaker binding of EAK16IV to the 
ODNs at pH 7.   
Both UV and anisotropy results showed that the different charge distribution of different 
EAK peptides does not affect the electrostatic interaction as a main driving force for EAK peptides 
binding to ODNs. 
 
4.3.2 Composition of the EAK16IV-ODN Solutions 
Solutions containing 3.6 μM of FAM-dC16 or 1.8 μM of FAM-dGC16 were mixed with increasing 
concentrations of EAK at pH 4 and pH 7. The solutions were centrifuged and the fluorescence 
anisotropy of the supernatant is shown in Figure 4.3 (solid symbol). The anisotropy of the FAM-
labeled ODN species left in the supernatants of the EAK16IV-ODN solutions ranges from 0.08 to 
0.12 at pH 4 and 0.03 to 0.04 at pH 7, very close to that of the free labeled ODNs. It demonstrates that 
the majority of species that lead to the anisotropy increase shown in Figure 4.3 before centrifugation 
(empty symbols) have been efficiently removed by centrifugation. The EAK16IV-ODN aggregates 
are large and rigid, certainly resulting from the interaction of the negatively charged ODNs with the 
peptides. The composition of what remained in the supernatant after centrifugation is investigated. 
A 5.7 μM dGC16 solution was mixed with 0, 12, and 24 μM of EAK16IV. The solutions were 
centrifuged and their supernatants were run on a 20 % native gel at pH 4 (Figure 4.4). The bands 
corresponding to the supernatants of the EAK16IV-dGC16 mixtures (Lanes 2-3) appear at the same 
position as the band corresponding to dGC16 (Lane 1). These results suggest that no EAK-dGC16 
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aggregate of size in the 6-100 bp range (i.e., the bp range of a 20% polyacrylamide gel)24 remains in 
the supernatants after centrifugation.   
   
 
 
Figure 4.3. Fluorescence anisotropy of the supernatant of EAK16-IV solution mixed with (A) 3.6 μM 
of FAM-dC16 at pH 4 (λex =452, λem =514 nm), (B) 3.6 μM of FAM-dC16 at pH 7 (λex =494, λem =514 
nm), (C) 1.8 μM of FAM-dGC16 at pH 4 (λex =452, λem =514 nm), and (D) 1.8 μM of FAM-dGC16 at 
pH 7 (λex =494, λem =514 nm) before (○) and after centrifugation (●). 
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1         2         3 
 
Figure 4.4. 20 % PAGE of 5.7 μM of dGC16 mixed with EAK16-IV peptide at pH 4. The peptide 
concentrations are 0, 12, 24 μM in lanes 1, 2 and 3, respectively. 
 
Absorption measurements were conducted on a mixture of Rh-dC16 and EAK16IV to 
investigate whether some EAK16IV-ODN aggregates larger than a 100 bp duplex but too small to be 
centrifuged out would remain in the supernatant. Two samples containing 3.9 μM of dC16-Rh in the 
absence and presence of 60 μM EAK16IV were prepared at pH 7. The absorption spectra of the 
resulting solution were acquired 30 minutes after sample preparation. As shown in Figure 4.5, the 
absorbance band at 563 nm characteristic of the rhodamine monomer decreases upon the addition of 
EAK16IV and a new prominent absorption band at 524 nm appears. The spectrum of the supernatant 
after centrifugation remains similar to that of the solution before centrifugation. The ratio of the 
absorbance at 524 and 563 nm (OD524/OD563) of dC16-Rh increases from 0.50 ± 0.01 to 1.01 and 0.96 
upon the addition of EAK16IV before and after centrifugation, respectively. Such an increase in the 
OD524/OD563 ratio is due to the formation of rhodamine dimmers (Hamman, et al., 1996) induced by 
the complexation of EAK16IV with dC16-Rh. Since the OD524/OD563 ratio of the supernatants is 
similar to that of the solution before centrifugation, it suggests that the supernantant contains some 
intermediate EAK16IV-ODN complexes which are too small to be centrifuged out. 
The concentration of each species in the supernatant can be calculated using the reported 
extinction coefficients of the rhodamine dimmer (Hamman, et al., 1996) as was done in the EAK16II 
study (Wang, et al., 2006). The supernatant contained 0.50 μM of unimers and 1.54 μM of 
EAK16IV-ODN complexes. Since the total ODN concentration equals 3.9 μM, the concentration of 
ODNs in the aggregates which are centrifuged out equals 1.86 μΜ. These concentrations result in a 
ΔODr value of (1.86 μM)/(3.9 μM) = 0.47, close to the value of 0.52 obtained from the K and n 
values listed in Table 4.2. The agreement observed between the ΔODr values obtained through two 
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different means supports the procedure used to generate the binding isotherms shown in Figure 4.2 




Figure 4.5. UV absorption spectra of dC16-Rh in the presence and absence of EAK16-IV at pH 7. (A) 
3.9 μM dC16-Rh (●), (B) 3.9 μM dC16-Rh and 60 μM EAK16-IV before centrifugation (−) and after 
centrifugation (×). 
 
It is worth noting that the anisotropy of the supernatant after centrifugation is close to that of 
the free ODNs (Figure 4.3B, solid symbol), even though there are around 75 % of complexes in the 
supernatant. In contrast, the anisotropy increases substantially when more than 10 % of the ODNs are 
incorporated into EAK16II-ODN aggregates that can be centrifuged out (Wang, et al., 2006). These 
observations indicate that the aggregates formed between EAK16IV and the ODNs are larger and 
more rigid than the corresponding intermediate complexes remaining in the supernatant after 
centrifugation. A similar conclusion was also reached with EAK16II. 
The experiments conducted in this section have established that the EAK16IV-ODN solutions 
contain four species which are the free ODN and EAK16IV molecules, EAK16IV-ODN complexes 
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4.3.3 Binding Pathway 
Due to its self-assembly capability, the peptide can form aggregates by itself. Thus, it 
becomes essential to establish whether the peptide-ODN aggregates result from the complexation of 
the ODNs with pre-existing EAK16IV aggregates, or from the association between individual ODN 
and EAK16IV molecules into complexes which further assemble into large, rigid EAK16IV-ODN 
aggregates. Static Light Scattering (SLS) was used to monitor the formation of the large ODN-EAK 
aggregates in solution as a function of time.  The results are shown in Figure 4.6. 
 
Figure 4.6. SLS experiments performed for 60 μM EAK solution without (triangle) and with the 
presence of 3.6 μM dG16 (circle) at pH 4 (empty symbol) and pH 7 (solid symbol), respectively. λex 
=λem =350 nm. 
 
The light scattering intensity of the buffer and EAK16IV solutions remain constant for the 
first 20 mins at pH 4 and 7 as shown in Figures 4.6. It indicates that the size of EAK remains constant 
during the first 20 mins after sample preparation. In comparison, the SLS intensity of the EAK-dG16 
mixtures increases initially and then levels off after the first few minutes at both pHs. Since an 
increase in SLS intensity reflects an increase in particle size, these results confirm that the formation 
of EAK16IV-ODN aggregates is complete within a few minutes after mixing.  
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Theoretically the increase in LS intensity observed at the early time in Figure 4.6 should 
provide a means to estimate the time scale over which the aggregates form. Unfortunately, the LS 
measurements were conducted a few minutes after the solution had been prepared and brought to the 
instrument. Consequently, it was estimated that the time required for the LS intensity to reach a signal 
in Figure 4.6 could be off by as much as five minutes. Nevertheless, the trends shown in Figure 4.6 
allowed one to conclude that the time scale for the formation of EAK16IV-ODN aggregates is shorter 
than 20 mins. During the same period of time, EAK16IV alone does not self-assemble. This result 
suggests that EAK16IV binds first to the ODNs in the molecular form to generate intermediate 
complexes, which further associate into the large aggregates that can be centrifuged out. Thus, the 
charge distribution did not change the pathway suggested for the formation of peptide-ODN 
aggregates obtained with EAK16II (Wang, et al., 2006).  
 
4.3.4 Size of EAK16IV-ODN Aggregates  
AFM and DLS were used to characterize the morphology and size of the EAK16IV-ODN 
aggregates. Images of the EAK16IV-ODN aggregates formed by mixing a 0.02 mg/mL (12 μM) 
EAK16IV solution with a 8.6 μM dG16 solution, equivalent to an EAK-to-dG16 molar ratio of 1.4:1 
were taken 5 and 20 mins after sample preparation. The images are shown in Figure 4.7A and B. In 
average, the aggregates are 36 nm wide, 5.2 nm tall, and over 100 nm long. Their morphology and 
size do not change after 20 mins. Since the dG16 or EAK16IV solutions do not generate any 
nanostructure on their own over one hour as imaged by AFM (images not shown), the aggregates seen 
in the AFM images of the EAK-dG16 solution must be due to EAK16IV-ODN aggregates. Since the 
morphologies of the aggregates observed after 5 and 20 mins are very similar, it suggests that the 
entire aggregation process between dG16 and EAK is completed within the first 5 min, which agrees 
with the conclusion drawn from the SLS experiments shown in Figure 4.6.  
The AFM images obtained by mixing a 0.1 mg/mL (60 μM) EAK solution with a 1.8 μM 
dG16 solution in an EAK-to-dG16 molar ratio of 33.5:1 at pH 4 at time of 5 and 20 mins are shown in 
Figures 4.7C and D. Figure 4.7C shows that at this molar ratio, the EAK-dG16 solution has two major 
populations of globular aggregates. One is mainly around 250 nm wide, 15 nm high, and 250 nm 
long. The other one is around 250 nm wide, 15 nm high, and over 800 nm long, much larger than 
those obtained at the lower EAK-to-dG16 molar ratio. This result suggests that the size of the 
EAK16IV-ODN aggregates can be affected by adjusting the EAK-to-ODN molar ratio.  
The hydrodynamic diameter of the EAK16IV-ODN aggregates in solution was obtained by 
DLS. The hydrodynamic diameter of a 1.8 μM dG16 solution at pH 4 mixed with varying 
concentrations of EAK16IV was measured 30 min after sample preparation (Figure 4.8). The dG16 
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solutions exhibit a species with a ~7.5 nm hydrodynamic diameter which is attributed to isolated dG16 
molecules in solution. The diameter of the species present in the solution increases to around 100 nm 
while the EAK16IV concentration increases from 0.002 to 0.010 mg/mL (1.2-6 μM). The 
hydrodynamic diameter increases further as the EAK16IV concentration increases from 0.02 to 0.10 
mg/mL (12-60 μM). At EAK16IV concentration of 0.10 mg/mL, two major sizes are around 250 nm 
and 1000 nm, respectively. The size of the aggregates generated at different EAK-to-ODN molar 
ratios is compatible with that obtained by AFM. Since the steady-state light scattering results (Figure 
4.6) suggest that EAK is present as a single molecule 30 mins after sample preparation, its size is 
expected to be much smaller than the large diameters observed by DLS. These large diameters 
characterize the aggregates of ODN and EAK16IV in solution. 
A) 




        
D)
350 nm350 nm 
C) 
Figure 4.7. AFM images of the EAK16IV-dG16 complexes formed at pH 4. The solution containing 
8.6 μM dG16 and 60 μM EAK16IV imaged after (A) 5 mins, (B) 20 mins. Scale bar = 100 nm. The 
solution of 1.8 μM dG16 and 60 μM EAK16-IV imaged after (C) 5 mins, (D) 20 mins. Scale bar = 350 
nm. 
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Figure 4.8. Population histogram of the EAK16IV-ODN aggregates as a function of particle diameter 
determined by dynamic light scattering. The solutions contained 1.8 μM of dG16 with increasing 
EAK16IV concentration (mg/mL) at pH 4. 
 
4.3.5 Binding Parameters 
The binding isotherms obtained by plotting ν/Pf as a function of ν were generated from the 
curves shown in Figure 4.1 following the procedure outlined in the Binding Assay section. The 
resulting binding isotherms (Figure 4.2) were fitted with Equation 4-2 according to the McGhee and 
von-Hippel (MvH) model to obtain the binding constant, K, and the binding site size, n, at two pH 
values. The K and n values are listed in Table 4.2. Although the MvH model does not account for the 
formation of the EAK16IV-ODN aggregates, the fits of the binding isotherms with Equation 4-2 were 
rather good, as shown in Figure 4.2. 
The effect of pH on the binding of EAK16IV to the ODNs can be seen from Table 4.2. The 
binding constant for EAK16IV binding to a given ODN increases when the pH is decreased from 7 to 
4. This result indicates that electrostatic interactions play an important role in the binding of 
EAK16IV to the ODNs.  
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Table 4.2. Binding constant K and binding site size n retrieved from the fits of the data shown in 
Figure 4.2 with Equation 4-2. 
 
pH 4 pH 7 pH 11 
ODNs 
n K (104 M-1) n K (104 M-1) N K (M-1) 
dG16 4.99 ±0.30 45.1 ± 4.4 1.50 ± 0.1 8.2 ± 1.4 No Interaction 
dC16 4.76 ± 0.13 37.4 ± 5.7 0.55 ± 0.02 4.0 ± 0.3 No Interaction 
dGC16 7.05 ± 0.24 9.7 ± 1.0 0.62 ± 0.04 4.1 ± 0.4 No Interaction 
* Each fit has R2 > 0.94 with at least 5 data points. The error on the K and n values is estimated by 
generating three binding isotherms based on the trends shown in Figure 4.2. These binding isotherms 
were generated by taking arbitrarily the larger, intermediate, and smaller ν/Pf values obtained 
according to the error bars shown in Figure 4-2. The three binding isotherms were fitted with the 
McGhee and von Hippel model (Equation 4-2). And the spread in the K and n values retrieved from 
the fits provided an estimate of the errors on K and n, as reported in Table 4.2.  
 
The binding parameters listed in Table 4.2 allow one to compare the binding strength of 
EAK16IV to a given ODN at a specific pH. At pH 4, K decreases according to the trend dG16 ≥ dC16 
> dGC16. Thus, the binding strength of EAK16IV to dG16, dC16, and dGC16 follows the same trend 
observed for EAK16II. Similarly one finds the trend dG16 > dC16 ≈ dGC16 for the binding of 
EAK16IV at pH 7. These trends are similar to those obtained with EAK16II. As has been argued 
earlier, the slight stronger binding of the EAK peptides with dG16 might be a result of the stronger 
hydrogen bonds being generated between lysine and guanine (Wang, et al, 2006). 
The effect of charge distribution of the peptides on the binding of EAKs to the ODNs can be 
investigated in a straightforward manner from the binding parameters listed in Table 4.2. The 
equilibrium constants obtained for the binding of EAK16IV to the ODNs range from 4.1 × 104 to 45.1 
× 104 M−1. In comparison, EAK16II has been reported to bind to these ODNs with binding constants 
in the range of 0.7 × 104 to 7.6 × 104 M−1. At a same pH and for a given ODN sequence, EAK16IV 
displays a larger K value than EAK16II. It suggests that EAK16IV binds to the ODNs more strongly 
than EAK16II. Considering that the charge distribution is − − + + − − + + for EAK16II and − − − − + 
+ + + for EAK16IV at neutral pH and that those negatively charged amino acid are protonated at pH 
4, all positively charged lysines accumulate at one end of the EAK16IV peptide, but are more evenly 
distributed along the EAK16II backbone. Thus concentrating the binding sites of a peptide at one 
position of the peptide backbone appears to be beneficial to enhance the binding strength of that 
peptide to an ODN.  
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4.3.6 Reduced Accessibility to Solvent of ODNs Embedded in an EAK16-IV Matrix 
A successful peptide-based ODN delivery system must ensure that the ODNs incorporated inside the 
peptidic matrix are protected against the nucleases present in vivo.  Consequently the location of the 
ODNs within the EAK16IV-ODN aggregates must be established. ODNs located inside EAK16IV-
ODN aggregates will be less accessible to the solvent than those located on the surface, and hence be 
better protected from the surroundings. Fluorescence dynamic quenching experiments were carried 
out to assess the accessibility of the ODNs to the solvent. dC16 was labeled at the 5’-end with 
fluorescein. KI was used as the quencher because it can dynamically quench fluorescein via diffusive 
encounters (Wang, et al, 2006). The K+ concentration was maintained constant at 0.6 M by addition 
of K2SO4 to the KI solution. The fluorescence emission of a 1.2 μM solution of the labeled dC16 was 
monitored as a function of KI concentration in the absence or presence of 120 μM EAK (0.2 mg/mL). 
The fluorescence intensity of fluorescein decreases upon addition of KI to the solution. The 
Stern-Volmer plot is given in Figure 4.9 where the Io/I ratio is represented as a function of iodide 
concentration. The quantities Io and I represent the fluorescence intensity of the chromophore without 
and with quencher, respectively. The Io/I ratio increases linearly with iodide concentration in the 
absence or presence of EAK. However the increase is stronger in the absence of EAK. 
The fluorescence decays of FAM-dC16 were acquired in the presence and absence of EAK. 
The pre-exponential factors and decay times obtained from the analysis of the fluorescence decays 
with a sum of exponentials are listed in Table 4.3. As for EAK16II, the lifetime of the chromophore is 













Figure 4.9. Stern-Volmer plots for a solution of 1.2 μM of fluorescently labeled dC16 free and bound 
to 120 μM of EAK16IV at pH 4 quenched by KI. Solid lines represent the fits to the Stern-Volmer 
equation with parameters listed in Table 4.4. FAM-dC16 (▲), FAM-dC16-EAK (□) with λex = 452 nm, 
λem = 514 nm. 
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Table 4.3. Pre-exponential factors and decay times obtained from the analysis of the fluorescence 
decays of the fluorescent ODNs in the absence and presence of 120 μM EAK16-IV in pH 4 buffer, 
respectively. 
 τ1 (ns) α1 τ2 (ns) α2 τ  (ns)a χ2
FAM-dC16 3.9 0.67 2.0 0.33 3.3 1.12 
EAK-FAM-dC16 4.1 0.67 1.6 0.33 3.3 1.01 









To evaluate the effect that the presence of EAK1-IV has on the accessibility of the ODNs to 
the solvent, the Io/I vs. [I−] plots in Figure 4.9 were fitted with the Stern-Volmer equation given in 
Equation 4-3 (Lakowicz, 1999): 
  
][1][1/ QkQKII oqSVo τ+=+=    (4-3) 
 
where, KSV is the Stern-Volmer constant, and kq is the bimolecular quenching rate constant, which 
reflects the accessibility of the chromophore to the solvent (Lakowicz, 1999). It is determined from 
the ratio KSV/το where το is the lifetime of the chromophore in the absence of quencher (Lakowicz, 
1999). Since the fluorescence decays of FAM-dC16 were not monoexponential, the number-average 
lifetime oτ  of the decays was used instead of το.  The values of KSV, oτ , and kq are listed in Table 4.4 
In the absence of EAK, kq for FAM-dC16 equals 2.5 × 109 M−1s−1. The presence of EAK reduces kq to 
0.9 × 109 M−1s−1. There might be two causes for the decrease of kq after incorporation of FAM-dC16 
into the EAK16IV-ODN aggregates: the diminution of the diffusion coefficient of FAM-dC16 or the 
reduced accessibility of FAM-dC16. Considering that the diffusion coefficient of the fluorophore-
labeled ODN with 16 bases is about 10-fold lower than that of the iodide ion (Gordan, 2005; Weast, 
1971), the diminution of the diffusion coefficient of the ODNs after binding to EAK16IV will be 
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expected to affect kq by no more than 10 %. Thus, the decrease in kq observed above (~ 64 %) 
suggests that the accessibility of ODNs must be reduced in the presence of EAK. 
 
Table 4.4. Stern-Volmer quenching constants KSV, bimolecular quenching rate constant kq, 
fluorescence lifetime το, and relative accessibility change γ when dC16 is in the absence or presence of 
120 μM of EAK16-IV in pH 4 buffer. 
5’ end fluorescein labeling 
 ODNs 
KSV (M-1) το (ns) kq (109 M-1S-1) γ 
Fluorescently labeled dC16  
(free) 
8.3 ± 0.2 3.3 2.5 ± 0.1  
Fluorescently labeled EAK-dC16  
(bound) 
2.8 ± 0.1 3.3 0.85 ± 0.0 0.34 
       
 
The relative change in accessibility of the ODNs to the solvent upon EAK binding was 
quantified from the ratio of the kq values obtained in the presence and absence of the peptides 
(Bujalowski and Klonowaka, 1994; Wang, et al., 2006). This ratio is referred to as γ. The value of γ  
is found to be 0.36 suggesting that the accessibility of dC16 to the solvent is reduced by about 64 % 
inside the EAK16IV-ODN aggregates.   
In addition, the quenching events which were monitored took place between the negatively 
charged quencher (I−) and either the negatively charged ODNs or the partially neutralized EAK16IV-
ODN aggregates. Consequently, the quencher would be expected to quench more efficiently the 
EAK16IV-ODN aggregates due to the reduction in electrostatic repulsion. The opposite is observed, 
which strengthens the claim that EAK protects the ODN from its environment (Wang, et al., 2006).  
Compared to EAK16II, the binding of EAK16IV to ODNs appears to induce a more efficient 
protection of the ODN by reducing the accessibility of FAM-dC16 to the solvent from 40 % for 
EAK16II to 64 % for EAK16IV (Wang, et al., 2006). It suggests that the stronger binding afforded by 
EAK16IV provides a better protection against small molecules or anions present in the solution, and 
consequently against large nucleases. This feature should help prevent ODN degradation. This 
property is desired for any oligonucleotide delivery candidate since the rapid degradation of ODNs in 
a biological system by nucleases is one of the major hurdles that must be overcome for a successful 
 101 
Chapter 4   
antisense delivery. The stability of the EAK16IV-ODN aggregates in the presence of the nuclease is 
the topic of next chapter. 
 
4.4 Summary 
This study has investigated the binding of EAK16IV to ODNs. UV-Vis absorption and fluorescence 
anisotropy experiments demonstrated the formation of large EAK16IV-ODN aggregates which could 
be centrifuged out of solution. The binding isotherms constructed from the UV-Vis absorption data 
were fitted with the modified non-cooperative MvH model to extract the equilibrium binding 
constants and binding site sizes. The results showed that EAK16IV, whose positively charged 
residues are clustered at one end of the peptide, binds to ODNs more strongly than EAK16II whose 
positively charged residues are distributed throughout the peptide. Static light scattering experiments 
demonstrated that EAK16IV binds to ODNs in a similar manner as EAK16II. Peptide and ODNs 
complex first in the molecular form followed by the association of the complexes into large 
aggregates.  
The size of the EAK16IV-ODN aggregates was determined by AFM and DLS. It ranged from 
a few hundreds of nanometers to several micrometers, depending on the molecular ratio of EAK16IV 
to ODNs. Fluorescence quenching experiments showed that the accessibility of the ODNs to the 
solvent is reduced by 64 % upon the addition of EAK16IV, a much higher reduction than the value of 
40% caused by EAK16II. In view of these results, EAK16IV might be a better peptide candidate for 
the protection of an ODN against degradation by nucleases. 
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Chapter 5 
 Aggregates of Oligonucletides and Self-Assembling Peptides. 
Nuclease Resistance of Oligonucleotides and Stability of the 
Aggregates 
5.1 Introduction 
Antisense oligodeoxynucleotides (ODNs) are being widely investigated to downregulate gene 
expression (Crooke, 1992; Dias and Stein, 2002). To inhibit the production of faulty proteins, 
antisense ODNs have to reach the cytoplasm or nucleus of cells where they act by specific binding to 
the target mRNA or DNA. An important challenge in antisense technology remains the lack of 
efficient delivery systems. Before the ODNs can reach their target site, they have to cross the cellular 
membrane, escape from the endosomal compartment, leave their carriers and hybridize with the target 
sequence (Garcia-Chaumont, et al., 2000). During these multiple steps of trafficking, rapid 
degradation of the ODNs results in shorter ODN segments, which are more likely to base pair with 
parasite mRNA sequence other than the target sequences (Crooke, 2000). Thus, the sequence 
specificity and efficacy of the ODNs are compromised and their success in therapeutic applications is 
limited.  
 One approach to improve the stability of antisense ODNs against nucleases is through 
chemical modification of the ODN phosphodiester backbone. However, the modified ODNs often 
have low transfection efficiency resulting in lowered biological activity (Ghosh, et al., 1993; Pavid, 
2000), non-specific protein binding, or poor solubility (Hogrefe, 1999). The other common approach 
to improving antisense activity is the development of suitable delivery systems. The delivery system, 
often composed of cationic lipids, polymers, or peptides, is designed to improve the cellular uptake of 
ODNs and facilitate their escape from the endosomes. Protection of the ODNs against nucleases is an 
important aspect in the design of delivery systems. Ideally, a delivery system should protect the 
ODNs during all the different steps involved in the trafficking of the ODNs from outside a cell to its 
target inside the cell. In general, cationic carriers are believed to protect the ODNs against 
degradation. Indeed, some carriers have been reported to enhance efficacy of antisense ODNs, while 
others have failed (Remaut, et al., 2005).  
 Previous work from our laboratory has established that ODNs can complex with a class of self-
assembling peptides of the EAK family (Wang, et al., 2006). These self-assembling peptides have an 
amphiphilic structure consisting of alternating negatively and positively charged amino acids on one 
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side, and hydrophobic amino acids on the other side. The ionic complementarity, together with 
hydrogen bonding and hydrophobic and van der Waals interactions promote the self-assembly of the 
peptides into highly stable aggregates over time. The positively charged amino acids facilitate the 
complexation of the peptide with the ODNs through electrostatic interaction. The inherent self-
assembling capability of EAK further enables the association of the resulting complexes into 
aggregates. The ODNs incorporated inside the aggregates exhibit reduced accessibility to the 
surrounding solvent, which may also reduce their accessibility to nuclease, and prevent their 
degradation. These peptides do not cause cytotoxicity, arouse minimal immune response and 
inflammation in the host, and are biocompatible (Zhang, et al., 1994; Zhang, 2002). They can be 
easily modified to incorporate cell targeting compounds to improve specific cellular uptake. These 
combined features make them promising carriers for gene delivery. 
The present study focuses on the stability of the ODN-EAK aggregates and the nuclease 
resistance of the ODNs embedded in the EAK matrix. Fluorescence resonance energy transfer 
(FRET) is a common tool used to monitor the degradation of ODNs (Uchiyama, et al., 1996). In 
FRET, the excited donor (D) transfers its excess energy to the acceptor (A) in a radiationless process, 
which causes a decrease in the fluorescence intensity of the donor. The FRET efficiency is extremely 
sensitive to the distance between the donor and the acceptor. FRET can be used to study the 
degradation of ODNs doubly-labeled with a donor and acceptor fluorophore at each end since 
degradation of the ODNs results in a longer donor-acceptor distance and a substantial decrease in 
FRET efficiency (Uchiyama, et al., 1996).  
In this study, the nuclease resistance of doubly-labeled ODNs in the EAK-ODN aggregates 
prepared at different pHs was evaluated using FRET. The percentage of degraded ODNs was 
determined from the ratio of fluorescence intensity of the donor to that of the acceptor, the ID/IA ratio, 
which is a measure of FRET efficiency. Intact ODNs where the donor and acceptor are held at short 
distances undergo efficient FRET and have small ID/IA ratios. Degraded ODNs have donors and 
acceptors that are no longer held in close proximity and the ID/IA ratio is large. The dissociation of the 
EAK-ODN aggregates generated at pH 4 and pH 7 after they were incubated with nuclease solution 
was investigated by UV-Vis absorption measurements to ensure that a reduced nuclease resistance of 
the ODNs was due to a break up of the EAK-ODN aggregates.  
The stability of the EAK-ODN aggregates upon dilution of the solution was also studied to 
predict the effect of dilution on the protection provided by the EAK matrix to the ODNs. The stability 
after dilution of an assembly resulting from the association between an ODN and its carrier is an 
important parameter to assess as the assembly is being diluted many folds after the delivery system 
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has been injected in the body. A break up of the ODN-carrier assembly exposes the ODNs to the 
surrounding medium which leads to their degradation by nucleases.  
 
5.2 Materials and Methods 
5.2.1 Materials 
The reagents, buffers, peptides, and oligonucleotides are the same as those reported in Chapter 2. 
E.coli exonuclease I (20 U/μL) and its 10× degradation buffer (670 mM glycine-KOH (pH 9.5 at 
25°C), 67 mM MgCl2, 10 mM DTT) were purchased from Fermentas Canada Inc. (Burlington, 
Canada).  
 A cytosine hexadecamer doubly-labeled with fluorescein at the 5’-end and rhodamine at the 
3’-end, namely Fl-dC16-Rh, was used for the nuclease resistance study. Two unlabeled guanine and 
cytosine hexadecamers, namely dG16 and dC16, were used for the stability study. The ODNs obtained 
were 95 % purity after HPLC purification and were purchased from Eurogentec North America (San 
Diego, USA).  
 
5.2.2 Preparation of the EAK-ODN Aggregates for Nuclease Resistance Studies 
The evaluation of the protection afforded to the oligonucleotides by the EAK matrix against nuclease 
degradation was conducted as follows. First, 100 μL of 2.3 μM Fl-dC16-Rh alone or encapsulated 
with 60 μM of EAK was prepared by mixing an ODN stock solution with binding buffer or with an 
EAK stock solution, respectively. The resulting solutions were vortexed vigorously for a few seconds 
and kept at 25 ºC for 30 mins prior to use. Second, 100 μL of the EAK-ODN solution was centrifuged 
at 10,000 rpm for 2 minutes in an Eppendorf Centrifuge 5410. The pellets, corresponding to the EAK-
ODN aggregates, were collected and incubated with 500 μL of 0.7 U/μL exonuclease I in 1× 
degradation buffer (pH 9.5) at 25 ºC.  
To ensure that degradation of the ODNs was occurring in the absence of EAK, 100 μL of a 
2.3 μM ODN solution was diluted 5-fold by adding the appropriate amount of stock exonuclease I 
solution (20 U/μL), 10× degradation buffer, and water to obtain a solution with 0.46 μM ODN, 0.7 
U/μL exonuclease I in 1× degradation buffer (pH 9.5) at 25ºC. Further controls included incubating 
the EAK-ODN mixture or ODN solutions with 1× degradation buffer under the same conditions as 
those treated with exonuclease I. For all these solutions, 55 μL of solution was removed at different 
points in time and inactivated by the addition of 2 μL of 40 % sodium dodecyl sulfate (SDS) (Moyer 
and Rothe, 1977). The resulting samples were lyophilized with the Savant Model ISS110 DNA 
SpeedVac system (Minnesota, USA) and redissolved in 55 μL of pH 11 buffer to completely release 
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the ODNs from the EAK-ODN aggregates. This releasing procedure was also applied to the ODN 
samples that contained no EAK to ensure that comparisons were drawn from results obtained with 
samples that had undergone the same experimental protocol. In the end, each sample was centrifuged 
at 10,000 rpm for 2 mins and the supernatant was collected for the FRET measurements.  
 
5.2.3 Fluorescence Resonance Energy Transfer (FRET) Measurement 
The fluorescence spectra of the supernatant were acquired using a Photon Technology International 
steady-state fluorometer (New Jersey, USA) equipped with a LPS 220-B xenon arc lamp and PTI 814 
photomultiplier. The fluorescein donor was excited at its peak absorption wavelength (λex = 494 nm). 
The ratio of the donor to the acceptor fluorescence intensity (ID/IA ratio) was determined by 
monitoring the fluorescein and rhodamine fluorescence at 517 and 583 nm, respectively.  
 
5.2.4 Stability Assay of the EAK-ODN Aggregates 
Samples containing 8.6 μM of ODNs and different amounts of the EAK peptides were prepared at pH 
4 and pH 7. Half an hour after mixing, each sample was treated in two different ways. In one 
procedure, the EAK-ODN mixtures were diluted 5- and 10-fold with the corresponding buffer. The 
resulting samples are referred to as “dilute-5” and “dilute-10” sample, respectively. In the other 
procedure, the EAK-ODN mixture was centrifuged at 10,000 rpm for 2 mins. Its supernatant was 
discarded and the carefully collected pellets of the EAK-ODN aggregates were resuspended in the 
same volume of buffer solution used to prepare the mixture solutions. The samples obtained from this 
treatment are referred to as “refill” samples. UV-Vis spectroscopy was utilized to measure the relative 
UV absorbance change (∆ODr) over time for these samples following a procedure outlined in an 
earlier study (Wang, et al., 2006).  
 
5.3 Results and Discussion 
5.3.1 Releasing the ODNs from the EAK-ODN Aggregates 
The stability of antisense oligonucleotides against degradation by nucleases is an important pre-
requisite for a successful antisense oligonucleotide delivery in vivo. In this study, fluorescence 
resonance energy transfer (FRET) was used to monitor the time-dependent degradation of the ODNs 
by a nuclease. The ODNs were labelled at one end with a fluorescence donor (fluorescein) and at the 
other end with a fluorescence acceptor (rhodamine). The FRET phenomenon is sensitive to the 
distance separating the donor from the acceptor. The distance between the two labels increases if the 
doubly-labeled ODNs are degraded and the degraded ODNs can diffuse freely away. Under such 
conditions, degradation of the doubly-labeled ODNs is accompanied by a decrease in FRET 
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efficiency. However, since the ODNs are initially encapsulated inside the EAK-ODN aggregates, the 
degraded ODNs might not be allowed to diffuse out of the EAK-ODN aggregates, holding the donor 
and acceptor at the same position in the EAK matrix. In order for FRET to reflect the true degradation 
profiles of the ODNs, it becomes important to ensure that the ODNs can be extracted from the EAK 
matrix.  
EAK contains four glutamic acids (Glu, E) and four lysines (Lys, K) with pKa values of 4.25 
and 10.53, respectively (Lehninger, 1993). According to these pKa values, the EAK molecules are 
expected to be negatively charged at pH 11 and not to interact with the ODNs due to electrostatic 
repulsion between the negatively charged amino acid residues of EAK and the phosphate groups of 
the ODNs (Wang, et al., 2006). Thus, adjusting the solution pH to 11 should provide a means to 
release the ODNs from the EAK matrix of the EAK-ODN aggregates.  
UV-Vis experiments were carried out to confirm this expectation. First, the EAK-ODN 
aggregates were formed by mixing 5.0 μM of dC16 with 120 μM of EAK16-II at pH 4. The UV-Vis 
absorbance at the peak wavelength at 276 nm of this solution was 0.75 and dropped to about zero 
after centrifugation (Figure 5.1). This indicates that in this solution, all ODNs were incorporated in 
the aggregates, which were centrifuged out (Wang, et al., 2006). This solution was then dried and 
resuspended in pH 11 buffer. The UV absorbance of the resulting solution at 276 nm before and after 
centrifugation was 0.73 and 0.71 (Figure 5.1). Since centrifugation has been shown to be very 
efficient at removing the EAK-ODN aggregates from the solution, the constant absorption before and 
after centrifugation demonstrates that when the solution pH is brought from 4 to 11, most ODNs are 
either successfully extracted from the aggregates or present in much smaller EAK-ODN aggregates, 
too small to be centrifuged out. This extraction method was applied in the next series of experiments 












Figure 5.1. UV-Vis absorption spectra of the supernatant of 5.0 μM dC16 mixed with 0.2 mg/mL 
EAK16-II at pH 4 after centrifugation (-); The above EAK-dC16 mixture was dried and resuspended 
in pH 11 buffer. UV-Vis absorption spectra of the new solution before centrifugation (○), and after 
centrifugation (×). 
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5.3.2 Nuclease Resistance of the ODNs Encapsulated in the EAK Matrix 
The extent of ODN protection against the nuclease when the ODNs are incorporated in the EAK-
ODN aggregates made of either EAK16-II or EAK16-IV at different pHs was investigated by 
performing fluorescence resonance energy transfer (FRET) experiments. Fl-dC16-Rh doubly-labelled 
with fluorescein at the 5’-end and rhodamine at the 3’-end was used as probe. The emission spectra 
were acquired from 500 to 700 nm while exciting the solution at the absorbance peak wavelength of 
the fluorescein donor (λex = 494 nm).  
Control solutions of the doubly-labeled ODNs prepared in the presence or absence of 
EAK16-IV at pH 4 were incubated in 1× degradation buffer solution at pH 9.5 without exonuclease I 
for 1 hr. FRET took place as seen from the two emission peaks at 517 and 583 nm corresponding to 
the fluorescein donor and the rhodamine acceptor, respectively (Figure 5.2). The ratio of the donor to 
the acceptor fluorescence intensity at the peak wavelengths (ID/IA) for the ODNs decreases from 1.4 
(control in Figure 5.2A) to 1.2 (control in Figure 5.2B) upon addition of EAK16-IV. Smaller ID/IA 
ratio indicates that association of Fl-dC16-Rh with EAK16-IV results in strong FRET, which might be 
due to the ODN adopting a more compact conformation in the EAK-ODN aggregates. 
The emission spectra were also taken at different points in time after adding exonuclease I to 
the ODN or EAK-ODN solutions at pH 4 (Figure 5.2). For the ODNs alone (Figure 5.2A), the donor 
fluorescein fluorescence immediately increased 2.6-fold as that of rhodamine decreased, indicating a 
lower extent of FRET and demonstrating the degradation of the ODNs. Figure 5.2A also indicates 
that a substantial percentage of the ODNs are degraded within 20 minutes, a result consistent with the 
expectation that the unprotected ODNs are rapidly degraded by nucleases (Agrawal, 1999). In 
contrast, the EAK-ODN aggregates generated with EAK16-IV at pH 4 are not degraded by 
exonuclease I even after 100 minutes, as indicated by the similarity of the emission spectra before and 
after nuclease treatment (Figure 5.2B). This result is consistent with the fluorescence quenching 
experiments, which showed that ODNs incorporated in an EAK matrix were less accessible to the 
solvent than naked ODNs were (Wang, et al., 2006). 
The ODN solutions with and without EAK were incubated with exonuclease I and aliquots 
were removed from the solution as a function of time. After applying the protocol described in the 
experimental section, the normalized ID/IA ratio was determined and the percentage of degraded 
ODNs was established as a function of time by applying the calibration curve shown in Figure 5.3. 
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Figure 5.2. FRET of Fl-dC16-Rh incubated with exonuclease I at pH 9 in the absence (A) or presence 
(B) of 0.1 mg/mL EAK16-IV at pH 4; A) without EAK16-IV: control (×), 20 min (∆), and 30 min 
(+); B) with EAK16-IV: control (×), 20 (+), 60 (∆), and 104 min (-). 
 
To monitor the degradation of the ODNs in a quantitative manner, the ID/IA ratio was 
determined for solutions containing different amounts of the intact and completely degraded ODNs 
(Figure 5.3). In these experiments, a 0.46 μM solution of the intact doubly-labeled dC16 was prepared 
and its fluorescence spectrum was acquired. It was mixed in different proportions with a solution 
containing 0.46 μM of fluorescein-labeled dC16 and 0.46 μM of rhodamine-labeled dC16. The 
equimolar solution of fluorescein- and rhodamine-labeled dC16 was used as a mimic of the fully 
degraded ODNs. The ID/IA ratios of the mixtures were normalized to the ID/IA ratio of the intact 
ODNs. Figure 5.3 shows that the normalized ID/IA ratio increases linearly with the percentage of 
singly-labeled ODNs present in solution. The plot in Figure 5.3 was used as a calibration curve to 
determine quantitatively the percentage of ODNs which were degraded by the nuclease.  
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Figure 5.3. Calibration curve correlating the normalized ID/IA ratio to the percentage of degraded 
ODNs. The dashed line represents the best fit to the equation: normalized ID/IA = A × % degraded 
ODN + 1 with A = 0.0409 and R2 = 0.999. 
 
Figure 5.4A shows the percentage of degraded ODNs in the presence or absence of EAK after 
the aggregates generated at pH 4 were incubated with exonuclease I at pH 9.5. The profile obtained 
for the naked ODNs with no EAK present indicates that 85 % of the ODNs are degraded within 20 
minutes. Ideally, 100 % of the ODNs should have been degraded. The fact that this was not observed 
might reflect some discrepancies between the calibration curve determined under ideal condition and 
the samples having undergone nuclease degradation. Nevertheless, the data shown in Figure 5.4A 
demonstrate that the naked ODNs are degraded efficiently by the nuclease. In contrast, the ODNs 
complexed with either EAK16-IV or EAK16-II at pH 4 did not exhibit any degradation even after 
being incubated for 100 mins with exonuclease I. These results suggest that the ODNs are located 
inside the EAK-ODN aggregates where they remain inaccessible to the nuclease. It is worth pointing 
out that in these experiments, the EAK-ODN aggregates are prepared at a pH which is much more 
acidic than the pH of 9.5 of the degradation buffer. The observation that the EAK matrix protects the 
ODNs against nuclease degradation at pH 9.5 demonstrates that the EAK-ODN aggregates prepared 
at pH 4 are stable even after being incubated at a more basic pH. These are promising properties for 
using EAK as a carrier for gene delivery.  
The degradation of the free ODNs and the ODNs encapsulated with EAK at pH 7 are shown 
in Figure 5.4B. The free ODNs prepared in a pH 7 buffer and incubated with the nuclease solution at 
pH 9.5 are strongly degraded within a few minutes, as was observed for the free ODNs prepared in a 
pH 4 buffer. The ODNs which were allowed to form aggregates with EAK16-II at pH 7 show a 
degradation profile in Figure 5.4B which is similar to that of the free ODNs. This indicates that the 
EAK-ODN aggregates prepared with EAK16-II at pH 7 do not offer any protection to the ODNs 
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against nuclease. On the other hand, the ODNs which were allowed to form aggregates with EAK16-
IV at pH 7 are also degraded over time (Figure 5.4B), but to a lesser extent than those prepared with 
EAK16-II at pH 7. The reason for EAK16-IV offering a slightly better protection than EAK16-II 





































N A) pH 4
Figure 5.4. The percentage of degraded ODNs in the samples prepared at A ) pH 4, and B) pH 7, as a 
function of incubation time with exonuclease I. Free ODNs (square), EAK16-IV-ODN (triangle), and 
EAK16-II-ODN (circle).   
 
 The apparently weaker protection provided by the EAK-ODN aggregates prepared at pH 7 
could be due to the breakup of the EAK-ODN aggregates under basic conditions. Indeed both EAKs 
bind to the ODNs much more strongly at pH 4 than at pH 7, and EAK16-IV binds more strongly to 
the ODNs than EAK16-II does. To investigate whether the nuclease protection experiments shown in 
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Figure 5.4B could be rationalized according to the binding strength of EAK to the ODNs, the 
following experiments were performed. 8.6 μM of dC16 was mixed with 0.1 mg/mL EAK16-IV at pH 
4 and pH 7. The resulting solutions were centrifuged 30 mins after preparation. The EAK-dC16 
aggregates were collected and resuspended in the pH 9.5 degradation buffer with no exonuclease I. 
The relative UV absorbance change (ΔODr) representing the fraction of ODNs in the aggregates was 














Figure 5.5. Relative UV-Vis absorbance change (ΔODr) as a function of time for the sample obtained 
by resuspending preformed aggregates prepared with 8.6 μM dC16 and 0.1 mg/mL EAK16-IV at pH 4 
(○) and pH 7 (●) in the pH 9.5 buffer used for the nuclease degradation experiments. 
 
Ideally, ΔODr is expected to equal 1.0 at t = 0 since all ODNs should be in the EAK-ODN 
aggregates (pellets). In practice, this was difficult to achieve and the EAK-ODN aggregates were 
recovered with an 85 % yield. Regardless of these experimental errors, the fraction of ODNs 
incorporated inside the EAK-ODN aggregates prepared at pH 7 decreased to 0.05 in one hour. In 
contrast, ΔODr decreased gradually over time for the aggregates prepared at pH 4. Since the decrease 
in ΔODr indicates a breakup of the EAK-ODN aggregates over time, the results shown in Figure 5.5 
demonstrate that the EAK-ODN aggregates prepared at pH 7 dissociate much more easily than those 
prepared at pH 4 when the pH is increased to 9.5. Since the EAK-ODN aggregates prepared with 
EAK16-IV at pH 7 dissociate at pH 9.5, their degradation profile is expected to be similar to that of 
the free ODNs. However, they still provide some protection against nuclease (Figure 5.4B). This 
might be due to the existence of some small EAK-ODN complexes in the solution. These small 
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complexes have been shown to contain a few ODN strands and are too small to be centrifuged out 
(Wang, et al., 2006).  
To obtain the data shown in Figure 5.4, the nuclease added to the solutions of EAK-ODN 
aggregates was inactivated by SDS and the ODNs were released from the EAK matrix by increasing 
the solution pH to 11. Theoretically, the remaining intact ODNs in these solutions should be 
susceptible to nuclease degradation. To confirm this point, the solutions used in Figure 5.4 were 
mixed with 1-octanol to extract SDS. Then exonuclease I was added to the EAK-ODN samples that 
still had some intact ODNs such as those prepared with EAK16-IV at pH 4 and pH 7 and EAK16-II at 
pH 4. The degradation of the ODNs was monitored over time and the results are shown in Figure 5.6. 
Almost all ODNs were degraded in 25 mins, even though the degradation occurred more slowly than 
for the naked ODNs. The slow initial degradation rate may be caused by traces of SDS left in the 
solution which could decrease the activity of the nuclease. Nevertheless, the fact that most ODNs are 
degraded indicates that the ODNs are released from the EAK-ODN aggregates when the pH is 
increased to 11, in agreement with the conclusions drawn from the UV-Vis absorption measurements 
shown in Figure 5.1. Furthermore, the results shown in Figure 5.6 indicate that no EAK-ODN 
complexes remain at pH 11. This is reasonable since EAK is negatively charged at pH 11, which 
prevents its binding to the ODNs due to electrostatic repulsion. This result is different from what 
happens at pH 9.5, where the EAK-ODN aggregates prepared at pH 4 are stable enough to protect the 




















Figure 5.6. Degradation profiles of the ODNs treated with exonuclease I after having been released 
from the EAK-ODN aggregates prepared with Fl-dC16-Rh and: EAK16-IV at pH 4 (▲),EAK16-II at 
pH 4 (●), and EAK16-IV at pH 7 (∆). 
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5.3.3 Stability of the EAK-ODN Aggregates 
The stability of the EAK-ODN aggregates was investigated to determine whether the EAK-ODN 
aggregates retain their structural integrity after being diluted several folds. The ODNs would be most 
likely unprotected and undergo nuclease degradation if dilution of the EAK-ODN solution induces 
the dissociation of the EAK-ODN aggregates. The EAK-ODN mixtures were prepared at pH 4 and 
pH 7. The relative UV-Vis absorbance change ΔODr of these mixtures, which reflects the percentage 
of ODNs in the aggregates, was measured 30 mins after sample preparation. The mixtures were then 
diluted 5 or 10 times with the corresponding buffer solution. The resulting samples were referred to as 
“dilute-5” and “dilute-10”, respectively. The ΔODr values of these diluted samples were monitored 
over time. ΔODr is expected to decrease over time after dilution of the EAK-ODN solutions if the 
EAK-ODN aggregates dissociate. 
A plot of ΔODr as a function of time is given in Figure 5.7A for the “dilute-5” and “dilute-
10” samples obtained from the dilution of the solution containing  0.017 mg/mL EAK16-IV and 8.6 
μM dG16 at pH 4. The ΔODr value of this solution before dilution equaled 0.46 ± 0.01. As evident 
from Figure 5.7A, ΔODr does not change much over time whether the original EAK-ODN solution is 
diluted 5 or 10 times. This experiment demonstrates that the EAK-dG16 aggregates prepared at pH 4 
do not dissociate after dilution. 
The EAK-ODN aggregates were also prepared at pH 7 by mixing 0.08 mg/mL EAK16-IV 
and 8.6 μM dG16 at pH 7. The aggregates were prepared with more peptide since the binding of EAK 
to the ODNs at pH 7 is weaker (Chapter 4). ΔODr of the original EAK-dG16 solution equalled 0.72 ± 
0.01. ΔODr did not change after the solutions were diluted 5 or 10-fold with pH 7 buffer, as shown in 
Figure 5.7B. The data shown in Figures 5.7A and 5.7B suggest that dissociation of the EAK-ODN 
aggregates prepared with EAK16-IV and dG16 at pH 4 or pH 7 is rather small upon dilution of the 
solutions.  
The weak dissociation of the EAK-ODN aggregates is observed not only with EAK16-IV, 
but also with EAK16-II. Figures 5.8A and 5.8B present the ΔODr vs. time for the “dilute-5” and 
“dilute-10” EAK-ODN solutions prepared by mixing 8.6 μM dG16 with either 0.04 mg/mL EAK16-II 
at pH 4 (Figure 5.8A) or 0.1 mg/mL EAK16-II at pH 7 (Figure 5.8B), respectively. No decrease in the 
ΔODr value over time is observed regardless of the pH at which the solutions were prepared. This 
result demonstrates that the EAK-ODN aggregates prepared with EAK16-II at pH 4 and pH 7 are 
stable and do not dissociate. According to the results presented in Figures 5.7 and 5.8, neither a 5- nor 
a 10-fold dilution can induce a break-up of the EAK-ODN aggregates formed at pH 4 and pH 7 over a 
period of at least 17 hrs. 
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B) pH 7 
 
Figure 5.7. Relative UV-Vis absorbance change (ΔODr) over time of the dilute-5 ( ) and dilute-10 (
▧) samples after diluting the EAK-ODN solutions generated by mixing 8.6 μM dG16 with (A) 0.0175 
mg/mL EAK16-IV at pH 4 and (B) 0.08 mg/mL EAK16-IV at pH 7.  
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B) pH 7 
Figure 5.8. Relative UV-Vis absorbance change (ΔODr) over time after diluting 5- ( ) and 10-fold (
▧) the solutions containing 8.6 μM dG16 and 0.04 mg/mL EAK16-II at pH 4 (A) and 0.1 mg/mL 
EAK16-II at pH 7 (B). 
 
The stability of the EAK-ODN aggregates was also studied through a refill treatment 
procedure. The EAK-ODN solutions were centrifuged 30 mins after sample preparation and the 
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supernatant was discarded. The pellets were resuspended with the same amount of fresh buffer. The 
resulting samples were referred to as “refill” samples. 
As shown in Figure 5.9, ΔODr does not change over time for the “refill” samples, regardless 
of the type of peptides or pH value. All ΔODr values range between 0.8 and 1.0.  Ideally, the fraction 
of ODNs in the aggregates for the “refill” samples should equal unity at time zero if no dissociation 
of the aggregates occurred, given that only EAK-ODN aggregates were collected to prepare the 
“refill” samples. ΔODr values for the “refill” samples were found to be smaller than 1.0, ranging from 
0.85 to 0.95 at time zero. This is certainly due to experimental errors introduced during the delicate 
centrifugation/supernatant removal steps. Nevertheless the absence of decrease for ΔODr in Figure 
5.9 over 20 hrs together with the data shown in Figures 5.7 and 5.8 suggest that the EAK-ODN 














Figure 5.9. Relative UV-Vis absorbance change (ΔODr) over time after refilling the solutions of 
EAK16-IV-dG16 at pH 4 (×), EAK16-IV-dG16 at pH 7 (□), EAK16-II-dG16 at pH 4 (*), EAK16-II-
dG16 at pH 7 (○), EAK16-II-dC16 at pH 4 (+), and EAK16-II-dC16 at pH 7 (∆). 
5.4 Summary 
In this work, the nuclease resistance of oligonucleotides against E.coli exonuclease I afforded by the 
protection of a peptidic matrix generated by two self-assembling peptides of the EAK family at pH 4 
and pH 7 was investigated using FRET. The results demonstrate a remarkable increase in nuclease 
resistance for the ODNs mixed with EAK16-II or EAK16-IV at pH 4. However, the protection 
 119 
Chapter 5   
provided by these EAKs when the EAK-ODN aggregates are prepared at pH 7 is much lower than 
that at pH 4. UV-Vis absorption measurements show that the EAK-ODN aggregates prepared at pH 7 
dissociate more easily than those prepared at pH 4 when the pH of the solution is raised to pH 9.5, the 
pH at which exonuclease I is active. These results suggest that the ability of the EAK-ODN 
aggregates to protect the ODNs depends on their structural integrity after being incubated with 
nuclease solution, and that a correlation exists between the efficiency of EAK-ODN aggregates at 
protection the ODNs and the binding strength of the EAK peptides to a given ODN.  
The stability of the EAK-ODN aggregates after dilution was determined by UV-Vis 
absorption over time. The aggregates are found to be stable, undergoing no detectable dissociation 
over 20 hrs after the solutions are diluted 5- and 10-fold in the same buffer used for their preparation. 
The EAK-ODN aggregates are also shown to remain stable after the refill treatment. 
The results of this work imply that the self-assembling peptides might be appropriate 
candidates for gene delivery, able to protect the ODNs from nuclease degradation in vitro and in vivo.  
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Conclusions and Recommendations 
6.1 Conclusions 
This thesis presents the first comprehensive study of the binding of self-assembling peptides to 
oligodeoxynucleotides (ODNs) and of the characterization of the resulting complexes/aggregates. A 
methodology has been successfully developed to quantitatively describe the binding of peptides to the 
ODNs into peptide-ODN aggregates. The effects of pH, charge distribution along peptides and 
oligonucleotide sequence on the peptide-ODN binding have been investigated by using different EAK 
self-assembling peptides, ODNs, and pHs. The size, ODN protection ability, and stability of the 
resulting complexes/aggregates were characterized by a series of physicochemical methods. Since 
formation of carrier-gene complexes is the fist step in the formulation of a gene delivery system, the 
detailed studies conducted in this thesis on peptide-ODN binding are expected to enable the 
development of strategies to control the formulation of peptide-DNA complexes and demonstrate the 
high potential of self-assembling peptides for gene delivery. 
Self-assembling peptides bind to ODNs and form aggregates, which can be centrifuged out, 
as demonstrated by UV-Vis absorption and fluorescence anisotropy measurements in Chapters 3 and 
4. This feature makes it possible to use UV-Vis absorption and centrifugation to obtain the fraction of 
ODNs incorporated in the EAK-ODN aggregates as a function of peptide concentration. The UV-Vis 
absorbance results were then analyzed with a binding density function to generate the binding 
isotherms, from which the binding parameters are extracted with the McGhee and von Hippel model. 
Some unique challenges were encountered in the characterization of the binding process of EAK 
peptides to the ODNs due to the potential for self-assembly of the peptides into nanostructures. 
Fluorescence anisotropy and static light scattering experiments in Chapters 3 and 4 demonstrated that 
the binding process of EAKs to the ODNs starts with the molecular complexation of individual EAK 
and ODN molecules, followed by the association of the complexes into aggregates. The remaining 
results obtained in this thesis are summarized as follows. 
In Chapter 3, UV-Vis absorption, fluorescence anisotropy, and PAGE experiments 
demonstrated that at equilibrium, the EAK-ODN solutions contain free EAK, free ODNs, small EAK-
ODN complexes which can not be centrifuged out, and large aggregates which are collected in the 
pellets after centrifugation of the solution. Equilibrium binding studies show that binding of EAK16-
II to different ODNs at pH 4 is stronger than at pH 7, and that no binding occurs at pH 11. Binding 
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constants decrease 5-8 folds when the pH changes from 4 to 7. This result demonstrates that 
electrostatic interactions play an important role in the EAK-ODN binding because EAK16-II 
becomes less positively charged as pH increases. In addition, hydrogen bonds might promote the 
binding of EAK16-II to dG16 to a greater extent than that of EAK16-II to dC16. The size of the 
resulting EAK-ODN aggregates measured by AFM and DLS ranges from a few hundreds of 
nanometers to several micrometers. The accessibility of the ODNs to the quencher is reduced by 40 % 
after binding to EAK16-II.  
EAK16-IV, another member of the self-assembling EAK peptide family, shows some 
similarities to EAK16-II when it binds to the ODNs, as illustrated in Chapter 4. EAK16-IV binds to 
the ODNs more strongly at acidic than at basic pH. EAK16-IV also binds more strongly to dG16 than 
to the other ODN sequences studied in this thesis. The size of the EAK-ODN aggregates depends on 
the molar ratio of peptides to the ODNs. The accessibility of the ODNs to the quencher is reduced 
after binding to EAK16-IV. In particular, the charge distribution along peptides is found to have an 
effect on the binding. EAK16-IV, whose positively charged residues are clustered at one end of the 
peptide, binds to the ODNs more strongly than EAK16-II, whose positively charged residues are 
distributed throughout the peptide, at a same pH and for a given ODN sequence. In addition, the 
accessibility of the ODNs in the aggregates to the solvent is more strongly reduced upon binding to 
EAK16-IV than to EAK16-II.  
The reduced accessibility of the ODNs described by the fluorescence quenching experiment 
is expected to prevent the nucleases from approaching the ODNs in the aggregates, and thus to protect 
the ODNs from degradation. In order to prove this, oligonucleotides complexed with EAK were 
incubated with E.coli exonuclease I to determine the level of protection afforded by the peptidic EAK 
matrix. The results of this study were described in Chapter 5. A remarkable increase in nuclease 
resistance for the ODNs mixed with EAK16-II or EAK16-IV at pH 4 is observed. However, the 
ODNs are protected to a much lower degree when the EAK-ODN aggregates are prepared at pH 7. 
The EAK-ODN aggregates prepared at pH 7 are found to dissociate more easily than those prepared 
at pH 4 when they are incubated with exonuclease I solution at pH 9.5. These results suggest that the 
ODN protection afforded by the EAK-ODN aggregates depends on their structural stability after 
being incubated with the nuclease solution, which correlates to the binding strength of the EAK 
peptides to the ODNs. The stability of the EAK-ODN aggregates after dilution was determined by 
UV-Vis absorption over time. The aggregates undergo no detectable dissociation over 20 hrs after the 
solutions are diluted 5- and 10-fold in the same buffer used for their preparation. The EAK-ODN 
aggregates remain stable after solutions are centrifuged, and the supernatant is discarded and replaced 
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by fresh buffer solutions. All in all, this thesis has demonstrated the potential of EAK self-assembling 
peptides at forming highly stable complexes that can protect ODNs from degradation by nucleases.  
 
6.2 Recommendations 
The binding isotherms generated in this thesis use the UV-Vis absorbance of the supernatants of the 
EAK-ODN solutions. This study has also shown that fluorescence anisotropy increases upon binding 
of the peptides to a fluorophore-labeled ODN. Since fluorescence anisotropy is a common method to 
study the binding of a ligand to a substrate (Arosio, et al., 2004), it can be used as an alternative 
technique to construct the binding isotherms by monitoring the changes in anisotropy as a function of 
peptide concentration for constant ODN concentrations. In so doing, the results obtained by UV-Vis 
absorption could be strengthened. 
In Chapter 3 and Chapter 4, the rhodamine dimer present in the supernatants of EAK-ODN 
mixture solutions indicates the existence of EAK-ODN complexes, which are too small to be 
centrifuged out. However, none of the other techniques, such as PAGE and steady-state anisotropy 
were able to detect the presence of complexes. Therefore, it will be good to have additional 
experiments to demonstrate the formation of complexes. One option is to label the ODNs with a 
fluorescence donor and EAK with an acceptor, and then to monitor the FRET change after mixing 
relatively low concentration of EAK and ODN. Another option would be use time-resolved 
anisotropy, which reflects the species with different sizes. The percentage of each specie could be 
quantified.  
The current binding study has shown that the self-assembling peptides have some of the 
desired features expected for oligonucleotide carriers, such as conferring ODN protection and 
undergoing slow dissociation from the ODNs after many folds dilution. However, the morphology of 
the peptide-ODN complexes together with surface features, such as charges or hydrophobicity, may 
affect where the ODN is being delivered in vivo and ultimately influence the ability of the delivery 
system to reach the target site (Simeoni, et al., 2003). Thus, it becomes important to investigate these 
physicochemical properties as well. The morphologies of the EAK-ODN aggregates prepared at 
different ratios of peptide-to-ODN can be investigated by atomic force microscopy. The surface 
charges of the EAK-ODN complexes/aggregates can be investigated based on zeta potentials 
measured by electrophoretic light scattering. The surface hydrophobicity can be examined by surface 
tension measurements (Adamson and Gast, 1997). 
The EAK-ODN aggregates have been shown to protect the ODNs from exonuclease I 
degradation in the current study. However, there are numerous other nucleases in any biological 
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system. For the EAK-ODN complexes to be a useable gene delivery system, it is necessary to 
investigate whether the EAK matrix can protect the ODNs from degradation against different 
nucleases. This can be done by studying with FRET the nuclease resistance of the ODNs provided by 
the EAK-ODN aggregates in cell culture medium containing serum.  
The ODNs used in the current study, containing hexadecamer cytosine or guanine only, are 
more homogenous than the antisense oligonucletides typically used. In order to use the EAK self-
assembling peptide to carry oligonucleotides, it is important to extend the current studies to real 
antisense oligonucleotides, which can be chosen based on a particular disease target.  
Once the peptide-ODN aggregates with ODN protection have been constructed, one must 
examine whether these constructs can enhance the cellular uptake of the ODN cargoes, which 
together with rapid ODN degradation are two major challenges in the gene delivery. The cellular 









A.  Resolution Limit of Fluorescence Anisotropy Measurement 
To evaluate the resolution limit of fluorescence anisotropy, the anisotropy of mixtures of 1 μM of 
FAM-labeled dC16 and EAK with concentrations ranging from 0 to 6 μΜ at pH 4 was measured 30 
mins after sample preparation without centrifugation. Samples were excited at 452 nm and the 
fluorescence intensity was monitored at 514 nm (the peak of the FAM-dC16 emission spectra). The 
percentage of dC16 bound to EAK was calculated at each EAK concentration from the binding 
parameters obtained from the MvH model, Equation 3-5. 
The fluorescence anisotropy of FAM-dC16 is shown in Figure A (empty circle) as a function 
of EAK concentration at pH 4. The error bars in Figure A represent the standard deviation obtained 






























Figure A. Anisotropy (○) and the calculated percentage (■) of the FAM-dC16 in aggregates upon the 
addition of EAK. 
 
Although the MvH model is not suitable to describe the two-step kinetics, it was found to fit 
the experimental data shown in Figure 3.2 very well. Thus, it was used to calculate the fraction of 
ODNs in the aggregates given in Figure A (solid squares). The anisotropy increases from 0.11 to 0.14 
as the fraction of the ODN in aggregates increases from 0 to 9 mol%. This result demonstrates that 
the presence of 10 mol% of the ODNs in aggregates will be detected by fluorescence anisotropy. 
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B.  AFM images of dG16 and EAK at pH 4.  (A) 0.1 mg/mL EAK after 45 minutes; (B) 1.6 μM 
dG16 after 45 minutes; the experimental conditions were described in the Experimental Section 
of Chapter 3.  No EAK-ODN aggregates were observed, especially in the form of fibers. 
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